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Natural materials and antimicrobial compounds for wound management are 
present in human history for over 5,000 years. Traditional wound dressings 
have become inefficient against bacteria and fungi due to increased usage 
of antibiotics and creation of antibiotic resistant strains.  Electrospinning is a 
method of creation of nanofibrous materials which gained much attention in 
the last two decades. Combination of electrospun nanofibers with its ability 
to ensure sufficient strength, support for cells and unique culture 
environment are ideal materials for modern advanced wound management 
techniques. Nanofibrous materials are characterized by very large surface 
and porous structure what enhances growth and proliferation of cells.  Silver 
as antimicrobial material have been used for centuries in various forms and 
application methods. Progress in biosciences, biotechnology and 
nanotechnology revealed some of the unique properties of silver in nanosize 
form and explained some questions about mechanism of interaction between 
silver nanoparticles and living organisms. In recent years’ number of 
published literature, in which silver nanoparticles were used to induce 
antimicrobial properties led to commercialization of some silver incorporated 
wound dressings. Perovskite material which is being evaluated in this work, 
is layered perovskite structure in which some of the atoms of sodium have 
been replaced with silver in order to introduce antimicrobial properties with 
minimal toxicity. In this work, Na2La2Ti3O10 Perovskite have been 
synthesized by solid state synthesis method and substituted with Ag atoms 
in order to create Ag0.3Na1.7La2Ti3O10 perovskite particles. Novelty in terms 
of antimicrobial behavior and small cytotoxicity have been reported for 
XIII 
 
perovskite powder in substituted form. In order to enhance properties of 
those two antimicrobial agents, they have been incorporated into polymeric 
biodegradable matrix from Poly(lactide-co-glycolide) also known as PLGA. 
Incorporation of inorganic particles into polymeric nanofibers is very 
promising method of creation of new, efficient and applicable wound 
dressings. Introduction of silver and perovskite material into polymeric 
structure of nanofibers had an aim to utilize best properties of those two. 
Microstructure of nanofibers and its high free surface energy is ideal for 
proliferation and excretion of extracellular matrix from living cells. Also 
temporary scaffolds for cells growth can greatly enhance healing process 
and provide support for wound to heal in natural manner. Addition of 
antimicrobial agents into polymeric structure, limits drawbacks of traditional 
dressings and limits risk of infection what is critical in wound management. 
Prepared novel wound dressings were investigated to measure their 
microstructure, mechanical strength, cytotoxicity and antimicrobial 
properties. Finally, creation of those fibers on spot without a need of 
packaging and storage of dressing materials, have been presented in the 
form of design of portable electrospinning device. Possibility to cover wound 
with nanofibrous antimicrobial dressings without limitation on size and 
shape, have a great potential to improve healing process as well as increase 
patients’ comfort. This research work summarizes our findings in market of 
modern advanced wound dressing with suggested new methods of dressing 
application and gives a reader understanding about advanced wound 
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Wound management for centuries was based on simple methods to keep 
wound clean, remove excessive amounts of secretions and dressing wounds 
in order to limit infection. Healing process was left to its natural course. This 
approach is still main way of treating wounds and it will not change until new 
active dressings (antimicrobials, hydrogels, drug release dressings etc.), 
become economically feasible. [1] Although traditional adhesive bandages 
represent very significant share of the market with $3.5 billion annual 
revenue and it is expected to grow significantly slower than other solutions 
in the following years, new technologies are emerging and will be cutting 
more and more significant shares of the market in the following decade. 
Projections shows that traditional bandages market will grow around 2% 
annually in the years 2012-2020, when negative pressure wound therapy, 
antimicrobial dressings and hydrocolloids will reach 6-10% growth, 
overtaken by bioengineered skin & skin substitutes and alginate dressings 
with expected growth rate of 14-16%. Growth factors as wound healing 
method is estimated to grow up to 30% annually. In 2013 antimicrobial 
dressings had 11% of global wound care market and was placed third 
biggest segment in this field [2]. Treatment of complicated wounds is still 
expensive and troublesome with estimated cost of treatment of ulcers or 
deep tissue injury of $43,180. Additionally, infections occurred during 
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hospital treatment becomes more frequent and increase need of 
hospitalization up to three times. [3] 
Chronic wound can be defined as wound that does not heal in predictable 
amount of time with inflammatory state occurring for too loo long. Main cause 
of remaining in this stage is bacterial colonization with or without creation of 
biofilm. In general, bacterial colonization cause damage of the surrounding 
tissue by recruiting greater number of neutrophils as well as excretion of toxic 
metabolic waste. Chronic wounds affect around 6.5 million people every year 
what causes a great need for novel materials for prevention or treatment. 
Existing limitations in treatment of this kind of wounds call for new materials 
for chronic wounds treatment.  
1.2 Motivation   
Wound dressings are wide group of materials in health care. Placement and 
stage of the wound plays an important role in choosing correct way of 
treatment and wound protection. Despite the initial cause, all wound go 
through a stage of naturally occurring inflammation stage which may be 
prolonged if number of bacteria present within the wound boundaries is 
greater than 1 x 106 per gram of tissue. [4] If bacteria colonization occurred 
and wound closure is impaired, chronic wounds are defined as wound in 
which have failed to proceed through natural process in order to restore 
normal functional and anatomic function over a period of 3 months. [5] Active 
compounds in order to reduce bacteria growth have been investigated and 
introduced to wound management, nevertheless those products are not very 
popular and used only in specific cases. [6, 7] 
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PLGA is co-polymer approved by FDA for specific applications. Among other 
medical polymers it has unique advantage of controllable biodegradability. 
Ratio of lactide (LA) to glicolide (GA) monomers within polymeric chain 
allows to control time of degradation of the material. So far PLGA was 
successfully used for surgical sutures, interference screws, suture anchors, 
clips, vascular closure devices, pins, rods, staples, surgical meshes or denal 
tissue restoration for more than 30 years. It is nowadays widely investigated 
in tissue engineering field for usage in reconstruction or replacement of bone 
tissue [8], functional arteries [9], drug delivery systems [10] etc.  
Silver in form of nanoparticles possess widely known antimicrobial properties 
due to very large surface area form which release of silver ions may occur. 
Due to this phenomenon smaller particles shows higher antimicrobial 
properties. [11] On the other side, smaller silver particles showed increased 
cytotoxicity with results showing that particles smaller than 10 nm may 
significantly increase cytotoxicity of the material. [12, 13] Additional, 
concentration of silver ions may cause toxic response from surrounding 
cells.[14] Therefore, concentration of silver nanoparticles needs to be 
carefully chosen before application. 
Perovskite materials are being currently intensively investigated by a number 
of researchers as a new material for more efficient solar cells. Layered 
structure of perovskites allows to modify it in a number of ways with a number 
of atoms or structures which enhances properties of this material. In layered 
perovskites atoms can be substituted with other atoms with similar diameter 
and released when needed. This suggests that silver ions may be 
incorporated into perovskite structure introducing antimicrobial properties to 
5 
 
whole material. Perovskite structure of material shows also less cytotoxicity 
in some cases. [15]  
Nanofibrous materials are good candidate for novel wound dressing due to 
its unique properties and ability of incorporation of various artificial or 
biological compounds to enhance its properties. [16] Nanofibers in addition 
to providing mechanical support, suitable porous microstructure or nutrients 
permeability, allows to modify its surface or bulk with various other nano 
compounds. Addition of biological agents like growth factors, proteins, 
nutrients or various particles creates specific drug eluting system which can 
recruit cells to the wound area or release active antimicrobial protection. [17] 
In general, creation of active antimicrobial materials is an attempt of release 
wound during natural healing process from excessive bacteria colonization 
with maintaining optimal environment for newly created cell as well as 
ensuring efficient removal of secretion produced by wound. Lack of microbes 
or fungi within wound boundaries and optimal environment enhances cell 
growth, and restore skin normal function. So far nanofibrous materials for 
wound regeneration have been produced form various materials including: 
natural polymers like type I collagen [18] or cellulose [19], hyaluronic acid 
[20] or synthetic: poly(vinyl alcohol) (PVA) [21], poly(ε-caprolactone) [22] or 
polyurethane [23]. Wide range of materials that can be successfully 
electrospun and use as wound dressing brings a question how those 
materials could be effectively and economically applied to wound site. 
Portable electrospinning device may be a good solution for application of 
nanofibrous wound dressings with various sizes and shapes directly onto 
skin what allows for preparation solutions of polymer and biological agent 
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with short storage capabilities or usage of minimal amount of material without 
lost. [24]  
As such nanomaterials in fibrous form with antimicrobial agents with its 
microstructure and properties are interesting candidates for novel medical 
materials as well as tissue engineering and regenerative medicine.  
1.3 Thesis Objectives and Hypothesis 
1.3.1 Objectives 
a) To fabricate electrospun nanofibrous mats from PLGA polymer 
incorporated with silver nanoparticles via electrospinning process, 
that meet suitable mechanical properties, cytotoxicity and 
antimicrobial properties. 
 
b) To synthesize layered perovskite material and substitute sodium ions 
within crystallographic structure with silver ions, in order to introduce 
antimicrobial properties to the material. 
 
c) To incorporate prepared perovskite material within PLGA nanofibrous 
matrix in order to obtain mechanically feasible nanocomposite with 
antimicrobial properties with minimal cytotoxicity.  
 
d) To design a device capable to create and apply nanofibrous mats 







Electrospun biodegradable nanofibers with antimicrobial agents can be used 
safely as novel wound dressings with sufficient mechanical strength and 
biochemical properties in order to enhance the natural wound healing 
process. 
a) A biodegradable polymer and silver nanoparticles can be successfully 
combined and used in form of nanofibrous mat and support wound 
closure and healing process with minimal amount of bacteria present 
within wound area. 
 
b) Synthesis of layered perovskite with substituted sodium ion with silver 
ion within crystallographic structure, enhances antimicrobial 
properties of material and limits its cytotoxicity. 
 
c) A biodegradable polymer and perovskite particles can be successfully 
combined and used in form of nanofibrous mat and support wound 
closure and healing process with minimal amount of bacteria present 
within wound area. 
 
d) Portable electrospinning device may be used to cover any surface 
with nanofibrous mesh including human skin in order to create thick 








2.1 Wound types classification and wound management 
Wound management is a part of medical field, dealing with methods and 
guidelines of applying of dressings in appropriate manner, and maximizing 
chances of full recovery after injury, burn or surgical intervention. In-depth 
understanding of wound origin and cellular mechanism of healing of specific 
injuries is essential to design and execute suitable treatment method. In 
general wounds are being divided into a number of groups based on its origin 
and subclasses based on its severity.     
2.1.1 Surgical wounds 
Surgical wounds are being intentionally created when skin is cut during 
surgery. Depending on the type of surgery initial incision is stitched or not, 
nevertheless risk of infection is still relatively high and was reported for 5% 
of all surgical procedure and can be as high as 30-40% of patients after 
abdominal surgery. This complications increase length of stay in the hospital 
and increases significantly costs of patients’ stay. In the United Kingdom 
surgical site infections increase cost of care between $814 up to $16 000. 
[25, 26] According to the Centers for Disease control and Prevention, since 
1985 surgical wounds can be classified as: [27-29] 
2.1.1.1 Class I: Clean 
 Refers to uninfected operative wound in which no inflammation was 
reported and urinary tracts, gastrointestinal tract (GI) and genital organs are 
not affected. In case of class I wound risk of infection is lower than 2%. 
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Surgical procedures in which class I wounds are created as an outcome 
include:  lumpectomy; mastectomy; axillary node dissection; vascular bypass 
graft; exploratory or diagnostic laparoscopy; adhesion lysis; exploratory 
laparotomy; ventral, inguinal, femoral, or incisional hernia repair. 
2.1.1.2 Class II: Clean/contaminated 
Occurs when wound enters the respiratory, GI, urinary or genital tract under 
controlled conditions. No contamination and no infection or major break is 
present in this kind of wounds. Risk of infection lies between 5-15%. 
Examples of procedures include: cholecystectomy with chronic 
inflammation, colostomy reversal, colectomy, bowel resection for ischemic 
bowel, roux-en-Y gastric bypass, laryngectomy, incidental or routine 
appendectomy, abdominal perineal resection, gastrostomy tube placement.  
2.1.1.3 Class III: Contaminated  
Relates to accidental wound from surgery with a major break in sterile 
procedure. It occurs when unintended spillage from GI tract is present. Non-
purulent inflammation is present (including dry gangrene). Those wound 
brings risk of infection on level of more than 15%. Class III wounds needs to 
be treated seriously as they carry risk of sepsis. Procedures which may lead 
to creation of this wounds include: cholecystectomy or appendectomy for 
acute inflammation, cholecystectomy for acute inflammation, bile spillage 
during cholecystectomy, open cardiac massage. 
2.1.1.4 Class IV: Dirty/infected 
Most dangerous kind of surgical wounds may be present in old traumatic 
wounds with retained devitalized tissue and within procedures with existing 
clinical infection. Risk of infection is greater than 30%. Most reports of this 
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type of wounds are correlated with following procedures:  incision and 
drainage of perforated peritonitis, bowel repair, and appendectomy with 
perforation and/or pus noted, perirectal abscess, perforated gastric ulcer, 
and ruptured appendectomy.  
Surgical site infections (SSI) are very hard to treat and requires extension of 
in-patient care. Up-to-date there is no one single document which would 
create standard procedures to prevent and treat SSI due to very big 
disproportion of medical care systems around the world as well as various 
microorganisms around the world which may lead to SSI. Therefore, some 
institutions are publishing their guidelines based on experience in minimizing 
risks of infection. Those guidelines focus on all aspects of patients’ 
preparation, equipment sterilization techniques, preparation of surgical field, 
surgical attire and drapes identification of potential risks during procedure as 
well as ventilation systems and use of specific antibiotics suitable for specific 
surgical procedure. [30] Moreover in-depth analysis of SSI cases showed 
that species of pathogens remained relatively stable over last 10 years, there 
is growing number of SSIs’ which are caused by antibiotic-resistant bacteria 
and fungi. [31] Also it is important to note that pathogens isolated from SSI 
tends to be originating from the endogenous flora of the operated organ, and 
those pathogens are mostly gram-negative bacilli and anaerobes. [32] When 
SSI originate from outer source than patients body like instruments, 
members of the surgical team or materials, isolated strains are mostly gram-
positive staphylococci and streptococci strains. Because of above treatment 
such a wounds may be complicated due to presence of a number of bacteria 
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and fungi strains as well as a need to identify all microorganisms in order to 
implement treatment procedures. [33, 34]  
2.1.2 Burns 
Burns are constantly challenging medical professionals around the world as 
this is the most common injury with around 11 million burns reported annually 
by World Health Organization in 2014. Out of this enormous amount of burn 
victims 265 000 deaths annually. WHO also reports that cost of treatment of 
children in US only exceeded $210 million in year 2000, and $10.5 million in 
Norway in 2007. [35] Burn is defined as damage of tissues caused by the 
contact with heat, flame, electricity or radiation. Burns may be divided based 
on factor that caused it (thermal, cold exposure, chemical burns, electrical 
burns, inhalation and radiation burns), and by burn depth (superficial, partial-
thickness, full-thickness, fourth degree burns). [36] Based on depth of the 
burn it is being classified as: [37] 
2.1.2.1 First-degree burn 
Affects only epidermis or outer layer of the skin. It is characterized by lack of 
presence of blisters; dry, red skin surrounding tissue and mild pain. It is 
mostly caused by mild sunburn, flash burn or contact with small amount of 
irritating agent. It is normally treated by cold compresses, ibuprofen or lotion 
application.  
2.1.2.2 Second-degree burn 
In this case epidermis and part of dermis layer in skin is affected by burn. 
Site becomes irritated, red, blistered and swollen. Second degree burns are 
mostly caused by prolonged contact with hot object, sunburns, electric 
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shock, chemicals or scald injuries. Treatment involves antibiotic ointments, 
frequent dressing changes and daily cleaning.  
2.1.2.3 Third-degree burn  
Also called full-thickness burn. Occurs entire outer layer of the skin and inner 
layer of the dermis was affected at the time of burn injury. Potential injuries 
which may result in third-degree burn involves: a scalding liquid, an electrical 
source, a chemical source and flames from a fire. This is the most difficult 
burn to heal as protective layer have to be applied in order to protect newly 
formed skin tissue from infections. Dry and leathery skin; black, white, brown 
or yellow skin; swelling and lack of pain due to nerve endings devastation 
are the most visible signs of third-degree burn. Those burns are being treated 
with intravenous fluids containing electrolytes; oral and intravenous 
antibiotics; pain medications and skin grafts to achieve closure of the 
wounded area.  
Advanced wound management techniques have to applied to patients which 
has significant amounts of body covered with third-degree burns what will be 
an aim of subsequent chapters.  
2.1.3 Injuries 
Beside surgical wounds and burns, wound dressings are being used in wide 
range of accidental injuries which was described in The International 
Statistical Classification of Diseases and Related Health Problems (ICD-10, 
chapter XIX). [38] This document describes a number of possible external 
and internal injuries (classified in ICD-10 as S00-T98). Objectives of wound 
dressings in acute trauma treatment include: reduction of pain; applying 
compression for hemorrhage or venous stasis; immobilization of an injured 
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body part; protection of wound and surrounding tissue and to promote moist 
wound healing. Based on type and placement of injury (internal or external) 
wound dressings should be adjusted to fulfil specific support (mechanical, 
absorptivity, antimicrobial properties), therefore mechanical wounds have 
been divided to: abraded wound (volnus abrasmus), punctured wound (v. 
punctum), incised wound (v. scissum), cut wound (v. caesum), crush wound 
(v. contusum), torn wound (v. lacerum), bite wound (v. morsum), shot wound 
(v. sclopetarium). [39] 
2.2 Wounds healing process 
Wound healing process depends on site of the wound, its depth and type of 
the injury that occurred. It is very complicated process related to normal 
growth and regeneration of tissue. In general, whole process is divided into 
four phases: homeostasis, inflammation proliferation and maturation. Those 
phases are overlapping each other and various cells are being recruited to 
the site of the injury during subsequent stages. [40] Detailed heling process 




Figure 2.2.1 Structure of wound healing process within specified timeline. 
Taken with permission from Elsevier. [41]. Copyrights © 2007 Elsevier Inc.  
 
When skin is injured, first visual symptom is usually internal or external 
bleeding which flushes out bacteria and recruits’ fibrinogen as clotting factor. 
Fibrinogen is converted into fibrin and creates specific mesh type structure. 
Pellets play an important role in this process as these blood elements are 
being “grabbed” and fixed by fibrin what creates impermeable clot and finally 
scab which acts as support and provides strength for surrounding tissues. 
[42] When blood loss is reduced homeostasis phase ends. Simultaneously 
inflammatory phase starts within couple of minutes from injury and lasts for 
about 3 days. Roughly, it can be described as cellular and vascular response 
to injury. Protein-rich exudates released during this phase cause 
vasodilatation and release of histamine and serotonin within healing area. 
Those two proteins help phagocytes to remove dead cells (necrotic tissue). 
Decomposition of dead cells due to enzymatic reactions, produces yellowish 
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mass called slough. [43] Migration phase involves recruiting fibroblasts and 
epithelial cells into wound area in order to repair damaged tissue. 
Regeneration starts from sides of the wound and progress toward its center 
by rapidly growing epithelial cells. This process increases wound thickness 
as scab is being pushed outside by growing tissue. Almost instantly 
proliferation phase starts where capillaries and lymphatic vessels grows into 
the wound. Granulation tissue created in this phase is supporting synthesis 
of various types of collagen by fibroblasts. End of this process (usually by 
day 5) is final step to ensure safety of wounded area. Final phase, named 
“remodeling phase” or maturation is a long process in which some parts of 
newly formed granulation tissue is replaced by fibrous scar tissue. 
Rearrangement of collagen in this phase increases scar tensile strength and 
takes place within weeks up to years after injury.  
2.3 Wound management procedures. 
Inflammation is natural healing process present in all types of injuries, 
scheduled surgical procedures including implantations and transplantations. 
Per contra infection occurs when wound is being colonized by significant 
number of microorganisms. This process can be predicted, assessed and 
prevented beforehand, saving patient from unnecessary complications. In 
extreme cases infection can spread and may cause whole-body 
inflammation called sepsis or lead to necessity of removing infected tissue, 
organ or whole limb. [44] Preventing, or when necessary, managing 
infections is very wide area of interest of clinical practitioners. All wounds are 
instantly colonized by bacteria which occupies skin, or in case of scheduled 
surgery, by bacteria that survived standard sterilization process or colonized 
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wound afterwards. Typically, infection occurs when amount of 
microorganisms exceeds 105 per gram, but in case of more aggressive 
bacteria strains less amount may be sufficient. Microorganisms cause 
damage to healthy tissues, either by their presence or by excretion of 
poisonous substances (endo and exotoxins). Figure 2.3.1 describes 
subsequent stages of bacterial load leading to clinical consequences.    
 
Figure 2.3.1. Severity of clinical signs of contamination: “The bacterial load 
escalator”. 
 
As shown, bacteria colonization is always present in every kind of open 
wound. If initial contamination is not treated or patients’ immune system is 
not able to fight excessive amounts of bacteria, colonization of surrounding 
areas initiates. Simple acute wounds may become chronic wound when 
biofilm is created and simple contamination is transformed into chronic 
wound. Factors influencing chronic and acute wounds are being described 
in section 2.3.1 and 2.3.2. 
 
2.3.1 Acute wounds 
Acute wounds affect around 11 million people every year with around 
300,000 hospitalized yearly in U.S. [45, 46] In normal conditions acute 
wound heal by itself with just minimal support and creates healthy scar tissue 
when collagen type III is converted to collagen type I. Assessment of acute 
wounds is being normally done after hemorrhage has been taken off. 
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Primary goals for successful wound care are focused on attaining closure, 
decrease risk of infection, and minimize scar formation. It should be 
mentioned that acute wound with hemorrhage bigger than 10% of the body 
surface are being considered as life-threatening and at initial stage, blockage 
of fluid loss is crucial. Risk factors for local or systemic infection are 
increased age, increased laceration width, wound contamination, diabetes 
or presence of foreign body. Analysis of wound management procedures 
and time of wound closure, done by Berk and Lammers showed that 6-10 h 
is appropriate time-frame for extremity laceration repair, and 10-12 h for the 
more vascular face and scalp. [47, 48] In case any kind of debris will get into 
the wound, it may act like infectious nidus and toxic contaminant. Based on 
level of contamination, wounds like this should be left open or cleaned 
surgically. Leaving debris inside closed wound significantly increases risk of 
developing an anaerobic infection. [49] Based on analysis of 1,142 cases, 
risk of developing infection is the highest after injuries of thigh/leg (23.0%), 
arm/forearm (15.3%), foot/toe (12.5%) or chest/abdomen (11.8%). [48] 
Overall risk of infection in this group was 7.2%. Acute wounds cleansing 
includes three techniques: compresses, irrigation, and soaking. 
Compresses, are used in order to remove surface debris and improve 
moisture balance. If surrounding tissue is dry, compresses are often soaked 
in water to moisture the wound. [50] When compress is dry there is a high 
risk of sticking of textile to wound which may cause severe pain during 
application and removal. Other drawback of compression method is that risk 
of infection rises if faulty technique of application of compresses is used. 
Wound irrigation is other method of cleansing the wound, nevertheless 
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irrigation pressure is often cited in the literature for complicated chronic 
wounds. Traditional equipment used for wound irrigation include syringes, 
syringes with nozzles or catheters, containers with nozzles or pressure 
containers. Recently more equipment is used to clean wounds as control of 
pressure reaching wound is still not very clearly defined in traditional 
procedures. [51] The last method called soaking is simply immersion of 
wound in solution and application of wet cloth or gaze, which allows hydrating 
the wound and physically removing debris from it. On the other hand, it may 
cause disruption of moisture balance, maceration of tissue and introduce 
some bacteria strains from immersion fluid. Low to medium tension wounds 
can be sutured by percutaneous sutures like monofilament sutures from 
nylon and polypropylene. Low tension wounds are closed with surgical strips 
and must be closed also with other method. Surgical glues are very 
comfortable for patients with minimal pain and are fast to apply, when more 
advanced tissue adhesives are most suitable for non-mucosal facial wounds. 
Most of high tension wounds should be closed in two layer by absorbable 
sutures like polydioxanone (PDS), polyglicolid acid (Dexon-Plus), or 
polyglactin 910 (Vicryl). [52] As shown in this part, there is no gold standard 
when it comes to management of acute wounds, as all cases should be first 
analyzed and evaluated by skin specialist.  
2.3.2 Chronic wounds 
Chronic wounds are more complex than acute wounds because in this case 
natural healing process is disturbed by debris, age and health of patient or 
other factors. Chronic wound by definition is a wound that failed to produce 
anatomic and functional integrity over the period of 3 months. [53] In is 
19 
 
estimated that 1% of population will develop chronic wound of some sort 
during lifetime. Cost of treating those wound in U.S. is estimated to be $5 
billion to $10 billion every year, with amount of patients 3 to 6 million 
annually. Each wound can be potentially transformed to chronic wound, and 
traditionally they are divided by etiology of initial wound. The most common 
chronic wound encountered by physicians is lower extremity ulcer, vascular 
or diabetic in nature, accounted for 98% of all lower extremity wounds. [54] 
On the cell level, chronic wounds are characterized by premature, senescent 
and not responsive to stimulation fibroblast with differentiated phenotype. 
[55] Chronic wound environment rich in pro-inflammatory cytokines and 
inflammatory products leads to imbalances in metalloproteases which results 
in destruction of extracellular matrix. Standardized clinical treatments in this 
case include: wound bed preparation (debridement, moist wound bed, 
bacterial load); surgical interventions (skin grafts, advanced bandages etc.) 
and addressing underlying patho-mechanism. As methodology of treatment 
of those wounds is very complicated issue that should be addressed in 
separate work. Figure 2.3.2 represents a management strategy for treatment 




Figure 2.3.2. A management strategy for treatment of chronic wounds. 
Obtained with permission from [4]  Copyright © 2009 The Author(s) under 
Creative Commons License.  
 
2.4 Classification and selection of wound dressings 
2.4.1 Factors influencing wound dressing selection 
Traditional wound dressings are mostly based on gauze which is very cheap 
material with good absorption properties. It is mostly woven and non-woven 
sponges, conforming bandages, non-adherent bandages and ABS pads, lint, 
plasters and wadding. This group of materials is still compromising more than 
50% of the total wound dressing market and it is used mostly to absorb fluids, 
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stop bleeding, protect the opening from harmful elements, inhibit infection 
and dries the wound bed. [56] In some cases, quality of healing is may 
become first instance of importance rather than time of wound closure and 
healing. For example, some patients require use of larval therapy (maggots) 
to remove necrotic tissue before securing wound and improve patient’s life 
by removing wound odor. [57, 58] When removal of old dressing induces 
severe pain in patient’s other solution needs to be considered to ensure easy 
removal of the dressings. Antibacterial properties are also important in many 
cases where clinical infection is present. Therefore, reasons for applying a 
dressing were summarized as follows: 
 To ensure rapid and cosmetically acceptable healing; 
 To minimize pain during removal; 
 To reduce or eliminate pain; 
 To prevent or treat infection; 
 To contain exudate; 
 To ensure maximum possible comfort for patient; 
 To hide wound for cosmetic reasons; 









Table 2.4.1 selection process of wound dressings based on wound related 
factors: [59-61] 
 
















 Heavily exuding 
 Malodorous 
 Excessively painful 
 Difficult to dress 










  Wound aetiology, 
 State of continence 
 Known sensitivity to dressings, 
 Fragile skin, 




  Conformability 
 Mass or volume  
 Fluid handling properties 
 Sensitization potential 
 Odour absorbing properties 
 Antibacterial activity 
 Homeostatic properties 
 Permeability to tissue fluid and microorganisms 
 Ease of use 






 Unit cost 
 Treatment cost 
 Cost of alternative materials 
Availability 
 On prescription, 
 In store or pharmacy departments 





2.4.2  Wound dressing’s types and applications 
Through ages wound dressings have been present in all shapes, origin, 
colors and sizes. Most of materials used to heal wounds were based on 
resource available at particular region and time. Already in 2100 BC 
Sumerian society mentioned “three healing gestures” which include: washing 
(at this time with beer), making plasters (ointments, herbs and oils) and 
bandaging the wound. Egyptians have been using mixture of honey, grease 
and lint already back in 1400 BC. Middle ages brought other methods of 
treating wounds in form of leaving it to rot in order to develop “laudable pus”. 
[62] 18th century brought enormous progress in wound management due to 
discovery of antiseptic techniques and introduction of antibiotics what greatly 
decreased mortality. Modern wound healing started in 20th century with huge 
progress in this field and nowadays more than 5,000 wound care products 
are present on the market. [63] In this work we will divide wound care 
materials into four groups: materials containing silver, negative pressure 
wound devices, advanced dressings and skin substitutes.  
2.4.2.1 Silver 
Silver was present as the antimicrobial material from centuries, with earliest 
document discovered from 69 BC. Silver has broad-spectrum coverage, 
especially with antibiotics resistant organisms. Currently a number of silver 
products are being used in medical fields. Silver based paints are used to 
cover operating theaters in order to limit possibilities of contamination. [64] 
Introduced in 1968, silver sulfadiazine combined antimicrobial properties of 
silver with antibiotic, sulphadizine in form of various glycols and alcohols. 
Nevertheless, these materials have shown to impair re-epithelialization, 
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bone marrow toxicity and pseudo-scar formation [65, 66]. In late 1990s 
dressing doped with nanocrystalline silver were developed. Standard 
structure of currently used silver based dressings are consisted from two 
layers of high-density polyethylene (HDPE) with layer of rayon/polyester 
gauze in between. Outer surface is coated with nanocrystalline silver with 
grain size of less than 20nm. Inner layer of dressings consists of non-
charged silver (Ago). Silver in this form is being discharged with lower rate 
than ionized silver and is used to keep moisture within wound borders. 
Advantage of this sandwich net method is less frequent need to change 
dressings when compared to silver sulfadiazine (twice daily) and silver nitride 
(up to twelve times a day). Mechanism of silver antimicrobial properties are 
still not fully understood and will be described later within this work, 
nevertheless it is worth to mention that silver has wide spectrum of microbial 
coverage including vancomycin resistant enterococci (VRE) and methicillin 
resistant Staph aureus (MRSA). Silver concentration need to be taken under 
consideration when designing appropriate method of healing. Silver nitrate 
have been shown to be toxic for fibroblasts, [67] when nanocrystalline silver 
showed negative impact for keratinocytes and delays reepithelization [68, 
69]. Above methods have led to recommendation against using 
nanocrystalline silver in skin substitutes. Silver is still being considered very 
good antimicrobial agent and development of materials based on various 
forms of silver is still undergoing. Commercially available medical products 
that contain silver include: silver incorporated dressings; antibacterial 
creams (mostly based on silver sulfadiazine) [70]; endotracheal tubes 
(approved by FDA in 2007, reduces risk of ventilation-associated 
25 
 
pneumonia) [71]; urinary catheters [72]; silver based eye drops (silver nitrate 
and silver proteinate are used to prevent conjunctivitis in newborn babies); 
bone prostheses (used in reconstructive orthopedic surgery as coating); 
cardiac devices (some parts exposed to blood of cardiac devices are covered 
with layer of silver) [73]. Chlorohexidine-silver-sulfadiazine is used in central 
venous catheters and silver diamine fluoride is used as intervention in 
dentistry in order to reduce rate of tooth-decay. [74]    
List of some antibacterial dressings with silver as active ingredient are 

















Table 2.4.2 List of commercial available silver reinforced dressings  





 Vapour deposition method, 
 Effective against 150 wound 
pathogens, 
 3-7 days effectiveness time, 
 67% reduction of SSI, 






 Composed of Hydrofiber®, 
 Absorbs fluid and bacteria in 
form of gel, 
 Can be used up to 7 days, 
 Reduces risk of maceration, 
[77, 78] 
Contreet® Coloplast ionic 
 Polyurethane foam with 
dispersed ionic silver,  
 Ions are released after 
contact with wound exudate, 
 7 days of dressing life, 








 Activated carbon impregnated 
with metallic silver, 
 Carbonized fabric enclosed in 
non-woven nylon, 
 Absorbs amines and fatty 
acids which produces odour, 
 Initially needs to be changed 
every 24h 







 Polyester mesh impregnated 
with hydrocolloid, petroleum 
jelly and silver sulphadiazine 
partciles, 
 Effective on 117 microbes, 
 Can be used in cavity 
wounds, 
 Best for superficial or deep 
second-degree burns, 
 For already infected wounds 
[82, 83] 
Avance® Molnlycke silver complex 
 Polyurethane foam with silver 
foam,  
 Decontaminates exudate 
absorbed into foam,  
 Prevents cross and self-
infection 








2.4.2.2  Negative pressure wound devices 
Negative pressure wound therapy (formerly known as vacuum-assisted 
closure or V.A.C.) is not focused on material used in wound care, but 
physical conditions that wounds are being kept on, nevertheless in last 
decade this method of treatment gained great popularity. [85] By applying 
sub-atmospheric pressure to affected area, researchers discovered 
significant decrease in time needed for wound to close. This method is used 
to promote healing in acute or chronic wounds and first and second degree 
burns. Miniaturization of equipment needed and efficiency of liquid removal 
as well as ability to instill fluids for continuous irrigation, were the biggest 
innovations implemented into this method in recent years. Advantage of this 
method is that wound borders are being brought to each other and overall 
volume and dimension of the wound reduces allowing for less complex 
reconstruction. NPWD method is utilizing foams and special sealed 
dressings as a medium between wound and pump, and type of this foam has 
very large implications in treatment efficiency. [86] In general dressing or 
filler material is placed and fitted to the wound shape and them foam layer is 
placed on top of it and sealed with transparent film. Special opening is being 
created in this film and vacuum tube is being attached to the site. [87] 
Procedure suggest that muscle or soft tissue should be placed between 
structure and the sponge and when this is not possible, polymeric mesh or 
Vaseline should be used to ensure sufficient isolation. Traditionally three 
types of sponge materials: foam dressings (it is used to fill the wound and 
then fil drape is placed to seal the site); open wave cotton gauze covered 
with transparent film (in this case flat drain is placed between those two 
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layers) or layers of non-woven polyester sealed and connected by silicone 
elastomer. [88, 89] Continuous or intermitted negative pressure applied to 
the dressings ranges from values of -125 to -75 mmHg depending on 
patients’ tolerance and wound type. [87, 90] 
2.4.2.3  Skin substitutes 
In some cases, especially in severe burns, damaged skin needs to be 
replaced with fresh tissue or artificial skin substitute. Autografts are always 
preferred method of healing those wound, however in case of large areas 
that needs to be repaired or patient condition it is in many cases impossible 
to apply. Bioengineered skin substitutes can be divided into two types: 
biosynthetic skin substitutes and cultured autologous engineered skin. First 
application of grafts cultured with cells was done by O’Connor in 1981. [91] 
Nowadays after two decades of creation of skin substitutes a number of 
systems have been implemented. Factors that needs to be considered when 
deciding to use those constructs include: availability of donor, depth of the 
wound or burn, possible infection rate, placement of the wound, like hood of 
contracture, cost, time necessary to heal, surgeon skills and aesthetic factor. 
[92] Therefore, ideal skin substitute should possess a number of qualities in 
order to create healthy skin tissue, namely: resistant to infections; ability to 
keep moisture; resistant to shear forces; limited cost and availability in short 
period of time; flexibility; antigenic neutrality; long shelf life; stable for a 
substantial time; adjustable to irregular wounds; relatively easy to be applied 
and secure. [93] Due to very fast progress in tissue engineering filed a 
number of more or less sophisticated scaffold/cells system have been 
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introduced. Following classification done by Kumar et al. [94] we can 
distinguish three classes of skin substitutes: 
Class I: Temporary dressing materials: 
a.) Single layer materials: natural dressing substitutes like potato peel, 
amniotic membrane, synthetic substitutes like polymer sheet 
(Tegaderm®, Opsite®, polymeric foams and sprays  
b.) Bi-layered materials like TransCyte® 
Class II: Single layer durable skin substitutes 
a.) Epidermal substitutes: cultutred epithelial autograft (CEA), Apligraft® 
b.) Dermal substitutes: collagen sheet (Kollagen®), porcine collagen 
sheets, bovine dermal matrix (Matriderm®), human dermal matrix 
(Alloderm®). 
Class III: Composite skin substitutes 
a.) Skin grafts: allograft, xenograft 
b.) Tissue engineered skin: dermal regeneration template (Integra ®), 
Biobrane®. 
Multiplicity of various grafts and structures that is nowadays used in as sking 
grafts, does not allow us to mention all of the constructs present currently on 
the market, however some of the commercially available products have been 
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2.4.2.4  Advanced dressings 
Plain gauze is still most popular material used to seal wounds and burns in 
the hospitals currently. New technologies and understanding of wound 
healing process led to creation and design of a number new advanced 
dressing which help the body to achieve protected, moist and warm 
environment. Even plain gauze underwent number of modification to adjust 
its properties to rising demand for dressings. Impregnation of gauze with 
zinc, iodine or petrolatum provides non-adherent coverage and prevents 
from desiccation [96]. Occlusive dressing is necessary to provide proper 
autolysis process. Phagocytosis will provide self-debridement if whole 
process occurs in isolated but moisture environment. Tegaderm® is 
impermeable to fluid and microbes but allows air and water vapor to pass 
through it. On the other hand, DuoDERM® is hydrocolloid which also keeps 
moist environment but additionally supports absorption of exudates from the 
site. Number of dressing used currently is great as well as demand for new 
solutions. As it is impossible to describe all of the recent discoveries in here 
a table was prepared to mention some of the most interesting solutions.  








Table 2.4.4. Commercialized advanced wound dressings [96-100] 
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2.4.2.5  Biologic wound products 
Biologic wound dressings are designed in order to accelerate natural healing 
process by augmenting or modulating inflammatory mediators. As for now 
this methods of treatment are still in developing phase, however some 
clinical trials have been already conducted. Process of natural occurred 
wound heling described in previous chapter is based on numerous proteins 
like cytokines, nitric oxide, growth factors and eicosanoids. Cytokines are 
responsible for regulating inflammation by influencing hematopoietic cells. 
This group include chemokines, lymphokines, monikines, interleukins, 
colony-stimulating factors and interferons. Some of them were proved to 
influence most cells in wound environment, where granulocyte/macrophage 
colony stimulating factor (GM-CSF) have been proven to stimulate 
keratinocytes, macrophages, neutrophils and VEGF production rate. [101, 
102] Eicosanoids are metabolites including prostacyclines, thromboxane, 
prostaglandis and leukotrienes. These compounds are mainly responsible 
for initial stage of vasoconstriction and vasodilation, vascular permeability, 
inflammatory cell adhesion and chemotaxis. For example, prostaglandin E1 
inhibits platelet and neutrophils activation, stimulates plasminogen activation 
and causes vasodilation by relaxing vascular smooth muscle. [103, 104] 
Growth factors are being investigated widely in regenerative medicine as 
compounds of scaffolds needed for fast and efficient regeneration process. 
In wound healing area they are mostly responsible for recruitment of 
fibroblast and keratinocytes with help of glycoproteins [105]. Platelet-derived 
growth factors (PDGF) were already approved by FDA for treatment of 
diabetic ulcers and are commercially available under name of Regranex®. 
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[106, 107] Although use of biological compounds in wound dressings is very 
attractive and efficient method there are still significant drawbacks that’s 
needs to be addressed before commercialization stage. The most significant 
is price reduction as well as reducing response from immunology system. 
Limited sources of growth factors are also factor that limits its wide usage. 
Because certain mixture of those proteins is necessary to treat specific 
wounds, dressings with growth factors cannot be produced and stored in 
large quantities.  
2.4.2.6  Hyperbaric oxygen in wound management 
Hyperbaric oxygen chambers (HBO) were develop to treat decompression 
illness. Nowadays it is being utilized to treat carbon monoxide poisoning, 
crush injuries, acute traumatic ischemia, radiation injuries or infection with 
anaerobic microbes and some kinds of chronic wounds. [108] In this method 
patient is placed in sealed chamber and subjected to pure oxygen 
environment pressurized to 1.5 to 3 atmospheres for 60-120 minutes. 
Drawback of HBO method include presence and breathing within 100% 
oxygen atmosphere. Contraindications include reactive airway disease, 
untreated pneumothorax and chemotherapy. Mechanism of influence of 
pressurized oxygen to tissues is still not fully known, nevertheless it is 
connected with increase of arterial oxygen pressure which causes 
vasoconstriction. Capillary pressure reduces what leads to absorption of 
liquids and reduces edema. This effect sustains for several hours to a day 
after treatment in HBO. [109] Neovascularization is a process when new 
blood vessels are being formed within a wound. It is dependent on first-
endothelial progenitor cells (EPCs) and other stem cells recruited form bone 
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morrow. Those cells are being brought to wound site by cytokines, (stromal-
cell-derived factor or SDF-1α). This recruitment process is un-sufficient in 
diabetic patients. Hyperbaric oxygen seems to stimulate EPCs and stem 
cells from bone marrow. This phenomenon is mediated through nitric oxide 
pathways. Clinical trials showed significant reduction of wound size in 
diabetic patients as well as time needed to completely heal the wound. Up 
to date treatment with HBO combined with growth factors and biological 
assistance has significant role in long term wound improvement, 
nevertheless more studies need to be conducted before this method become 
standard in treatment. 
2.5 Nanomaterials in wound management 
Previously described materials used in wound management procedures are 
mostly constructed with cotton or polymeric fibers in order to support wound 
closure, keep necessary moisture and absorb exudate. Nanotechnology 
gives a great promise in performance of wound dressings. Scaling down 
material to nanometer size reveals unique properties not present in 
traditional materials. In the bulk of the material all atoms in are aligned with 
equalized forces acting on them at any given time. At the surface of the 
material, forces acting on the atoms are not equalized, therefore those atoms 
possess small amount of extra energy. Also surface area increases greatly 
when materials are being produced in nanometer size. Richard Feynman, 
one of the greatest physicists and teachers of XX century, predicted 
emergence of nanotechnology in his Noble Price speech in 1959. [110] This 
chapter will be an attempt to summarize recent progress in wound healing 
and regenerative medicine from the perspective of nanomaterials and 
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biological compounds that are being investigated. Nanoparticles and 
nanofibers have due to its size has an ability to bond, interact or enclosure 
biological and non-biological factors which may be later released in suitable 
manner.  
2.5.1 Nanoparticles 
2.5.1.1 Nanoparticle-bearing endogenous molecules 
Active proteins like previously mentioned growth factors or cytokines can be 
attached to surface of nanoparticles and support healing on cellular and 
molecular level. As usage of bioactive proteins is very promising because of 
control they exert on wound repair. [111, 112] After many clinical trials done 
with nanoparticles and growth factors, only single system have been 
approved by FDA. Recombinant human PDGF-BB is now being 
commercially available for treatment of foot ulcers. [113] Drawback of this 
method is half-life of the proteins involves in signaling cascades is very short 
in order of seconds. To provide enough time some attempts have been done 
to preserve proteins from enzymatic degradation like gels, collagen or liquids 
thanks to nanoscale engineered structures that can preserve those proteins. 
[114] Novel compounds that are being tested nowadays include thrombin, 
nitric oxide, growth factors, opioids and protease inhibitors. [115-118] As 
growth factors are the most investigated biological compounds it will be 
described with more detail here. As mentioned before growth factors have 
potential to attract cells into wound site (TGF-β), promote its migration, 
stimulate proliferation of epithelial cells and fibroblasts (PGF and PDGF) and 
initiate formation of new blood vessels (PGF and VEGF). [117] 
Encapsulation of growth factors within polymeric matrix can greatly extend 
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time of protein release and therefore increase time of its storage. Process of 
protein release can be controlled by drug loading technique, type of polymer 
used and processing conditions. [119] Variety of various systems have been 
designed and tested so far, including both biodegradable and non-
biodegradable polymers like poly(lactic acid) (PLA) and poly(lactic-co-
glycolic acid) (PLGA) with and without surface modification with polyethylene 
glycol (PEG). [120] Biodegradable polymers can be design with various 
ratios of co-polymers which helps to regulate degradation of outer shells and 
release of bioactive compounds and influence porosity and permeability. 
Bioactive compounds used in those systems include TGF-β in gelatin 
microspheres [121], rhEGF in PLA [122], FGF in gelatin microspheres [123] 
and PDGF inside PLGA nanoparticles [124]. 
2.5.1.2 Nanoparticle-bearing antibiotics 
Antibiotics are important compound of antimicrobial materials for wound 
dressings. Preventing infection during recovery process is crucial to ensure 
proper wound closure and minimizing tissue damage. Over-usage of 
antibiotics in recent two decades, led to development of strain resistant 
microbes and required a novel approach for antimicrobial treatment. 
Incorporating antibiotics within nanoparticles promise controlled release of 
antibiotic with local higher concentrations when compared to oral dosage. 
Localized treatment may reduce the risk of development antibiotic 
resistance. [125] From physiochemical point of view best nanoparticles that 
can be used as drug delivery systems should be in range of 20-200 nm as 
bigger particles are being absorbed by reticulo-endothelial system and 
removal from the system. Smaller particles have been proved to be 
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accumulated in hepatic sinusoidal endothelium. [126] Vancomycin is known 
antibiotic to be efficient against staphylococcal infections. Vancomycin 
incorporated nanoparticles were tested against various infections. 
Vancomycin incorporated nanoparticles were used to treat endophthalmitis 
prophylaxis in form of intraocular continuous release. [127] Similarly 
carboxymethyl chitosan-based nanoparticles were incorporated with 
vancomycin and showed good results against staphylococcal strains [128]. 
To fight against MRSA, emulsion of polyacrylate nanoparticles with drug 
monomer (N-methylthiolated β-lactam antibiotics) incorporated within 
polymer chain have been developed and showed good results with human 
fibroblasts and were stable in serum for 24h. [129]  
2.5.1.3 Silver based nanoparticles 
Silver was proven good antimicrobial agent. Reduction of naturally 
antimicrobial material into nanosize, greatly increases surface of the active 
agent what also increases release of silver ions locally. Multilevel 
mechanism of antimicrobial activity of silver gives it unique possibility of 
fighting against most resistant bacteria strains. [130] Moreover, a number of 
ions released from silver compounds increases its clinical efficiency as well 
as increases its resistance to microbes. Silver nanoparticles are nowadays 
efficiently produced by photo-assisted reduction, ion stabilization or by 
applying silver nanoparticles into nanofibers. [131] It can be produced in 
many shapes (spheres, rods, tubes, wires, ribbons, plates, cubes or 
triangles). Additional small negative charge on the surface of NPs makes 
them very active which makes them very easily modifiable with 
biomolecules, especially ones with thiol or amine groups (proteins, enzymes, 
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DNA or organic molecules). [132] In-vitro silver nanoparticles showed 
promotion of wound healing through reduction of the cytokine-modulated 
inflammation. Also presence of silver nanoparticles promotes proliferation 
and migration of keratinocytes and differentiation of fibroblasts into 
myofibroblasts. [133]  
Mechanism of interaction of silver nanoparticles with microbes is based on 
multilevel interaction of silver ions with active groups present throughout 
microbe cell. Silver nanoparticles are binding with the bacterial cell wall and 
cell membrane and inhibits respiration process. Then chemical energy of 
molecules is released and partially captured in form of adenosine 
triphosphate. Sulfur containing proteins and phosphorus containing 
compounds such as DNA of the bacterial membrane are attracting silver ions 
which inhibits its functions. Inactivation of the enzyme phosphomannose 
isomerase which catalyze the conversion of mannose-6-phosphate to 
fructose-6-phosphate is one of the biggest disturbances in cell function done 
by silver ions. This catalysis is very important intermediate of glycolysis 
which is responsible for cell nutrition process. Figure 2.5.1 represents some 
of the events undergoing when silver nanoparticles are infiltrating bacterial 




Figure 2.5.1.Various modes of action of silver nanoparticles on bacteria – 
taken with permission from Springer [134]. Copyright © 2012, Prabhu and 
Poulose; licensee Springer 
2.5.1.4 Nanoparticles and gene therapy 
Delivery of DNA by nanoparticles have been possible because of 
development of high precision manipulation devices and growth of 
microscopic techniques connected with development of nanotechnology. 
Plasmid DNA delivery by nanoparticles offers protection against enzymatic 
degradation and controlled release. Deliver of DNA have been also studied 
in field of wound healing. PLGA and PLA nanoparticles have been used carry 
antiangiogenic plasmid DNA. [135] Prepared by supercritical fluid extraction 
of emulsion based on CO2 allowed to achieve of loading efficiency of >98%. 
Those methods showed promising results to treat wounds in which levels of 
VEGF are elevated. [136] Chitosan is also promising material to use with 
non-viral DNA chains as it can support prolonged time of release. 
Nanospheres with DNA chains were produced in sizes of 38 ± 4nm by 
osmosis-based method of production. [137] This method has been also used 
in a number of synthetic or natural biopolymers and showed capability of 
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producing particles in various shapes and sizes. Chitosan based DNA 
loaded nanoparticles have been tested on human macrophage cell line and 
showed significant increase of secretion of metalloproteinases from cells 
when compared to non-treated cells. As this research is still in relatively early 
stage, no reports about clinical usage of DNA based nanoparticles have 
been presented so far. [138]  
2.5.1.5 Nanoparticles and stem cells 
Stem cells have unique and wonderful ability to be transformed in any kind 
of cell. Usage of stem cell inside living organism still has big drawbacks as 
environment control and signaling between proliferated and stem cells. 
Nanoparticles has an advantage of dealing stem cells and provide temporary 
suitable environment and protection for proliferation, differentiation and 
maturation of cells. Bidegradable partciles have been used as a carrier for 
hVEGF gene to human mesenchymal stem cells (hMSCs) and human 
embryonic stem cell-derived cells (hESdCs). Results shown that this 
treatment increased hVEGF production and resulted in 2 to 4 fold higher 
vessel densities in timeline of 2 weeks after implantation. Increased blood 
supply reduced muscle degeneration and tissue fibrosis in mouse model. 
[139] This results suggest that nanoparticles may be successfully used as 
stem cells carriages and protein release.  
Above chapter summarizes recent progress in application of nanoparticles 
in modern wound management. Nanoparticles due to its multiple 
applications and size suitable to interact with proteins and cells within living 





Nanofibrous materials are ideal materials to use in wound dressings. Fibers 
in range of diameters from 100 to 1000nm possess unique properties that 
have not been known before. Nanofibrous scaffolds are being now very 
widely investigated in tissue engineering and regenerative medicine as 
structures needed to simulate natural extracellular matrixes (ECM). Because 
of small sizes of fibers and high porosity, those material are ideal for cells to 
attach and proliferate within the fibrous non-woven mesh. Up-to-date a 
number of production techniques of nanofibers have been developed. 
Polymeric, ceramic or composite fibers can be produced by: centrifugal 
spinning [140], melt blowing [141], biocomponent fiber spinning [142], phase 
separation [143], template synthesis [144] or self-assembly method [145], 
melt electrospinning [146] nevertheless the most popular technique with 
capabilities of mass production is electrospinning technique [147]. Table 
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2.5.3 Electrospinning method for nanofibers production 
Electrospinning method is used around the world in more than 200 scientific 
laboratories and intensively developed by them, with more than 200 
polymers already electrospun. Extensive scientific interest of this method led 
to development of numerous industrial systems and allowed for nanofibrous 
wound dressing production in larger quantities, what significantly reduced 
price of the final product. [149] In general electrospinning is a method of 
production of non-woven meshes from polymer solution. Simplicity of 
building basic set-up, vide range of polymers that can be manufacture with 
this method and possibility of scaling up are the main advantages of this 
method over other mentioned techniques. In general electrospinning is 
technique based on electro-hydrodynamic drawing of polymer fibers from 
polymer solution. Dissolved polymer is placed in container with small 
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diameter nozzle. High voltage, low current electrode is next being attached 
to the nozzle and polymer solution is being pushed through the nozzle with 
controlled flow rate. Charged polymer jet is attracted by grounded collector 
because of voltage gradient between nozzle and electrode. During this 
process, solvent evaporates and final fibers are becoming thinner. 
Electrostatic charges present at the surface of the fiber during 
electrospinning also contributes to the fiber thinning phenomenon. [150] Melt 
electrospinning technique is a variation of electrospinning in which polymer 
is being melt to form of viscous liquid instead of being dissolved in liquid 
solvent. [146] Figure 2.5.2 shows schematically basic electrospinning set-
up. Modification of collector or nozzle allows also for production of aligned or 
oriented fibers, patterns with fiber mesh, monofilaments or yarns of fibers as 





Figure 2.5.2. Schematic of basic electrospinning set-up. Taken with 
permission from Elsevier [151]. Copyright @ 2010 Elsevier Inc.  
Fiber diameter and properties of electrospun materials depends on a number 
of parameters which roughly can be divided into four groups namely: 
solution parameters (viscosity, electric conductivity); polymer 
concertation (molecular weight of polymer, conductivity, surface tension); 
processing parameters (applied voltage, distance between nozzle and 
collector, flow rate of polymer solution); and ambient parameters (humidity, 
temperature). [151]  
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Despite some difficulty in finding optimal parameters in order to achieve good 
quality fibers, electrospinning due to its universal set-up, can be used to 
produce wide range of polymers in nanoscale: [152] 
 Natural polymers: chitosan, hyaluronic acid, alginate, cellulose, 
collagen, chitosan, alginate, elastin etc. 
 Synthetic polymers: polycaprolactone (PCL), poly l-lactid acid (PLLA), 
Polydioxanone (PDO), polyglycolic acid (PGA), poly (lactic-co-glycolic 
acid) (PLGA).  
Number of variations between polymeric system, collector type and nozzle 
arrangement as well as electrospinning parameters, allows to manufacture 
thousands of various materials with different properties and microstructure. 
Due to number of possible outcomes some research have been done in 
order to model fiber diameter based on process parameter and polymer type.  
[153-155] 
2.5.4 Electrosprayed nanoparticles 
Methods production of nanoparticles include solvent evaporation [156], 
single and double emulsion method [157], porous glass membrane 
emulsification [158], coacervation [159] and spray-drying [160]. Those 
methods showed a number of disadvantages such as low drug-loading 
efficiency, difficulties in particles size control, ability to fabricate small 
particles, and limitations to scale-up. [161] As mentioned in previous 
paragraph, electrospinning is a method of production of nanofibrous 
scaffolds. Wide range of parameters which have to be taken under 
consideration during process in order to obtain fine fibers, allows to 
manipulate final product. By changing solution viscosity or conductivity, it is 
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possible to obtain various fiber diameters in range of hundreds of 
nanometers up to tens of micrometers. Some specific configurations of 
electric potential, nozzle diameter, polymer molecular mass and polymer 
flow, make possible to produce nanoparticles. Particles are being created 
when pulling force induced by electrostatic gradient is just slightly bigger than 
surface tension of polymeric solution. [162-164] Electrospraying is simple 
method of production of nanoparticles in various range of size as well as 
creation of core-shell particles where one phase is encapsulated within other 
material. Electrosprayed nanoparticles are especially interesting for 
application in medicine and drug delivery systems. [162] Some examples of 
drug loaded nanoparticles have been presented in Table 2.5.2. 
Table 2.5.2. Summary of investigated electrosprayed nanoparticles as drug 
carriers [161], [162] 
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Electrosprayed nanoparticles have been proved to be able to carry various 
treatment active compounds and incorporation of antimicrobial agents may 
be interesting method of creation of antimicrobial wound dressing with 
biodegradable polymeric nanoparticles incorporated within textile.  
2.5.5 Electrospun antimicrobial materials  
Electrospun materials because of its properties, have a great potential of 
being used in wound management and wound treatment techniques. So far 
a number of antimicrobial systems from electrospun materials with various 
active agents have been proposed. [17, 175, 176] First method of creating 
biocide fibers is electrospinning of antimicrobial polymers. This is a class of 
polymers with inherent ability of inhibit growth of microorganisms. Those 
polymers can be obtained from natural sources (biopolymers) and 
engineered (engineered polymers). The most common biopolymers are 
polysaccharides and proteins. Engineered polymers are materials with 
attached or inserted an active antimicrobial agent onto polymer backbone 
via alkyl or acetyl linker. Structural modification of those polymers, introduces 
inherent antimicrobial properties. Chitosan is an example of natural polymer 
which was successfully electrospun in various ways to enhance its 
antimicrobial properties. Electrospun chitosan-based fibers include: 
chitosan, chitosan/cellulose   chitosan/PEO, chitosan/silk, chitosan/PVA, 
chitosan/collagen, chitosan/PET, chitosan/PLA and chitosan/chitin. [177-
180] Because pure chitosan is hard to spin in natural form, blends with other 
polymers have been used to achieve ultrafine fiber characteristic. 
Antimicrobial property of chitosan is associated with protonated glucosamine 
fractions of chitosan in the solution. Oher approach to create suitable 
49 
 
electrospun antimicrobial polymers is to incorporate exogenous biocide 
substances into polymeric mesh. Most preferred biocides include antibiotic 
and silver in synthetic polymer mesh. Electrospun polymeric matrices are 
very promising materials for wound dressings because and ability to provide 
barrier from bacterial penetration while providing good path for vapor 
exchange. Moreover, nanofibers can conform to the contour of wound 
resulting in a better coverage and protection. They also provide base for scar 
free healing process because of good cellular promoting properties. [176] 
Another advantage of those materials in wound management is that 
advanced dressings need to be prepared in multilayered form with different 
properties to ensure proper healing process. Electrospun fibers may be 
prepared by blending all components into one system and achieve all-in-one 
wound dressing.  Table 2.5.2 presents some of the antimicrobial polymers 
with biocide elements. [181]  
Table 2.5.3. List of polymers with antimicrobial agents investigated as wound 
dressing materials  
Polymer(s) Antimicrobial agent Ref. 
PLA, PEVA, PLA/PEVA, PCL/PLA, Tetracycline hydrochloride [182] 
PLA Rifampin [183] 
PLAGA and PLAGA/PEG-b-PLA/PLA Mefoxin [184] 
PCL, PLA, PLA/collagen Gentamycin sulphate [185] 
PCL Biteral [186] 
Soy protein/PEO, PLA Allyl isothiocyanate [187] 
PVA Eugenol [188] 
Cellulose acetate Nano silver [189] 
PLA Nano silver [190] 
PCL Nano silver [191] 
PVP and PVA Nano silver [192] 
Silk fibroin Nano silver [193] 
PVP Nano silver/Cl [194] 




Silver nanoparticles brought much attention in wound management and in 
combination with biodegradable polymers and repeatable production 
method as electrospinning shows great potential for wound dressings. 
Polymeric matrix constructed with biodegradable polymer allows to replace 
artificial polymer with healthy tissue, by providing full mechanical support at 
the beginning and degrades over time, when amount of proliferating cells 
reaches point ensures production of natural extracellular matrix. Silver 
nanoparticles can be at the same time slowly released around the wound 
ensuring lack of serious infection. Biodegradable synthetic polymers like 
PLA, PGA or PLGA degrading mechanism is based on hydrolytic 
degradation which slowly reduces polymer chain to oligomers what causes 
molecular weight of polymer to decrease. In final stage oligomers degrades 
to water and carbon dioxide (Figure 2.5.3). [196] Silver nanoparticles 
because of its size and property can be sufficiently removed from the living 
system by phagocytosis in relatively small amounts. [197] 
 






2.6 Perovskites as potential novel materials in wound dressing 
Perovskites are the class of ceramic compounds which have this same type 
of crystal structure as CaTiO3 called perovskite structure (XIIA2+ VIB4+ X2- 3). 
This is a large group of minerals naturally or synthetic which include all 
materials with structure of ABO3 like: CdTiO3, CaSnO3, BaThO3, KMgF3, 
LaFeO3 or BaPbBi2O3. [199] In recent years it gained much attention 
because of some unique properties like superconductivity [200] in elevated 
temperatures, ferromagnetic behavior [201] and catalysis capabilities [202]. 
Perovskite materials shows extensive isomorphic substitutions of the rare-
earth metals. Those properties brought idea to use perovskite materials in 
electronic and solar cells. First perovskite based solar cell system have been 
presented in 2012, enormous progress in 2013 brought introduction of solar 
cell with efficiency of 19.3%.  [203] Industrial production of solar cells with so 
efficiency could lead to end of silica monopoly in this field. Those have led to 
realization that perovskites in submicron form, may possess other properties 
that could be utilized and investigated, especially in medicine and 
regenerative medicine.  
2.6.1 Perovskites structure and derivatives 
If a is defined as the cubic unite cell parameter then in ideal crystallographic 
structure in which atoms touch each other, distance B-O should be equal to 
𝑎/2 a/2 and A-O distance is defined as (𝑎/√2), therefore reation between 
ions radiuses should be equal to 𝑟𝐴+𝑟0 = √2(𝑟𝐵 + 𝑟0). In perovskites this 
equation is not obeyed and as a measure of deviation from the ideal 
crystallographic structure the tolerance factor t has been estimated to be: 
𝑡 = (𝑟𝐴 + 𝑟0)/√2 (𝑟𝐵 + 𝑟0) 
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This factor informs about theoretical size of the atoms that can fit into lattice 
structure and deviation from ideal structure at room temperature was 
calculated to be: 0.75 < t < 1.0. This finding showed that perovskite material 
has an ability to accept various atoms into its lattice and changes its cubic 
structure in ideal structure to other crystallographic structures like 
orthorhombic, rhombohedral, tetragonal, monoclinic and triclinic depending 
on its final composition. [204] Those availability of stacking unit cells in 
various ways brought development of other more complicated structures. In 
general, three main structures main be distinguished: cubic perovskites, 
double perovskites and layered perovskites. Cubic perovskites are the 
group of materials with traditional ABO3 formula. The easiest way to visualize 
the structure is in terms of the BO6 octahedral which share corners infinitely 





Figure 2.6.1. Representation of cubic perovskite structure SrTiO3 [205] 
Double Perovskites is so named because the unit cell of is twice that of 
perovskite. It has the same architecture of 12 coordinate A sites and 6 
coordinate B sites, but two cations are ordered on the B site (Figure 2.6.2). 
 
Figure 2.6.2. Representation of double perovskite structure Sr2FeMoO6 [205] 
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Layered Perovskties Layered perovskites consist of infinite 2D slabs of the 
ABO3 type structure which are separated by some motif. The general formula 
for the layers is: A(n-1)B(n)O(3n+1) (Figure 2.6.3).  
 
Figure 2.6.3. Representation of layered perovskite structure Sr2RuO4 [205] 
As part of metal atoms within perovskite structure can be non-stoichiometric 
replaced, a numerous of possible perovskite structures can be synthesized, 
what gives filed for development of silver, copper or gold substituted 
perovskite materials with possible antimicrobial properties.  
2.6.2 Silver based antimicrobial perovskites 
Silver based perovskites was previously reported with potential applications 
in solar cells [206], solid oxide fuel cells [207], NOx catalysis [208] or as 
ferromagnetic materials [209] and solid state piezoelectric components 
[210]. To the most investigated silver perovskites include perovskites oxides 
like AgNbO3 and AgTaO3 which showed interesting behavior when under 
high electric polarization or after chemical modification. AgNbO3 changes its 
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ferri-electric state into ferroelectric state. Similarly, AgTaO3 is quantum para-
electric but chemical substitution can change its property to ferroelectric. 
[209] Up-to-date only some of the perovskite like materials have been 
reported as antimicrobial materials. Mohseni et al. produced barium 
zirconate titanate nanoparticles [Ba(ZrxTi1-x)O3] (x = 0.5) by sol-gel method. 
The results showed significant antimicrobial properties of such a material, 
effective both on gram positive (Staphylococcus aureus, micrococcus luteus) 
and gram negative (Escherichia coli and Klebsiella pneumonia) bacteria. 
[211] Perovskite-type V-doped titanium-bearing blast furnace slag (VTBBFS) 
synthetized in high-temperature solid phase method by Wange et al. [212] 
showed antimicrobial activity against Candida albicans, fungus causing 
various oral and genital infections in humans. Research group of Zhang et 
al. [213] produced highly bactericidal nanoparticles by mechano-chemical 
high-energy ball milling. Strontium titanate ferrite (SrTi1-xFexO3-ς) (STFx) 
metal oxide with stoichiometry of x=0, 0.2, 0.4, 0.6, 0.8 and 1.0. Synthesized 
material STF0.8 showed antimicrobial activity against Escherichia coli with 
minimal dose of 105 CFU/ml in dark and light conditions. Material was 
proposed for use in water purification. Finally layered perovskite based on 
silver have been synthetized by group of Tan et al. [214] Unlike other 
mentioned materials antimicrobial property of this material was developed 
by substituting sodium atoms by silver which in combination with titanium 
oxide provided additional antimicrobial activity to the material. AgxNa2-
xLa2Ti3O10 with x=0.3 provided sufficient antimicrobial activity against 
Escherichia coli and staphylococcus aureus with minimal concentrations of 
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180μg/mL and 240μg/mL respectively. Table 2.6.1 summarizes already 
tested perovskite materials with antimicrobial properties.  
Table 2.6.1 Summary of antimicrobial perovskite materials 
Structure Method of 
production 









[171] Micrococcus luteus 3 μg/mL 
Escherichia coli 2.3 μg/mL 
Klebsiella pneumoniae 7.3 μg/mL 






























Wounds and burns as well as injuries and accidents are unavoidable events 
in life of every human being. Amount of injuries and surgical procedures in 
which wound management is necessary is rising every year with rise of world 
population and number surgical interventions. Despite extraordinary 
progress in medical field and infection management, number of infections 
and surgical site infections is rising and methods of its prevention are still 
limited. Extensive use of antibiotics within last decades and standardization 
of treatment methods led to situation where limited number of antimicrobial 
agents is being used in large number of infection cases. Development of 
antibiotic resistant strains and decrease in antibiotic efficiency against still 
vulnerable bacteria, created a need to search new methods of fighting 
bacterial and fungi biofilm development and severe infections. Knowledge of 
wound healing mechanisms as well as protein chain reaction with extensive 
investigation of proteins and it role in this process, allowed to design novel 
materials which not only prevents from microbe infiltration into revealed and 
vulnerable tissue, but also actively support this process. Active compounds 
present in advanced wound dressings have an ability to support natural 
healing progress in many ways, depending on method used. As mentioned 
in this introduction, not only protection against bacteria is required but also 
keeping optimized environment for treatment may influence its outcome, 
time needed to heal and scar formation. Therefore, modern, advanced 
wound management utilizes methods of wound covering as well as physical 
methods of healing in elevated or lowered pressure. Summary of topical 
wound care products are presented in Table 2.7.1.  
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Table 2.7.1. Summary of commercially available wound management 
products [216] 
Product Indication and 
action 
Advantages Disadvantages Use Examples 
Mupirocin 
Wounds infected 
with gram positive 
organisms. 
Prevents bacterial 
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 Nanosize materials due to its unique properties and new methods of 
production as well as modification possibilities provide ideal frame for newest 
generation of wound dressings with a number of biologically active 
compounds that may be incorporated into those materials. Nanofibers 
prepared by electrospinning technique can be easily incorporated by various 
other materials like proteins, metal nanoparticles, ceramics and antibiotics. 
Porosity and microstructure of those materials supports cell growth and 
release of active components while maintaining vapor removal. Additional 
use of biodegradable polymeric matrixes enables to use it internally and 
externally while maintaining microbial free environment. Silver have not been 
extensively used in commercial products which allowed to keep its 
antimicrobial property and has an ability to disturb and eventually kill bacteria 
cell on many levels, what makes it a good candidate as potential active 
compound placed in polymeric matrix. Very recent interest of material 
scientist in perovskite materials and therefore creation of various atomic 
composition, helped to create ceramic materials with ability to release silver 
ions from its lattice but maintain possible lowest toxicity of perovskite 
particles. Following chapters will describe some of those properties by 
examining antimicrobial properties, mechanical strength and microstructure 
of nanofibrous biodegradable polymeric meshes embedded with silver 
nanoparticles as well as layered perovskite material where some of the 
































 Silver nanoparticle incorporated Poly(L-lactide-co-
glycolide) nanofibers: Evaluation of their biocompatibility 
and antibacterial properties 
3.1 Introduction  
Polymeric nanofibrous scaffolds can function as a tissue engineered skin 
graft for the treatment of wounds, burns or post-surgical scars. Regenerative 
medicine using bioengineered grafts are widely investigated with the aim of 
bringing new solutions for current issues in medical care. At the same time, 
microbial infections are the most common complications associated with 
medical surgeries and wound management regimen. The presence of 
antibacterial and bioactive materials such as the antibiotics, [217, 218] metal 
particles, [219, 220] or medicaments, [221-223] within the polymeric 
nanofibrous scaffolds could minimize the risk of microbial infections as well 
as support the cell recruitment and growth. [147] Surgical site infections (SSI) 
which occurs in 0.5-15% of all hospitalized patients, depend on the type of 
operation carried out, and affect around 1.4 million people annually 
worldwide. [224] In the early stages of wound healing, neutrophils 
accumulate inside the wound to prevent bacterial film creation, nevertheless 
this process is often inefficient and biofilm formation prevents re-
epithelialization of the tissue. Resistance to neutrophil cells developed by 
bacterial biofilm transforms the relatively harmless acute wound into 
dangerously chronic wound. [225] Various polymeric systems have been 
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investigated in the field of skin tissue engineering. Natural polymers like 
collagen, gelatin or fibrin showed good biological properties but they lack 
sufficient mechanical properties to support the regeneration of the skin 
tissue. [226, 227] Synthetic polymeric materials investigated in this field 
including: polypropylene (PP), polyvinyl alcohol (PVA) or polyethylene glycol 
(PEG), [192, 228, 229] provide sufficient mechanical strength but without any 
natural antibacterial properties. Nanofibrous materials shows extraordinary 
mechanical resistance with very high surface energy and morphology similar 
to the natural extracellular matrix of human skin. [230] Fibrous form of these 
materials create a unique mesh of micro or sub-micro pores which allow the 
cells to attach, communicate and support the exchange of nutrients and 
metabolites. After implantation, the scaffolds slowly degrade with time, such 
that the natural tissue has sufficient amount of time to replace the synthetic 
polymeric mesh and re-create uniform tissue, while disintegrating to neutral 
compounds which are naturally processed by the human body [231].  
Poly(lactide-co-glycolide) (PLGA) is one of the aliphatic biodegradable 
polymers widely investigated in the field of healthcare and regenerative 
medicine. [232] PLGA degrades safely inside the biological systems through 
hydrolytic degradation and the rate of degradation can be controlled by the 
ratio of the lactide (L) and glycolide (G) monomers. [233, 234] PLGA as 
polymer already registered for usage in medical applications, it was chosen 
as good material, which can be used both externally and internally. 
Biodegradability of this polymer and specific mechanism of this degradation 
suggest that this may be a best material to construct novel wound dressings 
with enhanced antimicrobial properties. In recent years, polymers 
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incorporated with metal nanoparticles gained much attention, thanks to 
surface modification techniques and better understanding of its biological, 
magnetic and electric properties. [235, 236] Silver nanoparticles 
incorporated in polymeric foams showed antibacterial properties against 
gram-negative and gram-positive bacteria [237, 238] while high 
concentrations of silver nanoparticles in the matrix have even been 
demonstrated to show anti-cancer properties. [219] The mechanism of 
antibacterial properties of silver nanoparticles is still not fully understood 
however it was hypothesized, that it causes cell lysis or inhibit cell 
transduction. [239] Combining the nanofibrous biodegradable matrix with 
antibacterial properties of silver nanoparticles is a novel approach towards 
the fabrication of functionalized scaffold matrix for skin tissue engineering or 
as implantable wound dressings, to solve the problem of increasing number 
of SSI. In this study, we investigated two polymeric systems as potential 
materials for wound healing. PLGA with lactide:glycolide (L:A) ratio of 50:50 
and 75:25 was incorporated with silver nanoparticles to obtain nanofibrous 
composites by electrospinning technique. The electrospinning process 
optimization was carried out, and the evaluation of mechanical and structural 
properties of the developed fibers along with their cellular biocompatibility 
was investigated during this study. Further, the antibacterial properties of the 
scaffolds against the gram positive and gram negative bacteria strains: 
Staphylococcus sarophyticus, Klebisiella pneumoniae, Pseudomonas 
aeruginosa and Escherichia coli were conducted to investigate the potential 
of utilizing these nanofibrous scaffolds as novel wound dressings.    
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3.2 Materials and methods 
3.2.1 Materials 
Poly(L-lactide-co-glycolide) with L:G ratio of 50:50 (B6010-2, PLGA 50/50) 
and 75:25 (B6007-1, PLGA 75/25) both with an inherent viscosity of 0.55 - 
0.75, were purchased from LACTEL Absorbable Polymers (Durect, 
Birmingham, AL, USA). Dimethylformamide (DMF), chloroform, phosphate 
buffer saline (PBS); silver nanoparticles (TEM confirmed size <100nm, 
no.658804); Dulbecco’s Modified Eagle’s Medium (DMEM) and penicillin-
streptomycin antibiotic solution were purchased form Sigma-Aldrich Co. (St. 
Louis, MO, USA). Fetal bovine serum (FBS) and Trypsin (10x) were 
purchased from Gibco (Life Technologies, United Kingdom) and AlamarBlue 
BUF012B Cell Viability Assay reagent was purchased from AbD Serotec 
(Kidlington, United Kingdom). Human Dermal Fibroblasts (HDFs) were 
purchased from ATCC (Manassas, Virginia, USA) and used for the 
biocompatibility studies. Bacterial strains used for the experiments were 
purchased from ATCC (Manassas, Virginia, USA). Four gram-positive 
strains: Staphylococcus Saprophyticus (strain codes: 15305, BAA-750, 
49907, 49453) and four gram-negative strains: Klebisiella pneumoniae 
(DM4299), Escherichia coli (16027R), Pseudomonas aeruginosa (23155 
and 4299) were used for the antibacterial evaluation.  
3.2.2 Electrospinning of PLGA based nanofibrous scaffolds 
Electrospinning of PLGA 50:50, PLGA 75:25 and AgNPs incorporated PLGA 
nanofibers were carried out during this study. The polymers were individually 
dissolved in a mixture of chloroform and dimethylformamide (3:1) at a 
concentration of 25% (wt/v) for PLGA 50/50 and 20% (wt/v) for PLGA 75/25, 
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respectively. For preparation of the composite nanofibers, firstly the 
nanoparticles were added to the above solvent mixture at concentrations of 
1, 3 and 6% (wt/v) with respect to the concentration of PLGA, and stirred for 
24h by magnetic stirrer followed by ultrasound stirring (FB505, Fisher 
Scientific, Hampton, USA) for 20 min in 30 sec intervals. Further, the polymer 
(either PLGA50:50 or PLGA75:25) was added and the whole mixture was 
stirred for 12h period. Custom made electrospinning equipment used for this 
study consist of a high voltage power supply (Gamma High Voltage 
Research Inc., Florida, USA), syringe pump (KDS100, KD Scientific, 
Holliston, USA) and a flat lab jack as the collector. Polymer solution was 
loaded into 5ml syringe and attached with a 25G (0.51mm) blunt needle 
(Dickinson and Company, New Jersey, USA), which was further connected 
to high voltage power supply. The distance between the needle tip and 
collector was maintained at 12 cm. The flow rate of the solutions ranged from 
0.5 to 1.5 ml/h, while the applied electric potential ranged from 10-18 kV. 
Nanofibers were collected on aluminum foil covered jack, and dried in 
vacuum for 24h prior to characterization. For cytotoxicity and antibacterial 
studies, the scaffolds were sterilized under UV lamp for 30 min. 
3.2.3  Surface, chemical and mechanical characterization of the fibers 
3.2.3.1 Scanning electron microscopy 
Electrospun fibers were examined under the Scanning Electron Microscope 
(JEOL JSM-6010LV, Tokyo, Japan) after sputter coating with gold (JEOL 
JFC-1200 coater, Tokyo, Japan). Fiber diameter was measured from the 
SEM images by application of the  ImageJ software (National Institutes of 
Health, USA), [240] and around 80-100 measurements per sample was 
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performed. The best optimized parameters for electrospinning was identified 
upon obtaining uniform, beadles and random fibers. 
3.2.3.2 Atomic force microscopy 
Atomic Force Microscope (Nanowizard 3, JPK, Germany) was used to 
measure the surface roughness of the scaffolds. Cantilever of nominal 
stiffness of 5N/m (TAP-150G, Budget Sensors, Bulgaria) was used for 
imaging in tapping mode. Atomic force microscope (AFM) image 
measurements were done at 3 areas of size 20 x 20 µm with resolution of 
1024 x 1024 pixels which means that every average values for single image 
was based on 1024 roughness profiles. Three areas per sample were 
measured and the average roughness values were calculated.  
3.2.3.3 Contact angle 
Hydrophobicity/hydrophilicity properties of the electrospun nanofibers was 
measured by Water Contact Angle system (VCA Optima Surface Analysis, 
AST Products Inc., Billerica, USA), averaged from 5-8 individual 
measurements per sample. Each measurement was done by using 10µl of 
ultrapure water. Camera pictures were taken within 10s after the water drop 
touched the scaffolds, thus measuring their contact angle.  
3.2.3.4 Fourier Transform Infrared Spectroscopy 
Fourier Transform Infrared Spectroscopy (FTIR) measurements were done 
using Avatar 380 FTIR Spectrometer (Thermo Nicolet, Waltham, USA) over 
a range of 400-4000cm-1 at a resolution of 2cm-1.  
3.2.3.5 Universal tensile testing 
Mechanical properties of the scaffolds were determined using a Universal 
Tensile Machine (Instron 5943, USA). The electrospun mats were cut into 
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rectangular shapes (10x20 mm) and placed in UTM load cell with a maximum 
load of 250N. Size of cut samples was controlled by applying paper scaffold 
with double side tape of specify size. Next, side layers of paper scaffold was 
cut out but top and bottom paper layers were kept, in order to ensure proper 
grip to the UTM clamps. Thickness of each specimen was measured using 
digital micrometer (Multitoyo, Japan) and ranged between 80 -100 µm. 
Samples were stretched at a rate of 10 mm/min until they complete break. 
Tensile strength and Young’s modulus were obtained from the stress-strain 
curve drawn for each scaffold.  
3.2.3.6 UV-VIS spectroscopy 
Concentration of silver nanoparticles within the electrospun scaffolds was 
tested by UV-VIS spectrophotometer (UV-3600, Shimadzu, Japan). In order 
to do this, 2mg of nanofibrous sheets were individually dissolved in mixture 
of chloroform and DMF at appropriate ratios, such that an amount of 1mg 
per ml of solution was obtained.  After complete dissolution of the polymer 
and NPs, the mixture was stirred for 10 seconds with ultrasound mixer to 
break possible agglomerates of AgNPs and used for UV-Vis measurements. 
Mixture of chloroform and DMF at a ratio of 3:1 served as the reference 
during the UV-Vis study.  
3.2.4 Culture of Human Dermal Fibroblast and Cytotoxicity test 
Human Dermal fibroblasts (HDF) was cultured in complete medium that 
contained DMEM with 10% FBS and 1% antibiotic mixture and grown in a 75 
cm2 culture flask. Cells were incubated for 6 days in incubator under 
humidified atmosphere at 370C and 5% CO2. Culture media was changed 
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once every 3 days. Once the cells reached confluence, they were 
trypsinized, counted by hemocytometer and used for the assays. 
To study the cell proliferation, the nanofiber spun on cover slips (diameter of 
15mm) were placed in 24 well plate and metal ring was placed on top of the 
scaffold. Scaffolds, rings and well plates were pre-sterilized under UV light 
before using them. The scaffolds placed in 24 well plates were washed thrice 
with phosphate-buffered saline (1xPBS) and incubated overnight with 
complete culture medium in 37oC. Approximately 10 000 cells/well were 
seeded on each scaffold for cell viability test. In order to establish the 
calibration curve for cell viability assay, cells were also seeded in separate 
wells at a count of 10 000, 20 000, 40 000, 80 000, 160 000 and 320 000 
cells/well. 
The proliferation of cells on the scaffolds were evaluated by AlamarBlue® 
assay. The assay is commonly utilized to measure the proliferation of various 
human and animal cell lines, bacteria or fungi, quantitatively. The cell viability 
assays were performed at four different time points (2, 4, 6 and 8 days). On 
designated time periods, a 10% solution of AlamarBlue® in complete media 
was used to replace the media in culture well plates and kept for incubation 
for 4h at 370C.  After incubation, 100µl of the media containing AlamarBlue® 
was transferred into 96 well plates and the measurement was performed 
using a spectrophotometric plate reader (Varioscan Flash, Thermo Scientific, 
Fisher Scientific, Hampton, USA) with excitation wavelength of 545 nm and 
emission length of 590nm. In this test, cells viability is based on resazurin, a 
non-toxic, cell permeable compound which is being reduced by living cells to 
resorufin, which is fluorescent red in color. Blank wells without cells but with 
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AlamarBlue® solution was also used to minimize error. Calibration curve was 
drawn by measuring the intensity of emission for 10 000, 20 000, 40 000, 80 
000 and 120 000 cells seeded and incubated for 12 h at 370C. The curve 
linear fit to obtain a straight line and was later used to calculate the cell 
viability on each scaffold.  
3.2.5 Antibacterial properties of the scaffolds   
The antibacterial activity of the developed scaffolds was tested against four 
gram negative Klebisiella pneumoniae (DM4299), Escherichia coli (16027R), 
Pseudomonas aeruginosa (23155 and 4299) and four gram positive strains 
of Staphylococcus saprophyticus (15305, BAA-750, 49907, 49453). The 
bacterial cultures were grown overnight in Tryptic Soy Agar at 37ºC. A few 
colonies were inoculated to a turbidity of 0.5 McFarland standard and 
swabbed uniformly across a Mueller-Hinton Agar (MHA) plate which contains 
30.0% beef infusion, 1.75% casein hydrolysate, 0.15% starch and 1.7% agar 
with pH adjusted to neutral at 25 ºC. The scaffolds (size: 0.5cm x0.5cm) were 
placed on the surface of the MHA plate. In order to determine the 
antibacterial property of silver nanoparticles (positive control), 2 mg of the 
AgNPs was dispersed in 1 ml of water for injection and 100 µl was added on 
the surface of the MHA plate. All the culture plates were placed in 37 ºC 
incubator and the zone of clearance was measured after 24 h with photos 
were taken, and the experiments were performed in duplicates.       
3.3 Results and discussion 
3.3.1 Optimization of the electrospinning process and SEM analysis 
Optimization of the electrospinning process was carried out to obtain 
continuous and uniform nanofibers. PLGA50/50-NP0 was electrospun under 
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a high electric potential of 15kV and the flow rate was maintained at 0.5ml/h. 
PLGA50/50 mats with the addition of silver nanoparticles (1w%, PLGA50/50-
NP1; 3w%, PLGA50/50-NP3; 6w%, PLGA50/50-NP6) were produced under 
12kV of electric potential at a flow rate of 1ml/h. PLGA75/25-NP0 mats were 
electrospun at an electric potential of 15kV and 1ml/h, while 10kV with 1ml/h 
flow rate was used for electrospinning the nanoparticle doped PLGA75/25 
fibers (PLGA75/25-NP1, PLGA75/25-NP3, PLGA75/25-NP6). Scanning 
electron microscope (SEM) images showed bead-less nanofibers in the 
nanoscale range with uniform distribution of fiber diameters. The fiber 
diameter of PLGA75/25-NP0 were found higher than the fiber diameter of 
PLGA50/50-NP0. Incorporating silver nanoparticles into the polymer matrix 
greatly increase the electrical conductivity of the polymer solution which 
influences the minimal potential needed to create a Taylor cone and 
overcome the surface tension of the liquid, [241] which results in decreased 
fiber diameter for the AgNPs incorporated PLGA50/50 and PLGA75/25 





Figure 3.3.1 SEM images of electrospun fibers with their diameters: (A) 
PLGA50/50-NP0, (B) PLGA50/50-NP1, (C) PLGA50/50-NP3, (D) 
PLGA50/50-NP6, (E) PLGA75/25-NP0, (F) PLGA75/25-NP1, (G) 




The fiber diameter of PLGA50/50-NP0 decreased from 612 ± 144 nm to 487 
± 67 nm when a maximum amount (6 w%) of AgNPs was added. For the 
PLGA75/25-NP0 composites, the fiber diameter reduced from 781 ± 130 nm 
for PLGA75/25-NP0 to 538 ± 72 nm for PLGA75/25-NP6 scaffolds. The 
increase in the electrical conductivity of polymer solutions with incorporation 
of salts or particles were previously demonstrated by Angammana et.al, 
where they found that the fiber diameter decreased from 250 nm to 150 nm 
due to the increase in the solution conductivity with incorporation of NaCl into 
water solution of poly ethylene oxide. [242] Similar trend was also observed 
in our studies, where the fiber diameter of AgNP enriched PLGA scaffolds 
was lower than the fiber diameter of their respective pure PLGA scaffolds. 
However, further increase in the concentration of AgNPs did not cause a 
reduction in the fiber diameter. 
3.3.2 Atomic Force Microscopy 
Atomic force microscopy measurements revealed the nanofibrous three 
dimensional structure of the scaffold and the images were used to calculate 
the surface roughness of the scaffolds. Roughness of the scaffolds were 
calculated based on the average values for every scanning line in the area 




Figure 3.3.2. AFM images of the developed nanofibrous scaffolds (A) 
PLGA50/50-NP0, (B) PLGA50/50-NP1, (C) PLGA50/50-NP3, (D) 
PLGA50/50-NP6, (E) PLGA75/25-NP0, (F) PLGA75/25-NP1, (G) 




Average Roughness (Ra) is defined as the average value of roughness 
profile, while Root Mean Square Roughness (Rq) is defined as the root mean 
square average of the roughness profile. Compared to PLGA50/50-NP0, the 
average surface roughness (Ra) of PLGA50/50-NP6 scaffolds, decreased 
from 854±156nm to 510±69 nm. RMS roughness (Rq) for PLGA50/50-NP6 
was obtained as 634±59 nm, while those of PLGA50/50-NP0 was measured 
as 1055±142nm. For PLGA75/25 scaffolds, the decrease in roughness was 
gradual from a value of 841±209 nm (Ra) and 1038±221 nm (Rq) for 
PLGA75/25-NP0, leading to 322±51 nm (Ra) and 423±47 nm (Rq), 
respectively for PLGA75/25-NP6. Similar to the results of our SEM analysis, 
the roughness of the fibers reduced with the decrease in the fiber diameter, 
such that they became smoother with the increase in the amount of 




Figure 3.3.3. Average roughness (Ra) and Root Mean Square Roughness 







Wettability test was carried out for all the scaffolds prepared during this 
study. Every sample was tested 5-8 times with a drop volume of 10µl. The 
PLGA50/50-NP0 and PLGA75/25-NP0 scaffolds showed hydrophobic 
surface with a contact angle of around 130º. Addition of nanoparticles 
changed the hydrophobicity of the composite scaffolds to 126 ± 2º, 125 ± 3º 
and 124 ± 1º, respectively for PLGA50/50-NP1, PLGA50/50-NP3 and 
PLGA50/50-NP6. A similar trend was also observed for the AgNPs 
containing PLGA75/25 scaffolds. Figure 3.3.4 shows the trend in contact 
angle values for the different scaffolds of this study. No significant 
differences in the contact angle between the scaffolds were observed, 





Figure 3.3.4. (A) Change in contact angle of the scaffolds in response to the 
increased incorporation of AgNPs; and a comparative representation of the 
contact angle values for (B) PLGA50/50-NP0 (C) PLGA50/50-NP6, (D) 
PGLA75/25-NP0, (E) PGLA75/25-NP6 
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3.3.4 Fourier transform infrared spectroscopy 
The obtained spectra suggest that the addition of nanoparticles into the 
polymer matrix did not lead to significant changes in the chemical 
composition of the composite scaffolds. Intensities and localization of peaks 
did not change drastically with increased amount of silver nanoparticles. 
[243] Peaks around 1470 cm-1 showed sharper decrease of transmittance 
for polymeric systems with silver nanoparticles. Bands observed in the 
region around 1753 cm-1 are due to the stretching of carbonyl groups from 
PLGA, while peaks between 2944 and 2995 cm-1 shows the stretching 
vibrations of -CH, -CH2, -CH3 groups of PLGA (Figure 3.3.5). Also the peaks 
observed between 1250 to 1500 cm-1 (1268, 1382, and1452 cm-1) represent 
the deformation vibrations of the same groups. The peaks in the range of 
1300 – 1150 cm-1 represents ester (C-O) stretching vibrations as well as 
wagging vibrations of –CH2 and -CH (1270 and 1184 cm-1). [244] No 
significant differences between the infrared spectral images of PLGA50/50 
and PLGA75/25 was observed, and such details were also reported by 
Taheri et.al [243], nevertheless higher lactide content might be distinguished 
by the sharper peak observed at around 750 cm-1 along with a high intensity 
peak at around 1145cm-1. Absence of peaks in the range of 3600-3400 cm-1 





Figure 3.3.5 FTIR spectra of the developed electrospun scaffolds (A) 
PLGA50/50-NP0, (B) PLGA50/50-NP1, (C) PLGA50/50-NP3, (D) 
PLGA50/50-NP6, (E) PLGA75/25-NP0, (F) PLGA75/25-NP1, (G) 
PLGA75/25-NP3, (H) PLGA75/25-NP6 
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3.3.5  UV-VIS Spectroscopy 
With different concentrations of AgNPs incorporated in different scaffolds, an 
evaluation on the amount of NPs that actually got incorporated within the 
scaffold was determined qualitatively. According to Beer-Lambert law, the 
absorbance of a solution is directly proportional to the concentration of the 
absorbing compound and hence this method can be used to analyze the 
concentration of compound in the solution at a fixed path length. Increased 
absorbance with increasing amount of nanoparticles suggests increasing 
amounts of nanoparticles within the polymer matrix. Peaks in the range of 
390-420 nm are characteristic of AgNPs. [245-247] An increase in the 
intensity of the peaks was observed with increasing incorporation of AgNPs, 
with the highest peak intensity was observed for PLGA composites 




Figure 3.3.6 UV-VIS absorption spectra of PLGA-AgNPs nanofibers after 




3.3.6 Mechanical properties of the electrospun nanofibers 
Figure 3.3.7 shows the stress-strain curves of the different scaffolds obtained 
during this study. Maximum tensile strength of 4.83 ± 0.27 MPa was 
measured for pure PLGA75/25-NP0 scaffolds and it decreased to 2.55 ± 0.95 
MPa for PLGA75/25-NP6. On the other hand, PLGA50/50-NP0 showed 
lower ultimate tensile strength of 1.65 ± 0.11 MPa and it decreased to 0.71 
± 0.11 MPa for PLGA50/50-NP6. Young’s Modulus was calculated from the 
slope of the linear part of the initial strain by the method previously reported 
[248, 249]. Young’s modulus (YM) was found highest for PLGA75/25-NP0, 
and lowest for PLGA75/25-NP6 scaffold. Details of the Ultimate Tensile 
Stress, Ultimate Tensile Strain and Young’s Modulus of the different 
scaffolds are presented in Table 3.3.1.  
Table 3.3.1 Young’s Modulus, Ultimate tensile strength and ultimate tensile 









PLGA50/50-NP0 58.00 ± 8.31 1.65 ± 0.11 24.08 ± 3.36 
PLGA50/50-NP1 37.27 ± 5.99 1.26 ± 0.20 15.34 ± 1.91 
PLGA50/50-NP3 34.01 ± 10.90 1.73 ± 0.05 14.29 ± 0.81 
PLGA50/50-NP6 21.79 ± 11.58 0.71 ± 0.11 11.19 ± 1.50 
PLGA75/25-NP0 191.29 ± 14.85 4.83 ± 0.27 50.91 ± 6.63 
PLGA75/25-NP1 149.94 ± 15.29 4.59 ± 0.42 62.98 ± 6.82 
PLGA75/25-NP3 135.44 ± 11.61 2.91 ± 0.08 12.84 ± 1.21 
PLGA75/25-NP6 112.83 ± 4.34 2.55 ± 0.95 23.50 ± 3.14 
 
Significant decrease in Young’s Modulus of these scaffolds, measured 
respectively as 191.29 ± 14.85 and 58.00 ± 8.31 MPa due to differences 
between molecular weight between PLGA75/25-NP0 and PLGA50/50-NP0.  
Introduction of AgNPs decreased the stiffness of PLGA75/25-NP6 scaffold 
by 41% compared to pure PLGA75/25-NP0, while 62% reduction in stiffness 




Figure 3.3.7 Stress-strain curves obtained for (A) PLGA50/50 and (B) 
PLGA75/25; (C) trend in Young modulus of the developed scaffolds with 
respect to the amount of AgNPs incorporated into fibers   
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3.3.7 Proliferation of HDF on the electrospun scaffolds 
HDF proliferation on the scaffolds was determined by AlamarBlue™ assay 
during day 2, 4, 6 and 8. Calibration curve was obtained after seeding a 
known amount of cells in 24-well plate and the measurement was taken 
approximately 12h post-seeding. Student’s t-test was done by in order to 
check statistical significance of obtained results. Linear fitting of the 
calibration curve was performed and this was used to estimate the number 
of cells present on the scaffolds. For cell proliferation study, the cover slips 
containing the nanofibers were sterilized under UV light for 2h. By day 8, the 
cell proliferation on TCP (control) increased by 50%. The number of cells 
was found to increase during the cultivation time on all scaffolds. TCP 
samples at day 8 of cultivation showed higher proliferation rate by 11.6% and 
16.5% than PLGA75/25-NP0 and PLGA50/50-NP0 respectively. The cell 
proliferation assay on PLGA75/25-NP0 and PLGA50/50-NP0 scaffolds 




Figure 3.3.8 Proliferation of HDF determined by Alamar blue test (* 
Significant against cell proliferation on PLGA50/50-NP6 scaffold at p ≤ 0.05; 
# Significant against cell proliferation on PLGA75/25-NP6 scaffold at p ≤ 
0.05) 
Our cell proliferation studies showed that an incorporation of 1w% of AgNPs 
did not cause any negative cell response and the proliferation rate was 
similar to that of the pure polymer matrix. Further increase in the 
concentration of the nanoparticles caused an increase in the cell proliferation 
rate (65.6%) on PLGA75/25-NP3 and (62.8%) PLGA50/50-NP3 scaffolds.  
However, the incorporation of 6w% of nanoparticle was found toxic to 




3.3.8 Antibacterial activity of PLGA-NPs 
Antibacterial activity was measured against four types of bacteria: Klebisiella 
pneumoniae, Escherichia coli, Pseudomonas aeruginosa and 
Staphylococcus Saprophyticus. Three different strains of Staphylococcus 
Saprophyticus and two different strains of Pseudomonas aeruginosa were 
also used for this study. Bacteria free area was measured as the zone of 
inhibition for both gram positive and gram negative bacteria, in order to 
determine the potential of antibacterial activity of the scaffolds. Pure PLGA 
nanofibrous mat was used as the negative control, while 1mg of AgNPs itself 
served as the positive control. No antibacterial activity was observed for 
PLGA50/50 and PLGA75/25 nanofibers, while higher concentration of silver 
nanoparticles within the composite scaffolds enhanced the antibacterial 




Figure 3.3.9 Antibacterial activity of the different electrospun scaffolds 




Figure 3.3.10. Antibacterial activity of the different electrospun scaffolds 




Due to the presence of higher concentrations of the antibacterial agent 
(AgNPs), the positive control showed significantly larger bacteria free circles 
in all cases from 0.8 cm for Escherichia coli (16027R) and Pseudomonas 
aeruginosa (PA23155); and up to 2.3 cm for Staphylococcus sarophyticus 
(SS49907).  For the PLGA50/50, the antimicrobial activity ranged from 0.4 
cm (PLGA50/50-NP1) and went up to 1.2 cm (PLGA50/50-NP6) for gram 
positive Staphylococcus sarophyticus (SS15305 and SS49907). For gram 
negative bacteria, this ranged from 0.5 cm (PLGA50/50-NP1) for Klebisiella 
pneumoniae (DM4299) and Pseudomonas aeruginosa (PA23376) and up to 
1.1 cm for PLGA50/50-NP6 using the same strains. Lowest activity for PLGA 
50/50-NP6 was observed for Escherichia coli (16027R gram negative) and 
Staphylococcus saprophyticus (SS49453 gram positive) with values of 0.9 
and 0.6 cm, respectively. For PLGA75/25-NP1, the lowest values of 0.3 cm 
were observed for gram positive Staphylococcus saprophyticus (SS49907) 
and 0.2 cm for gram negative Escherichia coli (16027R).  Both the PLGA 
polymers with 1% AgNPs showed no antimicrobial activity for following 
strains: Staphylococcus saprophyticus (SSBAA750 and SS49453), 
Escherichia coli (16027R) and Pseudomonas aeruginosa (PA23155) (Table 
3.3.2). Scaffolds with concentration of AgNPs of 3w% and higher showed 
satisfactory antibacterial properties comparable to free AgNPs. It is important 
to keep maximal antimicrobial activity with possible minimal concentration of 
NPs inside the polymeric matrix and an incorporation of 3w% of NPs was 
also compatible with fibroblasts, while they showed high antibacterial 
properties. Moreover, PLGA75/25 polymer with 3w% of AgNPs showed 
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sufficient mechanical properties similar to native skin, and are more suitable 
compared to other scaffolds of this study, to apply as a skin patch for 





Table 3.3.2 Antibacterial zone of inhibition of different electrospun scaffolds along compared to AgNPs itself.  All values are 














DM4299 16027R PA23155 PA23376 SS49907 SS15305 SSBAA750 SS49453 
Gram negative/ 
gram positive. 
(-) (-) (-) (-) (+) (+) (+) (+) 
Silver NPs 1.8-1.9 0.8 0.8 2.1 2.3 1.6 1.1-2.4 1.4-1.5 
PLGA50/50-NP0 0 0 0 0 0 0 0 0 
PLGA50/50-NP1 0.5 0 0 0.5 0.5 0.4 0 0 
PLGA50/50-NP3 0.5 0.8 0.8-0.9 0.4-0.5 0.5 0.4-0.5 0.7-0.9 0.3-0.4 
PLGA50/50-NP6 1-1.1 0.9 1.0 1-1.1 1.1-1.2 1-1.1 0.9-1.1 0.6-0.7 
PLGA75/25-NP0 0 0 0 0 0 0 0 0 
PLGA75/25-NP1 0.4-0.5 0 0 0.5 0.3 0.3-0.4 0 0 
PLGA75/25-NP3 0.5-0.7 0.2-0.4 0.4 0.3-0.6 0.4 0.4 0.5 0.3-0.4 







Silver nanoparticles provide a very large surface area and are a good source 
of silver ions, such that they can act like growth-inhibitors against the 
microorganisms. Recent discoveries showed direct anti-inflammatory 
properties of AgNPs with ability to enhance the healing process of living 
tissues. [250] Use of silver nanoparticles in wound healing have also been 
demonstrated with better collagen alignment along the treated wound 
compared to the control group. [219, 251, 252] Electrospinning technique 
allows for the fabrication of nanofibrous structures from a variety of polymers 
and allow for the incorporation of silver nanoparticles within the scaffold. 
Additionally, synthetic aliphatic block polymers like PLGA introduces 
biodegradability which is essential for the treatment of wounds without the 
need of multiple surgeries. Nanofibrous morphology of the scaffolds are 
especially interesting in the field of skin tissue engineering due to its ability 
to mimic the natural ECM. Random alignment of fibers, high porosity and 
extraordinary surface-to-volume ratio induces cells to proliferate and assist 
in tissue regeneration. The biodegradability of matrix polymer allows for its 
replacement by natural ECM during the wound healing process.  
Analysis of the morphology of the prepared scaffolds by AFM, showed 
connection between surface roughness and wettability. Roughness of 
prepared scaffold was shown to be sufficient in order to enhance cell 
proliferation as well as ensure exchange of water and nutrients. Obtained 
scaffolds were shown to be hydrophobic and no significant change was 
observed after addition of silver nanoparticles due to shielding effect of 
polymeric matrix, and scaffolds remained hydrophobic. Addition of AgNPs 
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into the polymer solution increases the electrical conductivity of the solution, 
which influence the electrospinning process resulting in the decrease of fiber 
diameters. Fiber diameters changed drastically after addition of even smaller 
amounts of AgNPs, though the differences in fiber diameter was not 
significant among the different PLGA-NPs scaffolds. Lower porosity of 
densely packed fibrous mesh reduced the roughness of the scaffold, and our 
results of wettability was in agreement to the results of the AFM studies. [253, 
254] 
Mechanical property evaluations of the prepared scaffolds showed that the 
ultimate tensile stress of PLGA75/25-NP3 was similar to those of the ultimate 
tensile stress values of the human skin tissue. Human abdomen and thorax 
were reported to have a UTS of 2-15 MPa [255] while forehead and arm are 
suggested to have a UTS of 5.7-12.6 MPa [256]. The nanocomposites 
prepared during this study had UTS values of approximately of 1-5 MPa, and 
are suggested for wound dressing applications. Young’s modulus of the 
scaffolds decreased with the addition of AgNPs, but it was still comparable 
to the YM of natural skin tissue. [256, 257] Decrease in the stiffness of the 
scaffolds is due to the presence of AgNPs which act as a lubricant within the 
polymeric matrix, mobilizing the fibers to move between each other. At the 
same time, the ratio of lactide:glycolide is known to influence the ultimate 
stress, since the amorphous glycolide impart lower mechanical properties to 
the scaffold. [258] In fact, the incorporation of AgNPs to the polymer matrix, 
did not help to strengthen the scaffold, and a mere integration of the polymer 
with the metallic particles might have occurred and act like breaking points 
within the polymer chains. Increase in the amount of AgNPs within the 
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polymer matrix, increased the chances of fiber breakages when mechanical 
stress was applied and this was confirmed from the reduced values of 
ultimate tensile stress and strain obtained for 6 w% AgNPs containing PLGA 
scaffolds. 
Spectroscopic measurements showed the interaction between polymer 
matrix and AgNPs, with increased absorbance values was obtained with 
increased incorporation of AgNPs. No changes in matrix properties have 
been measured which suggests no specific bonding between the 
components and this allows the silver to be present in its ionic form. 
Dispersed AgNPs inside the polymeric matrix release the silver cations and 
introduces antibacterial activity against the gram negative and gram positive 
bacterial strains (Staphylococcus sarophyticus, Klebisiella pneumoniae, 
Pseudomonas aeruginosa and Escherichia coli) used in this study. Since the 
amount of silver ions released is proportional to the concentration of the 
AgNPs incorporated within the polymer matrix, the antimicrobial activity also 
increased, and this was highly observed for the PLGA-NP6 scaffolds.  
Antibacterial activity of the electrospun nanofibers incorporated with AgNPs 
was also compared with the antibacterial activity of pure silver nanoparticle 
powder, used as the positive control. The antimicrobial properties of silver 
nanoparticles are still not fully understood, nevertheless a number of 
researchers have investigated interaction between bacteria and fungus and 
silver nanoparticles or ions. Antimicrobial mechanism of silver nanoparticles 
is complex and multi-site reaction between nanoparticles, silver ions and cell 
membrane as well as organelles. Silver nanoparticles anchor itself to cell 
membrane and infiltrate causing changes in its permeability eventually 
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resulting in cell death. Silver NPs also have a tendency to agglomerate onto 
the membrane of the bacteria [134, 239]. Other group of researchers focused 
on the creation of free radicals by silver nanoparticles and the interaction of 
those with cell organelles was suggested. Electron spin resonance 
spectroscopy studies revealed that the silver nanoparticles released free 
radicals when in contact with bacteria further leading to the infiltration of cell 
membrane, making it porous and finally cell death occurred. Silver ions 
release from AgNPs interact with thiol groups of bacteria cell, causing the 
Inactivation of vital enzymes which further inhibits the cell metabolism rate. 
[259, 260] The differences in their antibacterial activity is mainly related to 
the mode of existence of Ag, such that the silver was dispersed within the 
nano-scale fibrous material for the electrospun scaffolds, while the 
concentrated silver nanoparticle powder functioned as the positive controls. 
About 1mg of Ag powder was used to test on all strains simultaneously with 
the prepared scaffolds. Free AgNPs at a concentration of 1mg, showed 
better antibacterial properties than AgNPs containing scaffolds. However 
lesser amounts of AgNPs could introduce less toxicity to cells, and we 
observed 3% AgNPs within PLGA as the optimal scaffold with good 
antibacterial properties, which might be due to the uniform distribution of 
AgNPs within the polymer matrix. At the same time, PLGA composites 
containing 6w% of AgNPs had similar activity as 1mg of pure agglomerated 
silver nanoparticle powder itself. Nevertheless, the cell proliferation on 
scaffolds containing 6w% of AgNPs is minimal suggesting certain extent of 
toxic properties of AgNPs. The presence of 3w% of AgNPs in PLGA matrix 
showed higher biocompatibility with HDF, with positive attribute towards 
96 
 
antibacterial properties. This results are in accordance with the results 
demonstrated by Rinaldi et al. [261] where they combined AgNPs with PLGA 
shells in the form of composite nanocapsules. The presence of 3w% AgNPs 
inside the nanospheres showed high antimicrobial properties. However, the 
isolation of antimicrobial agents within the nanospheres limits the ability of 
such system as wound dressings. Mohiti-Asli et al. [262] showed decrease 
in the viability of HDF and human epidermal keratinocytes on poly(l-lactic 
acid) scaffolds, when silver ion release exceeded some typical value and it 
was specific for each type of cells. Similarly, Chaubey et al.[220] showed that 
an increase in the level of AgNPs above certain levels decreased the viability 
of Hela (cervical cancer cells) and MCF-7 (breast cancer cells). Though the 
toxicity of silver nanoparticles has been investigated previously, there is still 
no conclusion regarding the mechanism of the metabolism process occurring 
inside the human cells. Few research groups suggest that the size and 
concentration of silver particles are the main factors involved in this process. 
[263] Our results shows that an optimal amount of 3w% of AgNPs was 
sufficient to produce biodegradable PLGA composite scaffolds with suitable 
mechanical, antibacterial and cytotoxic properties to functional as a 
bioengineered skin graft for regeneration of wounds.  
3.5 Conclusions 
Various biodegradable and non-biodegradable materials have been tested 
as carriers for silver nanoparticles or silver ions, thus improving the 
antibacterial properties of the developed scaffolds. The integration of silver 
nanoparticles within the PLGA matrix was carried out during this study 
creating nanofibrous scaffolds with mechanical properties comparable to 
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various skin tissues. The antibacterial activity of the scaffolds was evaluated 
against Pseudomonas aeruginosa, Klebisiella pneumoniae, Staphylococcus 
Saprophyticus and Escherichia coli, and the scaffolds were found to inhibit 
the bacterial growth, which was also dependent on the concentration of 
AgNPs incorporated within the scaffold. However, high concentrations of 
AgNPs inside the polymeric matrix showed toxicity against Human Dermal 
Fibroblasts lead us to the conclusion that the antibacterial activity must be 
compromised with cytotoxicity of biodegradable antibacterial nanofibrous 
materials and the concentration of silver nanoparticles must be adjusted on 
the level which preserves the antibacterial activity with minimal toxicity to 
cells. The electrospun PLGA75/25 incorporated with 3w% AgNPs had 
sufficient mechanical properties, induced cell proliferation and have sufficient 
antibacterial activity to be used as wound dressing for treatment of skin 
injuries, burns or chronic wounds. 
  
(NOTE: Most of the text and results in this chapter have been published and 
reprinted from Journal of Applied Polymer Science (132) 2015; 42686; 
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Rajamani Lakshminarayanan and Seeram Ramakrishna. “Silver 
nanoparticle incorporated poly(l-lactide-co-glycolide) nanofibers: Evaluation 
of their biocompatibility and antibacterial properties” DOI: 







Fabrication and evaluation of polymeric poly(L-lactide-co-
glycolide) nanofibers incorporated with antimicrobial 
layered perovskite Ag0.3Na1.7-La2Ti3O10 
4.1 Introduction 
Antimicrobial materials are gaining more and more interest in scientific 
community. Development of antibiotic resistant strains as well as new insight 
into wound healing mechanisms on a cellular level, allowed for development 
of new materials that not only protects wounds from infection, but actively 
fighting pathogens around wound and stimulate tissue for self-regeneration. 
Those materials include various polymeric structures with proteins, metal 
oxides, metal nanoparticles particles as well as antibiotics and growth 
factors. Rising amount of antibiotic resistant microbes, forced researcher to 
find materials that could limit use of antibiotics in wound management. [264-
266]  
Perovskites are a group of ceramic materials based on crystallographic 
structure of calcium titanium oxide (CaTiO3). Standard cell unit can be 
altered during synthesis with creation of double or layered structures. [267] 
In recent years a number of materials with perovskite structure have been 
proposed as novel materials due to its unique electric and magnetic 
properties. So far the biggest interest of use of this new structures lies within 
solar cell technology, due to much higher efficiency than traditional materials. 
[268, 269] Synthesis of perovskites allows for construction of structures with 
various properties and arrangement of atoms, with possible substitution of 
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atoms in ceramic lattice and production in sub-micron range of particles. 
Recently antimicrobial behaviors of some custom synthesized perovskites 
have been proposed for wound healing. [270] 
Titanium oxide (TiO2) is very well known material with antimicrobial 
properties. However commercially it is being used in skincare as excellent 
UV absorber as well as pigment and thickener of the product and in industry 
as catalyzer. [271] Titanium oxide as antimicrobial nanoparticle have been 
proven to work against most gram positive and gram negative bacteria. [272, 
273] 
Silver is very known antimicrobial material with long history of usage, dated 
back to XX century. Because it was not extensively used in the last century, 
bacteria’s and fungi did not gained resistance against silver. [274] Complete 
mechanism of reaction between silver and bacteria cell is not completely 
known so far, nevertheless it was suggested that silver ions and particles are 
accumulated on multiple sites on the cell membrane, changing its 
permeability as well as interact with DNA and inhibits enzymatic balance. 
This multisite reaction gives silver significant advantage over traditionally 
used antimicrobial agents. [275] Studies on silver nanoparticle cell intake 
showed that in higher amounts it becomes toxic due to accumulation of 
nanoparticles within the cell structures. [276, 277] 
Use of antimicrobial perovskite materials in advanced wound dressing, have 
a potential to limit cell toxicity but preserve antimicrobial behavior of the 
dressing. During synthesis process atoms in perovskite lattice can be 
substituted with silver atoms and released in form of ions into the wound to 
ensure antimicrobial activity. Antimicrobial perovskites have been proven to 
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be efficient against gram negative and gram positive bacteria with minimal 
cytotoxicity. [211-215]  
Electrospinning technique is one of the methods of production of nanofibrous 
non-woven polymeric or ceramic materials with high scaling up potential. 
This electro-hydrodynamic process utilizes polymer solution in organic or 
non-organic solvent as well as polymeric blends or polymers mixtures with 
additional proteins, particles, antibiotics or precursors. [278] Modifications of 
this method are used to produce nanoparticles (electrospraying) with 
embedded active agents for drug delivery purposes [279] or microfibers from 
polymer melts (melt electrospinning) [146]. In recent years a number of 
nanofibrous systems have been produced by this method. Nanofibers are 
especially interesting materials in wound management because of its high 
porosity, high strength, controllable composition, ability to release drugs or 
other compounds, very high surface to volume ratio and permeability to 
vapor. Therefore, nanofibrous wound dressings are able to ensure sufficient 
protection against microbes due to possible incorporation of active agents 
and maintaining suitable microclimate between wound and dressing. [280] 
Moreover creating dressings from biodegradable polymeric matrix gives 
additional control over release of antimicrobial agents and allows dressing to 
be used internally to prevent deep surgical site infections. Poly (lactide-co-
glycolide), also called PLGA is a biodegradable polymer which undergoes 
hydrolytic degradation in living organism with harmless degradation 
products. By controlling ratio of lactide to glycolide monomers, degradation 
time of this polymer can be controlled within period of time of 4 weeks up to 
2 years. [281, 282]  
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This work summarizes work on synthesis of layered perovskite Na2La2Ti3O10 
by solid state synthesis and substitution of sodium atoms with silver in order 
to create Ag0.3Na1.7La2Ti3O10 perovskite. Particles of perovskite have been 
next incorporated within PLGA nanofibrous scaffolds by electrospinning 
method, what have not been reported before. This novel material has been 
characterized by SEM, FTIR and UTS. Antimicrobial properties were 
evaluated, against the gram positive and gram negative bacteria strains: 
Staphylococcus sarophyticus, Klebisiella pneumoniae, Pseudomonas 
aeruginosa and Escherichia coli to investigate the potential of utilizing these 
nanofibrous scaffolds as novel wound dressings. Also cytotoxicity of 
substituted and non-substituted perovskite has been evaluated in order to 
obtain optimum non-cytotoxic concentration of material in cell culture. 
Perovskite materials and perovskite embedded into PLGA nanofibrous 
membranes was assessed with human dermal fibroblasts (HDF) by Alamar 
Blue® assay. In this work we will show that in this perovskite structure, 
antimicrobial properties are related to presence of silver ions within structure 
instead of titanium oxide present in the structure.  
4.2 Materials and methods 
4.2.1 Materials 
Poly(L-lactide-co-glycolide) with L:G ratio 75:25 (B6007-1, PLGA 75/25) with 
an inherent viscosity of 0.55 - 0.75, was purchased from LACTEL Absorbable 
Polymers (Durect, Birmingham, AL, USA). Dimethylformamide (DMF), 
chloroform, dimethylformamide (DMF) phosphate buffer saline (PBS); 
sodium carbonate (E5460), lanthanum (III) nitrate (238554), titanium oxide 
(634662) and silver nitrate (209139), Dulbecco’s Modified Eagle’s Medium 
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(DMEM) and penicillin-streptomycin antibiotic solution were purchased form 
Sigma-Aldrich Co. (St. Louis, MO, USA) and used without further purification. 
Fetal bovine serum (FBS) and Trypsin (10x) were purchased from Gibco 
(Life Technologies, United Kingdom) and AlamarBlue BUF012B Cell Viability 
Assay reagent was purchased from AbD Serotec (Kidlington, United 
Kingdom). Human Dermal Fibroblasts (HDFs) were purchased from ATCC 
(PCS-201-012, Manassas, Virginia, USA) and used for the biocompatibility 
studies. Bacterial and fungi strains used for the experiments were purchased 
from ATCC (Manassas, Virginia, USA). Four gram-positive strains: 
Staphylococcus Saprophyticus (strain codes: 15305, BAA-750, 49907, 
49453) and four gram-negative strains: Klebsiella pneumoniae (DM4299), 
Escherichia coli (16027R), Pseudomonas aeruginosa (23155 and 4299) 
were used for the antibacterial evaluation. 
4.2.2 Synthesis of perovskite particles 
Layered perovskite with Ruddlesden-Popper (R-P) phase material 
Na2La2TiO3O10 was synthesized by solid state synthesis method by mixing 
ingredients in molar weight and subject mixture to high temperature. [283, 
284] Lanthanum nitrate (La(NO3)3), titanium oxide (TiO2) and sodium 
carbonate (Na2CO3)  were mixed in molar ratios of 2:3:1.6. Excess of sodium 
carbonate of 60% (mol) was add intentionally in order to compensate mass 
loss during synthesis. Mixed powders were placed in alumina crucible and 
dried at 105oC for 10h in air. Next mixture was calcined at 500oC for 10h and 
heated to 1000oC for 5h. After synthesis material was washed in distilled 
water and dried at 105oC for 10h. To achieve ion exchange 1 mol of prepared 
Na2La2TiO3O10 powder was mixed with 0.3 mol of AgNO3 in presence of 
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distilled water (10% suspension) and heated to 600C with magnetic stirrer for 
6h in dark vessel. After ion exchange product was filtered, washed with 
distilled water and dried at 105oC for 10h.  
4.2.3 Electrospinning of perovskite incorporated fibers 
Nanofibers in this work were prepared by electrospinning method from 
mixture of PLGA 75/25 polymer and perovskite compound. 1, 5, 10 and 15% 
of perovskite were added to mixture of chloroform and DMF with ratio of 1:3 
and stirred for 24 h by magnetic stirrer, followed by ultrasound stirring 
(FB505, Fisher Scientific, Hampton, USA) for 20 minutes in 30 s intervals. 
Next, 25% (wt/v) of PLGA75/25 polymer was added and stirred for 12 h in 
magnetic stirrer in order to completely dissolve polymer. Solution was mixed 
again with ultrasound stirrer prior to electrospinning. Electrospinning 
equipment of this study consists of High-voltage power supply (Gamma High 
Voltage Research, FL, USA), syringe pump (KDS100, KD Scientific, 
Hollistion, MA, USA), and a flat collector. Prepared polymer solution was 
placed in 5ml syringe and blunt needle with diameter of 0.51 mm (25G, 
Dickinson and Company, NJ, USA) was used as electrode. All solution was 
electrospun under 13.7-14.0 kV voltage applied and distance from collector 
of 13-14 cm with polymer flow of 1.2 ml/h. Prepared scaffold were finally 
placed in vacuum chamber for 24 h prior to characterization in order to 
remove solvent residues. Sterilization of scaffolds before cell culture and 
antimicrobial tests was done by placing materials under UV lamp for 30 
minutes and kept in sealed sterile environment.  
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4.2.4 Characterization of Electrospun Nanofibers 
Scanning Electron Microscope (FESEM Hiachi S-4300, Japan) was used to 
examine and measure diameters of prepared scaffolds. Scaffolds were 
sputter coated with gold (JOEL JFC-1 200, Tokyo, Japan) before analysis. 
Diameters of the fibers were measured and analyzed by Image J Software 
(National Institutes of Health, USA). 100 measurements per sample were 
performed and average value as well as standard deviation have been taken 
under further consideration. Mechanical properties of scaffolds were 
calculated from Universal Tensile Machine (Instron 5943, USA) 
measurements results. Each samples were cut to rectangular shape (10 x 
20 mm) and placed in load cell with maximum force of 250 N. Thickness of 
scaffold sheet was measured with micrometer (Multitoyo, Japan) in three 
places and average value was taken under consideration. Thickness of 
samples varied between 80-100 μm. UTS measurements were done with 
rate of 10 mm/min until complete separation. Young modulus (YM) for 
subsequent samples was calculated from stress strain curves, by applying 
linear fit to curve in region of 1-5% of elongation. Ultimate tensile stress 
(UTS) and ultimate tensile strain were taken as maximum values from stress 
strain curve.  
Hydrophilic properties of materials have been measure by Water Contact 
Angle (VCA, Optima Surface Analysis, AST Products, Billerica, MA, USA). 
Values have been averaged from 3 measurements per sample and 
presented together with SEM analysis. For each measurement 10μl of ultra-
pure water was placed on surface of the scaffold and picture was taken within 
10s afterwards. Fourier transform infrared spectroscopy (FTIR) were 
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conducted on Avatar 380 FTIR Spectrometer (Thermo Nicolet, Waltham, 
MA, USA). Range of 400-4000 cm-1 was scanned with resolution of 2 cm-1.  
X-Ray Diffraction (PanAlytical MRD X-Ray Diffractometer, Spectris, UK) and 
particle size measurements (Zetasizer Nano S; Malvern Instruments Ltd, 
UK) were conducted. XRD measurements were done by using Cu-Kα 
radiation (40.0 kV, 30.0 mA) in continuous scan between 5.0 – 65.0 degrees 
with speed of 2 degrees per minute. Zeta-sizer samples were prepared by 
placing 100mg of powder in 1ml of distilled water and particles distribution 
was measured in 25oC wit set dispersant RI of 1.330.  
4.2.5 Culture of Human Dermal Fibroblasts 
HDF were cultured in medium composed of DMEM with 10% FBS and 1% 
antibiotic mixture. Cells were grown in 75 cm2 flask for 6 days in incubator 
under humidified atmosphere at 37oC and 5% CO2 until 70% confluence. 
Culture medium was replaced every 3 days. Subsequently cells were 
trypsinized, counted and used for further experiments. HDF were cultured on 
surface of the scaffolds prepares especially for this experiment. Scaffold 
were electrospun on glass cover slides and sterilized under UV light for 2 h. 
Glass slides (15 mm in diameter) were placed in 24 well plate with clean 
glass slide used as control group (TCP). In order to secure polymeric 
scaffolds on surface of the glass slip, metal rings were placed on top of every 
sample. Scaffolds in well plates were washed thrice with phosphate-buffered 
saline (1 x PBS) and immersed in complete culture medium. So prepared 
material was placed in incubator at 37oC for 24 h. Approximately 10 000 cells 
were placed in the each well for viability test and cultivated for 8 days with 
AlamarBlue® assay performed every second day. Calibration curve was 
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calculated by seeding 10,000, 20,000, 40,000, 80,000, 160,000 and 320,000 
cells/well and performing AlamarBlue® assay after 12 h. Amount of cells was 
calculated by substituting results to linear fitting equation from calibration 
curve. AlamarBlue® assay is commonly utilized to quantitatively measure 
viability of human and animal cell lines. Those assays were performed at four 
time points of experiment (2, 4, 6 and 8 days). During test day 10% of 
AlamarBlue® in complete media was used to replace medium in the well and 
incubated for 4 h at 37oC. 10 samples of volume of 100μl from each 
incubated well was transferred to a 96 well plate. Readings from each well 
were performed by spectrophotometric plate reader (Varioscan Flash, 
Thermo-Fisher Scientific, Hampton, USA) with exciation and emission length 
of 545 nm and 590 nm respectively. Test viability in AlamarBlue® assay is 
based on reduction of resazurin to resofurin which shifts excitation 
wavelength towards red. In order to minimize error of measurement, two 
wells were filled with blank assay and incubated together with scaffolds and 
measured values were deducted from samples measurements.  
4.2.6 Antimicrobial Properties of the Scaffolds 
Antimicrobial activity of nanofibrous scaffolds were performed on four Gram 
negative K. pneumonia (DM4299), E. coli (16027R), P. aeruginosa (23155 
and 4299) and four Gram positive S. saprophyticus (15305, BAA750, 49907, 
49453) strains as well as two species of fungi C. albican (CA1976, CA2672). 
All cultures were grown overnight in Tryptic Soy Agar at 37oC. Mueller-Hinton 
Agar (MHA) contained: 30.0% beef infusion, 1.75% casein hydrolysate, 
0.15% starch, and 1.7% agar with natural pH at 25oC. Colonies were 
inoculated in turbicity of 0.5 McFarland standard and swabbed uniformly 
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across agar surface. Scaffolds of size of 0.5 x 0.5 cm were placed on the 
surface of agar plate and incubated for 24 h. Non-substituted and substituted 
perovskite material was dissolved in water in concentration of 2 mg of 
powder in 1 mL of distilled water. 100 μL of this solution was placed on MHA 
plate surface. All experiments were performed in duplicates and 
measurements of bacteria and fungi free zones were done after 24 h of 
incubation at 37oC.  
4.2.7 Confocal microscopy of Human Dermal Fibroblast on the surface 
of scaffolds 
 Confocal laser scanning microscopy (LSCM) was performed on scaffolds on 
day 8 of cells cultivation on LSM-700 microscope system (LSM-700, Carl-
Zeis, Gemrany). Firstly, scaffolds were washed with complete media twice 
at 37oC. 4% of formaldehyde (Sigma Aldrich Co.) was added in amount of 
200 μL per well and kept for 20 minutes at -20oC. Scaffolds were raised twice 
with PBS at room temperature subsequently. Next 0.1% Triton X 100 
(Sigma-Aldrich Co.) solution was added to wells and kept for 90 seconds and 
washed again with PBS trice. 3% Bovine Serum Albumin (BSA) was next 
added to well and kept for 30 min at room temperature. BSA was replaced 
with Phalloidin TRITC (Sigma-Aldrich Co.) diluted in ratio of 1:600 and DAPI 
in dilution of 1:1000 (Sigma-Aldrich Co.) and kept in room temperature for 40 
min. After staining scaffolds were raised four times with PBS and gently 
shake. All scaffolds were kept in PBS overnight before analysis. Vectashield 
mounting was used to prepare samples for microscopy. 40x lens was used 
for all experiments (EC Plan-Neofluar 40x/1.30 Oil DIC M27, Carl Zeiss) with 
excitation wavelengths set to 488 and 405 nm and pinhole set to 45 μm.  
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4.3 Results and discussion 
4.3.1 Perovskite particle analysis 
Size of the perovskite particles synthesized in this work was measured by 
ZetaSizer Nano S. Each sample was measured trice and experiment was 
doubled in order to obtain statistically relevant data.  Results revealed size 
of non-substituted perovskite of 424.4 ± 13.0 nm and 484.8 ± 14.1 nm for 
substituted material. Analyzing of size also particles showed presence of 
residual phase with size around 5000 nm in amounts ranging from 1-5% of 
whole volume (Figure 4.3.1.). 
 
Figure 4.3.1. Size distribution of (A) Ag non-substituted and (B) Ag 
substituted perovskite particles 
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4.3.2  X-Ray Diffraction of Perovskite particles 
X-Ray Diffraction was performed on non-substituted and substituted 
perovskite material with scanning range of 5-65o. Obtained spectrum was 
analyzed by Match 2 software (Match2!, Crystal Impact, Germany) and fitting 
by Rietveld method (FullProf) between experimental and theoretical data 
was used with Crystallography Open Database (COD_07_01_2015) as 
reference data (Figure 3.3.2.). Results showed reflection conditions for 
Na2La2TiO3O10 and Ag0.3Na1.7La2Ti3O10 to be h +k +l = 2n what indicates 
tetragonal crystalline structure of both obtained compounds [285]. Because 
of difference between atom sizes of Na+ (0.98 Å) and Ag+ (1.13 Å) 
substitution to Na2La2TiO3O10 do not results in change in crystalline structure 
due to tetragonal structure limitations. Therefore unit cell parameters for both 
compounds were calculated as follows: Na2La2TiO3O10 (a = 3.8331 Å, c = 
28.6428 Å and z = 2); Ag0.3Na1.7La2Ti3O10 (a = 3.8382 Å, c = 28.6545 Å and 
z = 2) what is in agreement with previously reported data. [214] Because of 
atoms size difference and small amount of silver added to the system, very 




Figure 4.3.2. XRD spectrum of: (A) Na2La2TiO3O10 and (B) Ag0.3Na-
1.7La2Ti3O10 with respective standard data 
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4.3.3  Electrospinning Process Optimization ad SEM analysis 
All scaffolds were electrospun under this same conditions (25oC and 
humidity of approximately 60%) with polymer flow of 1.2 mL/h and electric 
potential of 13.7-14.0 kV. Distance between needle and collector was set to 
12-13 cm. Initial quality of fibers was evaluated on optical microscope. Fiber 
diameters was measured in 100 points on every picture of magnification of 
3 000 x. All measurements were done in ImageJ software. Average of fiber 
diameters decreased from 610 ± 15 nm (PLGA-1P) to 408 ± 80 nm (PLGA-
15P) with addition of perovskite material to polymeric matrix. Increase of 
diameter between pure polymeric matrix (PLGA-0P) and incorporated 
material (PLGA-1P) was not statistically significant (Figure 3.3.3.). Also 
decrease in diameter between PLGA-10P and PLGA-15P is insignificant, 
nevertheless change of diameter between incorporated and non-
incorporated fibers remains detectable. Distribution of fiber diameters also 
showed shift of median value, towards smaller diameters with increase of 
perovskite concentration (Figure 4.3.4.). All histograms showed Gauss 





Figure 4.3.3. Scanning electron micrographs of electrospun nanofibers and 
respective contact angle photographs of the material surface: (A) PLGA-0P; 




Figure 4.3.4. Average and Distribution of measured fiber diameters vs 
concentration of perovskite 
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4.3.4 Mechanical Properties and Contact Angle of Electrospun Fibers 
All scaffolds prepared by electrospinning process were evaluated with 
Universal Tensile Machine. Examples of stress-strain curves and values of 
Young Modulus, Ultimate Tensile Strain and Ultimate Tensile Stress have 
been presented on Figure 4.3.5. Calculation of Young Modulus showed 
similar values between PLGA-0P and PLGA-1P of 130.80 ± 7.54 and 139.12 
± 7.33 MPa respectively. Increase of perovskite content showed stable 
decrease of Young Modulus from 94.50 ± 3.51 MPa for PLGA-5P, through 
83.65 ± 6.56 MPa for PLGA-10P, and 74.59 ± 7.21 MPa for PLGA-15P. 
Similar behavior for Ultimate Tensile Strain and Ultimate Tensile Stress was 
observed for increasing amount of perovskite. Maximal strain we have 
observed showed value of 254.42 ± 53.04 % for PLGA-0P. Immobilization of 
polymer chains by particles decreased Young Modulus and maximum strain 
of scaffolds to 94.82 ± 3.98 % for PLGA-1P and 56.63 ± 9.68 % for PLGA-
15P. Maximum stress that can be applied to scaffolds before breakage was 
shown to be 4.49 ± 0.15 MPa for PLGA-0P and decreased to 2.26 ± 0.53 
MPa for PLGA-15P. Simultaneously hydrophobicity of obtained scaffolds did 
not show significant change and ranged from 134.3 ± 0.7o for PLGA-0P and 




Figure 4.3.5. (A) Stress-strain curves of nanofibrous scaffolds; (B) Ultimate 
Tensile Strain vs perovskite concentration; (C) Ultimate Tensile Stress vs 
perovskite concentration; (D) Young Modulus vs perovskite concentration. 
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Table 4.3.1. Summarized results of mechanical properties and contact angle 











Contact Angle [o] 
PLGA-0P 130.80 ± 7.54 4.49 ± 0.15 264.42 ± 53.04 134.3 ± 0.7 
PLGA-1P 139.12 ± 7.33 3.51 ± 0.37 94.82 ± 3.98 134.8 ± 0.9 
PLGA-5P 94.50 ± 3.51 2.81 ± 0.50 44.86 ± 8.61 136.9 ± 2.1 
PLGA-10P 83.65 ± 6.56 2.75 ± 0.41 40.71 ± 6.53 138.1 ± 2.4 
PLGA-15P 74.59 ± 7.21 2.26 ± 0.53 56.63 ± 9.68 139.6 ± 1.2 
 
4.3.5  FTIR analysis of polymeric, perovskite incorporated scaffolds 
Fourier transform infrared spectroscopy was performed on polymeric 
scaffolds cut to circular samples of diameters of approximately 5mm. 
Scanning between range of 400-4000 cm-1 was done with transmittance 
method and results of measurement were later analyzed by Origin Pro 8.1 
software (OriginLab, MA, USA). Results revealed no significant changes 
between PLGA-0P and other incorporated scaffolds. Bands observed near 
1759 cm-1 are present due to stretching of carbonyl groups from polymeric 
matrix. Similarly, bands around 2944 and 2993 cm-1 are present due to 
stretching vibrations of –CH, -CH2 and –CH3 groups. Peaks in range of 1200-
1500 cm-1 (1272, 1383, and 1453cm-1) are representing deformation 
vibrations of polymer –CH, -CH2 and –CH3 groups. Peaks in range of 1100 
– 1300 cm-1 are connected to stretching vibrations of ester bond (C-O) and 
wagging vibrations of –CH2 and –CH at 1371 and 1150 cm-1 respectively 
(Figure 4.3.6.). Perovskite incorporated polymeric fibers in nanoscale have 
been proposed for the first time in this work therefore lack of presence of 
peaks characteristic for perovskite may be caused by shielding effect of 




Figure 4.3.6. Transmittance FTIR spectra of (A) PLGA-0P; (B) PLGA-1P; (C) 
PLGA-5P; (D) PLGA-10P; (E) PLGA-15P 
4.3.6 Antimicrobial characteristic of synthesized perovskite and 
electrospun fibers 
Antimicrobial activity was measured for non-substituted and substituted 
perovskite materials as we all for fibrous scaffolds with various 
concentrations of perovskite material. Four Gram negative K. pneumonia 
(DM4299), E. coli (16027R), P. aeruginosa (23155 and 4299) and four Gram 
positive S. saprophyticus (15305, BAA750, 49907, 49453) strains as well as 
two species of fungi C. albican (CA1976, CA2672) were used in this test to 
evaluate antimicrobial properties. Bacteria free area was measured as the 
zone of inhibition for all microorganisms. Substituted perovskite powder 
Na2La2TiO3O10 (Perovskite S) was used as positive control when PLGA-0P 
as negative control. Non-substituted powder Ag0.3Na1.7La2Ti3O10 (Perovskite 
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NS) was also tested for antimicrobial presence in order to estimate if newly 
synthetized materials release silver ions from crystallographic structure. 
Summary of zone of inhibition of all materials have been presented in Table 
4.3.2. Na2La2TiO3O10 perovskite powder showed no antimicrobial properties 
similarly to PLGA-0P scaffolds. Substituted material Ag0.3Na1.7La2Ti3O10 
showed good antimicrobial properties against Gram negative bacterial 
strains with range of inhibition of 0.7-1.9 cm when this same results against 
gram negative bacterial strains showed zone of inhibition of 0.4-0.9 cm. 
Perovskite also showed positive results against two fungi species with zone 
of inhibition of 0.5-0.7 cm. Perovskite incorporated fibers showed very limited 
antimicrobial properties in higher concentrations. PLGA-1P and PLGA-5P 
showed none zone of inhibition for all strains where when PLGA-10P was 
effective against P. aeruginosa (PA23376) and S. saprophyticus 
(SSBAA750) strains. PLGA-15P effectively inhibited bacterial growth for K. 
pneumoniae (DM4299), P. aeruginosa (PA23376) and three out of four 
strains of S. saprophyticus (SS49907, SSBAA750 and SS49453). No 
inhibition zone against fungi strains have been reported for perovskite 
incorporated scaffolds (Figure 4.3.7.). Limited zone of inhibition for 
mentioned materials but good results of pure powder of this material allows 
us to claim that lack of silver ion release is due to shielding of perovskite 







Table 4.3.2. Antimicrobial Zone of Inhibition of Different Electrospun 

















K. pneumoniae        
DM4299 0 1.8-1.9 0 0 0 0 0.35-0.4 
E.coli        
PA23155 0 1.0-1.1 0 0 0 0 0 
P. aeruginosa        
PA23155 0 0.7-0.8 0 0 0 0 0 
PA23376 0 0.9 0 0 0 0.2 0.25 
S. saprophyticus        
SS49907 0 0.8 0 0 0 0 0.3 
SS15305 0 0.8-0.9 0 0 0 0 0 
SSBAA750 0 0.6-0.8 0 0 0 0.3 0.4 
SS49453 0 0.4-0.7 0 0 0 0 0.4 
C. albican        
CA1976 0 0.6-0.7 0 0 0 0 0 
CA2672 0 0.5-0.6 0 0 0 0 0 





Figure 4.3.7. Zones of inhibition of prepared materials against all strains 
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4.3.7 Proliferation and morphology of Human Dermal Fibroblasts 
Proliferation AlamarBlue® assay was performed 2, 4, 6 and 8 days after cells 
was seeded on scaffolds surface. Assay was performed every two days and 
scaffolds were kept at incubation environment at 37oC in between 
experiments. Calibration curve was used as described above to ensure 
correct amount of calculated cells. Each well was seeded with 10 000 cells 
and amount of cells was calculated at every stage of proliferation study. 
Number of cells proliferated on surface of PLGA-0P after 8 days showed 
values similar to TCP control group (115,348 ± 7,731 and 128,152 ± 6,705 
respectively). Perovskite incorporated fibers showed increase of cell number 
by 62 – 68 % for all examined scaffolds between day 2 and day 4. Cells 
proliferated steadily between day 6 and 8 and showed increase of cells 
number by 25; 14; 10; 30 and 19 % for PLGA-0P, PLGA-1P, PLGA-5P, 
PLGA-10P and PLGA-15P respectively. When comparing initial amount of 
cells with amount after 8 days, of cells seeded on TCP grew by 980% and 
by 1,103; 947; 842; 859 and 1007 % for PLGA-0P, PLGA-1P, PLGA-5P, 




Figure 4.3.8. AlamarBlue® assay results for produced nanofibrous scaffolds 
with perovskite particles. (* Significant against cell proliferation on PLGA 
scaffold at P≤0.05) 
In order to analyze morphology of cells and its interaction with perovskite rich 
scaffolds: DAPI (4’,6-diamidino-2-phenylindole) and TRICT staining have 
been performed. DAPI binds with regions rich in A-T bond within DNA helix 
and is able to pass intact through cell membrane. With excitation wavelength 
of 358 nm and emission maximum of 461 nm, it is usually detected by blue 
filter. [286] Emission radiation was measured in this test by detector set up 
to 490 nm. TRICT (Tetramethylrhodamine) is orange fluorescent dye and 
was used to stain F-actin protein within HDF cells cytoskeleton. TRICT in this 
experiment was excited by laser wavelength of 488 nm and emitted light was 
detected by 555 nm detector. [287] Figure 4.3.9 represents pictures obtained 
by confocal microscopy of cells present on scaffolds. Staining and imaging 
123 
 
have been performed on day 9 of culture ant tested on Laser Scanning 
Confocal Microscope (LSCM). Results revealed very good interaction and 
cells amount in TCP sample with presence of fibrous F-actin chains which 
are typical for Human Dermal Fibroblasts cells. [288] All scaffolds 
incorporated with perovskite showed similar results with cells tightly attached 
to the fibrous construct and presence of fibroin F-actin structure which 
ensures good communication between cells. We have noticed that F-actin 
produced on cells on TCP are fibrous and randomly oriented when protein 
presence on scaffolds was arranged toward one direction which is connected 
with arrangement of fibrous meshes. PLGA-0P showed slightly lower 
presence of cells and F-actin when compared with PLGA-15P and TCP 
surface. Also PLGA-5P showed complete coverage with cells similarly how 
it happened with TCP sample but with oriented fibers with F-actin along the 




Figure 4.3.9. Laser Scanning Confocal Microscope (LSCM) of TCP and 
polymeric scaffolds: (A) TCP; (B) PLGA-0P; (C) PLGA-1P; (D) PLGA-5P; (E) 




There is a great need for novel antimicrobial materials to be developed and 
safely implemented in wound management strategies. New materials are 
especially needed in age of increasing number of antibiotic resistant 
bacteria, number of burn and acute wound cases as well as volume of used 
wound dressings in recent years. Novel antimicrobial materials in 
combination with nanofibrous structures with its mechanical properties and 
microstructure can become interesting alternative to traditional wound 
dressings. The aim of this study was to fabricate nanofibrous biodegradable 
scaffolds with incorporated synthesized antimicrobial perovskite particles. 
XRD analysis of synthesized material showed existence of tetragonal 
structure of Na2La2TiO3O10 and Ag0.3Na1.7La2Ti3O10 as well as size of unit 
cell. Those results were in accordance with reported previously work. [214, 
215] Size of the particles obtained from solid state synthesis was relatively 
small to be incorporated into nanofibrous polymeric matrix what was also 
presented in analysis of mechanical and morphological changes. 
Morphology of electrospun fibers illustrated by Scanning Electron 
Microscope showed satisfactory size and characteristic to support cells 
growth with tendency to finer fiber diameters with increasing amount of 
antimicrobial perovskite what is more preferable for HDF cells. [289]  
Young modulus of obtained fibers decreased from 130.8 to 74.6 MPa for 
PLGA-0P and PLGA-15P respectively what suggest that presence of 
perovskite material enhanced fiber mobilization but also acted like possible 
breaking point when force was applied what was in accordance 
measurements of ultimate tensile stress and strain. Values of stress 
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decreased from 4.49 MPa for PLGA-0P to 2.26 MPa for PLGA-15P and from 
254.4 to 56.6 % for PLGA-0P to PLGA-15P respectively for strain 
measurements. Mechanical properties of incorporated polymeric nanofibers 
remain in agreement with mechanical properties of human skin with ultimate 
stress maximum of 3.0 ± 1.5MPa. [256, 290] Surface contact angle remained 
unchanged with relatively small variations between samples what suggested 
that perovskite crystals may be in high rate isolated by presence of polymeric 
shielding. FTIR analysis did not revealed significant changes in prepared 
materials due to lack of chemical interaction between ceramic particles and 
polymeric matrix and proved shielding effect between those two phases.  
Test for antimicrobial properties of prepared powders and perovskite 
incorporated fibers revealed antimicrobial activity of synthesized material 
and some of polymeric constructs presented in this work. Non-substituted 
perovskite materials showed no antimicrobial reaction against all four gram 
positive and gram negative bacterial strains and two species of fungi. 
Polymeric material PLGA-0P as well as perovskite incorporated scaffolds 
PLGA-1P and PLGA-5P showed no antimicrobial activity. Substituted 
perovskite material showed good antimicrobial properties comparable with 
efficiency of silver nanoparticles against those same bacterial strains [291] 
Scaffolds with increased amount of perovskite PLGA-10P showed some 
antimicrobial activity against  P. aeruginosa (PA23376) and S. saprophyticus 
(SSBAA750) when PLGA-15P with highest concentration of perovskite 
showed effectiveness against K. pneumonia (DM4299), P. aeruginosa 
(PA23376) and S. saprophyticus (SS49907; SSBAA750; SS49453). Those 
results indicate that despite good antimicrobial properties of perovskite 
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powder alone, concentration of perovskite material within polymeric fibers is 
too low to create good resistance for bacteria and fungi. Also size of 
perovskite particles, possible agglomeration, interaction between polymer 
and perovskite and release rate of silver ions from crystal structure are 
factors that also limits antimicrobial properties. Effectiveness of PLGA-10P 
and PLGA-15P, against this same bacteria strains and increase of size of 
bacteria free area with increase of perovskite content also suggests that 
concentration is only factor which limits antimicrobial properties.  
Electrospun materials showed very good interaction with Human Dermal 
Fibroblasts with values comparable to pure polymeric matrix what suggest 
that perovskite used in this work does not show significant cytotoxicity. Also, 
unlike silver nanoparticles, increase of local concentration of perovskite did 
not show increase of cytotoxicity. [292] Presented results show possible 
application of perovskite incorporated nanofibers as wound dressings with 
concentrations of perovskite more than 15% (w/w) of final composition 
without decrease in cytotoxicity.  
4.5 Conclusions 
The aim of this study was to produce and evaluate possible application in 
medicine of perovskite incorporated, biodegradable nanofibrous materials. 
Synthesis and analysis of two layered perovskites and its antimicrobial 
properties have been evaluated in order to ensure that antimicrobial 
properties of this novel material are induced by presence of silver ions in the 
lattice. Mechanical properties of produced materials showed similarity to 
native skin tissue and smaller size of the fibers with increasing perovskite 
content increased positive response from Human Dermal Fibroblasts. The 
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antibacterial activity was measured against E. coli, P. aeruginosa, K. 
pneumoniae, S. saprophyticus and C. albican and scaffolds PLGA-10P and 
PLGa-15P were found to inhibit bacteria growth, dependent on perovskite 
concentration. Antimicrobial properties of pure perovskite powder against 
both bacteria and fungi, were found to be comparable with other know 
antimicrobial agents, therefore this material was found to effective due to 
release silver ions. Polymeric meshes with perovskite as antimicrobial 
agents were found to be a good candidate in as novel material for wound 













Portable electrospinning device as a method of nanofibrous 
wound dressings applications 
5.1 Introduction 
In the previous chapters, novel antimicrobial nanomaterials have been 
presented and evaluated. We have shown that nanofibers may become good 
candidate as new materials for wound management. Role of the wound 
dressing in healing process is to provide and maintain optimal environment 
and provide healing agents that will support this process. Traditional gauze 
or polymeric dressings are being applied onto wound by unrolling it from roll 
or by application in form of patch. This method of application certainly has 
some drawbacks in terms of contact of wound dressing with wound and 
possible contamination during procedure. [293] Polymeric nanofibers has an 
ability to stick to surface very tightly due to high surface energy and lack of 
electric conductivity of polymeric matrix. Electrostatic charge present of 
surface of fibers creates small adhesion force and ensures good contact with 
of dressing with wound.    
Electrospinning is widely recognized method of production nanofibers from 
vast range of polymers. In brief it is stretching polymeric fibers from solution, 
under electric potential gradient. [294] Traditional equipment consist of bulky 
power supply, infusion pump, collector and polymer solution container. The 
most basic electrospinning device for laboratories and research facilities 
prices starts from $12,000 where industrial scale set-ups can reach price tag 
of hundreds of thousands. Portable electrospinning device combines 
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mentioned components into one, affordable, compact, portable and 
upgradeable device with estimate cost of production below $2,000. Product 
this incorporates all parts of electrospinning process into one enclosure what 
except industrial scale machines was not reported so far. This approach will 
bring electrospinning to research facilities which did not work with nanofibers 
before due to costs of equipment, as well as may be foundation to create 
number of medical devices to produce high-end wound dressings. Proposed 
device is composed of miniaturized low noise DC-DC converter, syringe 
pump, polymer container with nozzle, environment sensors, counter-
electrode and controllable fan enclosed in one device. Moreover, idea of 
miniaturized electrospinning equipment can be easily modified to number of 
other devices and used in other applications.  
As portable electrospinning device is enclosing all electrospinning systems 
into one universal, battery powered device it can be used in hospital to create 
nanofibrous dressings instantly, on site with any shape or size. Electrospun 
fibers are visible for naked eye when thicker surface is being created and by 
visual inspection thickness of the dressing may be controlled by person 
applying patch. As mentioned portable electrospinning has three main 
systems that allows for control of fibers creation and deposition. Namely: 
high voltage, low current DC converter; pump which creates flow of the 
polymer and fan which creates air flow in order to deposit fibers n desired 
surface. In this chapter we will describe all those systems and general idea 
of working of portable electrospinning device together with subsystems 
required to build this device as well as other similar devices which are 
currently in research phase.  
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5.2 Other portable electrospinning devices   
So far two portable electrospinning devices have been presented as 
described as machines designed to support dressing application. Mouthuy 
et. al. [24] reported construction of portable electrospinning device based on 
linear actuator (TNA08A25-S, Zaber technologies, Canada) and high voltage 
converter (F101, EMCO, USA) controlled by microcontroller PIC16 
(Microchip Technology Inc. USA). Those researchers reported use of this 
device with a number of polymeric structures in various solvents like: 
Polycaprolactone in Hexafluoro-2-propanol (HFIP), Poly(p-dioaxanone) in 
HFIP; PLGA in HFIP; Polyvinyl alcohol in water; and Polyvinyl butaral in 
mixture of ethanol and methanol. This device allowed then to produce fiber 
diameters of 168 nm to 1,607 nm depending on polymer/solvent system 
used in experiment (Figure 5.2.1.). Use of linear actuator in this design allow 
for very precise polymer solution flow control, nevertheless drawback of this 
design includes lack of measurement of force needed to push solution 
through needle as well as need of use of electric grounded surface in order 
to achieve correct potential difference. Author of this work also noted 
difference of fiber diameters between various systems and showed slight 
reduction of fiber diameter when portable device was used (889 ± 557 nm 
for benchtop vs. 747 ± 535 for portable device). Also electrospraying have 
been reported to be possible for this kind of device and was checked on 
Alginate/water and PLGA/HFIP systems. Test on pig skin with PDO polymer 
have been also carried out and showed that sufficient layer of nanofiber to 




Figure 5.2.1. Design and pictures of portable electrospinning device – taken 
with permission from Elsevier [24]. Copyright © 2010 Elsevier Inc.  
Other device that was designed to work as portable electrospinning wound 
dressing applicator was designed by team of Xu et al. [295]. This apparatus 
operates only on high voltage power supply and polymer flow is being 
controlled only by pushing build-in syringe container by the operator. Novelty 
of this approach brings a lot of control in hands of person operating it but 
repeatability of nanofibrous mesh is compromised. Figure 5.2.2 presents 
device as well as method of application. Those researchers also reported 
number of polymeric/solvent systems that have been successfully used to 
create nanofibers by using this device, namely: Polyvinylpyrrolidone in 
anhydrous ethanol; Polycaprolactone in acetone; polystyrene in 
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tetrahydrofuran; Poly(vinylidene fluoride) in dimethylformamide and acetone 
and Poly(lactic acid) in acetone. Reported fiber diameters ranged from 170 
nm (PVDF) to 1.8 μm (PVP). This suggests that lack of precise flow control 
may lead to creation of thicker fibers in this design. Authors also presented 
experiment involving fresh wound on rats back. Application of medical glue 
(N-octyl-2-cyanoacrylate) was electrospun on freshly made wound and 
showed that nanofibrous structure of glue allows for fast and reliable wound 
closure and stop bleeding.  
 
Figure 5.2.2. Portable electrospinning design and application method with 
fiber morphology – taken with permission from Royal Society of Chemistry 
[295]. Copyright @ 2015, Royal Society of Chemistry 
5.3 Design and functionality of portable electrospinning device  
In this design, polymer solution is pushed by on-board pump which can 
accommodate standard size 5ml syringes. Polymer jet is stretched on a 
distance between nozzle and grounded counter-electrode but instead of 
attaching to it, fibers will be carried away towards aimed object, by controlled 
air stream (with possible temperature control). Precise control of air stream 
and polymer flow rate allows to carry away fibers with specific diameter when 
heavier fibers will attach to counter-electrode. Additional temperature control 
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will influence solvent evaporation rate. This device is also prepared to 
remove counter-electrode and fasten grounded cable that may be attached 
to any surface what gives operator control over electric field density. In order 
to deliver stable positive electric potential to nozzle, low noise DC-DC 
converters will be used. This type of devices converts 12V (0.5A) input 
voltage (from battery or charger) into 25 000 V (60µA) output potential. 
Advantages of this solution are small size and weight of compounds as well 
as very low power consumption. In modified version of the device two 
converters with opposite polarizations can be installed to create bigger 
potential gradient (nozzle and counter-electrode). Whole system is controlled 
by Arduino or similar open source microcontroller through touch screen, 
however special circuits used to power and control specific elements were 
designed. Use of open source microcontroller allows for easy installation of 
sensors, communication modules, screens and controllers. Temperature 
sensor, humidity sensor, accelerometer for device positioning as well as 
safety features can be incorporated inside enclosure, which improves 
process control. Up to date couple portable electrospinning designs have 
been proposed, nevertheless very limited portability was reported. In those 
designs pump and power supply were presented as external parts connected 
with portable handle. Proposed design involves full integration of all parts 
into one battery powered enclosure. At current stage of this project our team 
finalized mechanical and electrical designs and simple proof of concept 
prototype was build. Also code used to print sensors’ measurements of LCD 
screen was written. Next steps involve manufacturing fully functional 
prototype, as well as further development of additional sensors and 
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functionalities such as: temperature control, air flow sensor, accelerometer, 
wireless connectivity, process logging and pump improvements. 
Simultaneously work on standalone version of device will be carried out as, 
many other versions, based on this system, can be easily adopted. This 
project also includes finalizing list of suppliers and vendors for future 
production. Standalone prototype version will incorporate all the above-
mentioned functionalities, in different laboratory’s applications, more suitable 
for stationary settings. Figure 5.3.1 shows enclosure design of portable 









In the following subchapter we will discuss working principles of every 
subcomponent together with control circuits that may be used in order to 
build working device. As we mentioned before this design can be easily 
adopted to work as bench top electrospinning set-up, nevertheless in this 
chapter we will focus only on portable variation of this apparatus.  
5.3.1 High Voltage power supply 
Main component in any electrospinning device is a part which is able to 
deliver high voltages with small current. High current is undesirable in 
electrospinning, due to high risk of spontaneous electric discharge between 
nozzle and collecting surface or between single fibers. It is worth to 
remember that during process, solvent evaporates slowly what changes 
electric conductivity of fibers significantly. A number of work of behavior of 
polymer jet have been presented. [296-299] In general high voltage supply 
should constantly charge nozzle with specific charge which is later 
transferred to flowing polymeric solution. When critical amount of electric 
charge is present, attracting force between grounded surface and nozzle 
increases and overcomes forces of surface tension of viscous liquid. When 
it happens, charge is being accumulated on relatively low conductive surface 
of polymer solution. Solvent evaporates, decreasing further conductivity of 
polymer fiber which solidifies accordingly. Charge accumulated on the 
surface of the fiber is causing further thinning of the fiber diameter due to 
electrostatic repulsive force between positively charged surfaces of the fiber. 
Because morphology of non-woven fibers is complicated three-dimensional 
structure consisted of small fibrous objects, not all accumulated charge is 
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being discharged on the grounded surface what causes electrostatic 
attraction between nanofibers and deposition surface. [300, 301] 
In this design high-voltage low-current power supply is manufactured by 
EMCO High Voltage Corp. Depend on application to kind of those converters 
may be used. Model Q101 allows to convert 5 V, 250 mA DC signal to 10,000 
V, 50 μA output signal. Because often to create good nanofibers potential of 
more than 10 kV is necessary, other model of DC-DC converter can be used 
with maximum output of 25,000 V, 60μA with model EMCO DX250 from 12V, 
400mA input signal. Both of those converters can be easily controlled by 
precise potentiometer and measurement of output current. As DC-DC 
converter supplies high voltage supply, it is very important to isolate 
additional charge from microcontroller circuits. This design includes fail-safe 
solution which is to measure output current instead of power of the device. 
Output of converter is connected with ground through voltage divider with 
values of R1 and R2 of 100 and 0.01 Ω respectively. This circuit is changing 
output signal to range of 0-5 V. Microcontroller input signal can be divided 
by 1024 steps within range of 0-5 V and it can be calculated into the range 
of 0 – 25,000 V what gives resolution of control of around 25 V. Similar 
methods can be used to control 10,000 V output power supply with resolution 
of 10 V per step when resistors of values of 100 and 0.05 Ω used. This 
resolution is sufficient to efficiently control potential for electrospinning 
procedure. Calculated values are later displayed on build-in screen to inform 
operator of electrospinning process. Very low current produced by DC-DC 
voltage converter ensures that this device may be used near skin of the 
patient without causing any damages to the skin when accidently touched.  
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High-voltage power supply is attached by positive wire to removable needle 
and with other end with counter electrode which is necessary to create 
potential difference. Figure 5.3.2 is presenting placement of two possible DC 
converters as well as potentiometer and counter-electrode. 
 
Figure 5.3.2. Model of electrospinning device with emphasis on high voltage 
supply components (red); and additional 10 kV converter (green) and 
method of ensuring connection between needle and high voltage converter 
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5.3.2 Air flow fan system 
In opposite to the portable devices presented at the beginning of this chapter, 
this design does not require deposition surface to be grounded. Device 
ground is connected to metal ring placed at the end of the counter-electrode. 
Grounded ring in distance of around 5 cm from needle, creates distance 
required for fiber to stretch to nanosize. Creating air flow around spinning 
fiber, creates drag force which takes fibers over and forces them to move 
linearly towards target. Constant flow of air around drying fibers is also 
supporting removal of solvent from viscous liquid. [302, 303] Flow of air is 
ensured by placement of 6V electric fan with diameter of 15 mm just behind 
the nozzle which creates stable air tunnel. Speed of the fan is controlled by 
Pulse Width Modulation (PWM) control method due to simplicity of control. 
Power cables of the fan are directly connected to microcontroller. 
Microcontroller switches of an on power supply in modular form what is 
directly proportional to the speed of controlled fan. Figure 5.3.3 shows fan 




Figure 5.3.3. Placement of air flow fan inside portable electrospinning device 
(blue) 
5.3.3 Polymer Pump 
In order to ensure repeatability of obtained fibers and allow to use device 
without supervision, polymer pump have been placed as integral part of the 
device. Pump consists of electric motor and construction which translates 
rotational movement of the motor into linear movement of syringe knob. 
Polymer flow is essential in electrospinning process as it influences amount 
of polymer solution that needs to be charged above the critical point of 
charge concentration. In case flow rate is to high small diameter fibers are 
increasing. With too small accumulated charge drops are being created and 
electrospraying phenomenon occurs. [164, 304] Polymer pump was 
designed to ensure optimal polymer flow and consists of electric brushless 
motor, gear wheel and guide rods to ensure linear movement. Control of the 
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pump is based similarly to fan control and is based on PWM module. Sped 
of the linear movement can be also controlled with resolution of 1024 steps 
which gives control of flow between 0.1 to 2 ml/h. it is also possible to use 
micrometer linear actuator to increase resolution of polymer flow 
nevertheless this approach will increase final price of the device. Significant 
advantage of this design is a possibility of using standard size and type 
syringes. As shown on Figure 5.3.4. Syringe placed in the holder is standard 
5 ml syringe and is connected with blunt needle which can be also replaced 
after every spinning and with flexible tube which is also widely available in 
medical centers or hospitals. Syringe during electrospinning is placed on the 
holder and kept on place with top cover with small linear window to observe 
level of liquid inside. Also, sensor of force is place just behind syringe holder 
what allows to measure force needed to push solution through the nozzle. 
This sensor is directly attached to microcontroller and is measuring 
acceptable forces acting on the syringe plug. This allows to inform user about 
possible blockage of the nozzle during process. Significant increase of force 
needed to push solution can be read and showed on the build-in screen. 
Front and top part of the device is placed on hinges what allows user to 




Figure 5.3.4. Schematics of placement and working principle of build-in 
pump system in portable electrospinning  
5.3.4 Microcontroller and display 
All systems mentioned above are being controlled by Arduino® micro 
controller or Spark microcontroller with WiFi functionality. Microcontrollers 
like that are ideal for this application due to its small power consumption, size 
and number of possible subcomponents which can be attached to the 
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controller. Arduino has 20 digital input/output pins of which 7 ca be used as 
PWM control pins. Whole system is based on 16 MHz oscillator and micro 
USB connection. Also open source microcontroller gives an ability of 
designing final board by the designer of equipment in later stages of product 
development and is powered by 5 V input signal. Arduino is also attached to 
LCD screen with possibility to display 24-bit graphics. Screen in later 
iterations of device can be replaced with touch display what will reduce 
number of required buttons. Coding of such devices is standardized what 
allows to switch between different microcontrollers and add new 
functionalities very easily.     
 
Figure 5.3.5 Schematics and picture of back panel and screen design for 
portable electrospinning device 
LCD screen used in this solution is designed to gives an operator all 
necessary information about process like: measured potential, speed of 
polymer flow, speed of fan, battery level as well as sensors measurements 
of humidity and temperature from sensor build next to fan. It also gives 
information about time of procedure as well as indication about high voltage 
converter status (Figure 5.3.5) Buttons placed on the back of the panel 
allows to set-up desirable parameter values and can be used to input basic 
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commands into device. Know visible on the back panel is used to control 
high voltage power converter. All those sub-systems are also being 
constantly monitored by microcontroller with rate of couple measurements 
per second. In variation of this device other microcontroller may be used in 
order to add more functionalities like WiFi connectivity or additional sensors 
which may be on board. Also, once code is uploaded into the device, there 
is no possibility to recover it back from the device what ensures unauthorized 
access to software of the device by the users.  
5.3.5 Power system in portable electrospinning device 
Portable electrospinning device which is presented here is being powered 
by standard battery used in power drillers. It has capability of powering 
devices up to 12 V and 1.8A which is more than sufficient to power up all the 
subsystems present in this design. Based on estimation device can work in 
battery powered state for up to 12 h which is sufficient time for use in both 
clinical and laboratory environments. Battery is being monitored by 
microcontroller by similar circuit presented for measurement of high voltage 
where initial potential of 12 V is normalized to range of 0 – 5 V. Battery and 
charger mode can be switched on and off by one of the buttons. There is 
also gun type on off switch which is being used to turn on and off high voltage 
converter when short pulses are necessary for desired effect. Battery can be 
charged outside device and set of batteries can ensure constant working 





Figure 5.3.6. Representation of battery and switch placement in the design 
of portable electrospinning (red) 
5.3.6 Summary 
Manufacturing affordable compact electrospinning equipment will open wide 
range of potential applications, as well as research opportunities. 
Electrospinning technique is being used as method of production complex 
fibers in various fields including electronics, solar energy, batteries, filtration, 
textiles, food packaging, anti-reflective coatings, wound dressings or tissue 
engineering. Universities and research organizations from various fields 
have been identified as potential clients for this kind of device. Moreover, 
progress in wound dressing application of nanofibers may create market 
niche for device used for direct application of fibrous dressing directly onto 
wound. Simplicity in modification and further development may bring more 
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commercial opportunities. Further development projects involve also 
remodeling device to be compatible with 3D printing x,y,z stages as potential 
“printer” for creating 3D tissue scaffolds. Other idea is to incorporate number 
of those devices in clusters and scale up production process up to industrial 
scale. The main application of this device is to use it as instant wound 
applicator of nanofibrous wound dressings. Usage of battery powered device 
to cover wounds was shown to bring promising results and does not require 
a lot of time. It was shown by other researchers that nanofibrous dressings 
can stop bleeding from a fresh wound and enhance healing progress when 
applied onto wound. Number of possible polymeric structures that can be 
obtained by this device and number of various surfaces that it can cover with 
nanofibers, creates number of possible applications for such a device in the 
future. Newly discovered materials can be easily and cheaply produced by 
medical professionals as well as researchers all around the globe with 
minimum cost and training. First build prototype showed possibility of 
integration of all mentioned systems and showed capability of fiber 





Figure 5.3.7. Schematics and prototype representation of portable electrospinning device; (A), (B) models of electrospinning 





Conclusions and Recommendation  
The scope of this research encompasses the production and evaluation of 
two antimicrobial nanofibrous systems based on silver nanoparticles and 
novel synthesized perovskite material within Poly(lactide-co-glycolide) 
matrix. It focuses on evaluation of scaffolds for usage as new antimicrobial 
wound dressings for wound management procedures. This work also 
describes novel device designed and created for instant implementation of 
nanofibrous wound dressings onto wound to ensure better adhesion 
between material and wound as well as create custom size and shape 
dressings. Mechanical, biological and structural properties of all produced 
scaffolds have been evaluated and compared with traditionally used 
materials. Antimicrobial behavior of those materials have been evaluated 
together with cytotoxicity rate of prepared materials for wound healing 
applications. 
6.1 Main conclusions  
1. Nanofibrous substrate incorporated with silver nanoparticles of size of 100 
nm in diameter have been produced by electrospinning process within two 
polymeric matrixes of Poly(lactide-co-glycolide) biodegradable polymer with 
ratio of glycolide to lactide of 50:50 and 25:75. Mechanical properties and 
antimicrobial properties have been sufficient to replace traditional wound 
dressings.   
2. Perovskite ceramic materials: Na2La2TiO3O10 and Ag0.3Na1.7La2Ti3O10 
were synthesized and antimicrobial properties of those materials have been 
150 
 
evaluated against multiple bacteria and fungi strains and showed good 
antimicrobial properties of pure powder against bacteria strains as well as 
fungi species.  
3. Nanofibrous composites have been electrospun from PLGA polymer with 
ratio of L:G of 75:25 with incorporated perovskite particles with antimicrobial 
properties. Mechanical properties of constructed scaffolds showed integrity 
with mechanical properties of human skin and lack of cytotoxicity for Human 
Dermal Fibroblasts mature cells.  
4. Antimicrobial test performed on perovskite incorporated PLGA scaffolds 
revealed small or none antimicrobial properties for scaffolds with 
concentration of perovskite of 1-10% and some antimicrobial properties 
against gram negative and gram positive bacteria with concentration of 
perovskite higher than 15 (% w/w).  
5. Design and principle of working of portable electrospinning device have 
been presented and discussed against other similar projects and showed 
advantages of portable electrospinning device described in this work against 
other similar devices.  
6. As an outcome, nanomaterials which can be successfully used as wound 
dressings as well as method of application of various nanofibrous structures 
onto skin or any other surface have been presented and analyzed with 







The biodegradable composite materials with incorporated silver 
nanoparticles and perovskite material have shown promising results in terms 
antimicrobial properties as well as compatibility with human cells and 
mechanical properties. However, further investigations are required to 
understand mechanism of interaction of cells with silver nanoparticles 
incorporated polymeric nanofibers and mechanism of silver ions release 
from polymeric matrix. Further study of interaction of living cells with 
polymeric fibers is necessary to understand mechanism of whole process. 
Also despite the fact, that perovskite powder possesses clearly antimicrobial 
properties as shown based on interaction between bacteria strains and 
material, there is a need to explain mechanism of silver ions release from 
the perovskite material as well as rate of ions released from perovskite inside 
polymeric matrix are needed. As antimicrobial properties of fiber 
incorporated with perovskite material have been shown to be limited, there 
is a need to investigate and analyze mechanism of interaction between 
polymer matric and perovskite particles. Data presented in this work suggest 
that if concentration of perovskite increases, antimicrobial properties of 
material increases. Investigation of effect of concentration of perovskite in 
polymeric matrix as well as chemical modification of perovskite material in 
order to achieve better integration between polymer and particles are 
needed in order to understand fully efficiency of nanofibrous materials with 
perovskite incorporation.  Although functionality of portable electrospinning 
device has been tested in prototype stage, nevertheless production of fully 
working prototype and commercialization path needs to be further 
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investigated. Preparation of component suppliers and enclosure injection 
molding technique should be initial step toward these goals. Portable 
electrospinning has a great potential to be implemented by medical 
professionals and improve wound management process. It is also innovative 
device for all professionals who need access to cheap and reliable 






















1. Jones, M.L., A short history of the development of wound care 
dressings. British Journal of Healthcare Assistants, 2015. 9(10): p. 
482-485. 
2. Med Market Diligence, L., Worldwide Wound Management, Forecast 
to 2021: Established and Emerging Products, Technologies and 
Markets in the Americas, Europe, Asia/Pacific and Rest of  World. 
2013. p. 376. 
3. Diligence, M., Worldwide Wound Management, Forecast to 2024: 
Established and Emerging Products, Technologies and Markets in the 
Americas, Europe, Asia/Pacific and Rest of World, M. Diligence, 
Editor. 2015: Washington D.C. p. 410. 
4. Werdin, F., et al., Evidence-based Management Strategies for 
Treatment of Chronic Wounds. Eplasty, 2009. 9: p. e19. 
5. Eming, S.A., T. Krieg, and J.M. Davidson, Inflammation in Wound 
Repair: Molecular and Cellular Mechanisms. J Invest Dermatol, 0000. 
127(3): p. 514-525. 
6. Moritz, S., et al., Active wound dressings based on bacterial 
nanocellulose as drug delivery system for octenidine. International 
Journal of Pharmaceutics, 2014. 471(1–2): p. 45-55. 
7. Boateng, J.S., et al., Wound healing dressings and drug delivery 
systems: a review. J Pharm Sci, 2008. 97(8): p. 2892-923. 
8. Gentile, P., et al., An Overview of Poly(lactic-co-glycolic) Acid 
(PLGA)-Based Biomaterials for Bone Tissue Engineering. 
International Journal of Molecular Sciences, 2014. 15(3): p. 3640. 
9. Niklason, L.E., et al., Functional arteries grown in vitro. Science, 1999. 
284(5413): p. 489-93. 
10. Locatelli, E. and M. Comes Franchini, Biodegradable PLGA-b-PEG 
polymeric nanoparticles: synthesis, properties, and nanomedical 
applications as drug delivery system. Journal of Nanoparticle 
Research, 2012. 14(12): p. 1-17. 
11. Jeong, Y., D.W. Lim, and J. Choi, Assessment of Size-Dependent 
Antimicrobial and Cytotoxic Properties of Silver Nanoparticles. 
Advances in Materials Science and Engineering, 2014. 2014: p. 6. 
12. Gliga, A.R., et al., Size-dependent cytotoxicity of silver nanoparticles 
in human lung cells: the role of cellular uptake, agglomeration and Ag 
release. Particle and Fibre Toxicology, 2014. 11(1): p. 1-17. 
13. Ivask, A., et al., Size-Dependent Toxicity of Silver Nanoparticles to 
Bacteria, Yeast, Algae, Crustaceans and Mammalian Cells In Vitro. 
PLoS ONE, 2014. 9(7): p. e102108. 
14. Greulich, C., et al., The toxic effect of silver ions and silver 
nanoparticles towards bacteria and human cells occurs in the same 
concentration range. RSC Advances, 2012. 2(17): p. 6981-6987. 
15. Bhalla, A.S., R. Guo, and R. Roy, The perovskite structure – a review 
of its role in ceramic science and technology. Material Research 
Innovations, 2000. 4(1): p. 3-26. 
154 
 
16. Lin, T., D. Lukas, and G.S. Bhat, Nanofiber Manufacture, Properties, 
and Applications. Journal of Nanomaterials, 2013. 2013: p. 1. 
17. Ignatova, M., I. Rashkov, and N. Manolova, Drug-loaded electrospun 
materials in wound-dressing applications and in local cancer 
treatment. Expert Opin Drug Deliv, 2013. 10(4): p. 469-83. 
18. Powell, H.M., D.M. Supp, and S.T. Boyce, Influence of electrospun 
collagen on wound contraction of engineered skin substitutes. 
Biomaterials, 2008. 29(7): p. 834-43. 
19. Foster, L. and P. Moore, The application of a cellulose-based fibre 
dressing in surgical wounds. J Wound Care, 1997. 6(10): p. 469-73. 
20. Xu, S., et al., Chemical crosslinking and biophysical properties of 
electrospun hyaluronic acid based ultra-thin fibrous membranes. 
Polymer, 2009. 50(15): p. 3762-3769. 
21. Hong, K.H., Preparation and properties of electrospun poly(vinyl 
alcohol)/silver fiber web as wound dressings. Polymer Engineering & 
Science, 2007. 47(1): p. 43-49. 
22. Merrell, J.G., et al., Curcumin Loaded Poly(ε-Caprolactone) 
Nanofibers: Diabetic Wound Dressing with Antioxidant and Anti-
inflammatory Properties. Clinical and experimental pharmacology & 
physiology, 2009. 36(12): p. 1149-1156. 
23. Khil, M.S., et al., Electrospun nanofibrous polyurethane membrane as 
wound dressing. J Biomed Mater Res B Appl Biomater, 2003. 67(2): 
p. 675-9. 
24. Mouthuy, P.-A., L. Groszkowski, and H. Ye, Performances of a 
portable electrospinning apparatus. Biotechnology Letters, 2015. 
37(5): p. 1107-1116. 
25. Coello, R., et al., Adverse impact of surgical site infections in English 
hospitals. J Hosp Infect, 2005. 60(2): p. 93-103. 
26. Plowman, R., et al., The rate and cost of hospital-acquired infections 
occurring in patients admitted to selected specialties of a district 
general hospital in England and the national burden imposed. J Hosp 
Infect, 2001. 47(3): p. 198-209. 
27. BP., S., Guideline for prevention of surgical wound infections. Infect 
Control, 1982. 3: p. 185-196. 
28. Mangram, A.J., et al., Guideline for Prevention of Surgical Site 
Infection, 1999. Centers for Disease Control and Prevention (CDC) 
Hospital Infection Control Practices Advisory Committee. Am J Infect 
Control, 1999. 27(2): p. 97-132; quiz 133-4; discussion 96. 
29. Reichman, D.E. and J.A. Greenberg, Reducing Surgical Site 
Infections: A Review. Reviews in Obstetrics and Gynecology, 2009. 
2(4): p. 212-221. 
30. Anderson, D.J.M.D.M.P.H., et al., Strategies to Prevent Surgical Site 
Infections in Acute Care Hospitals: 2014 Update. Infection Control 
and Hospital Epidemiology, 2014. 35(6): p. 605-627. 
31. Poggio, J.L., Perioperative Strategies to Prevent Surgical-Site 




32. Mangram, A.J., et al., Guideline for prevention of surgical site 
infection, 1999. Hospital Infection Control Practices Advisory 
Committee. Infect Control Hosp Epidemiol, 1999. 20(4): p. 250-78; 
quiz 279-80. 
33. Felkner, M., et al., The Wound Care Team: A New Source of Group 
A Streptococcal Nosocomial Transmission. Infection Control & 
Hospital Epidemiology, 2005. 26(05): p. 462-465. 
34. Pertowski, C.A., et al., Nosocomial outbreak of Candida albicans 
sternal wound infections following cardiac surgery traced to a scrub 
nurse. J Infect Dis, 1995. 172(3): p. 817-22. 
35. WHO. BURNS - Fact Sheet No 365. April 2014; Available from: 
http://www.who.int/mediacentre/factsheets/fs365/en/#. 
36. Church, D., et al., Burn wound infections. Clin Microbiol Rev, 2006. 
19(2): p. 403-34. 
37. Dinis-Oliveira, R.J., et al., Clinical and forensic signs related to 
chemical burns: A mechanistic approach. Burns. 41(4): p. 658-679. 
38. Fingerhut, L.A. and M. Warner, The ICD‐10 injury mortality diagnosis 
matrix. Injury Prevention, 2006. 12(1): p. 24-29. 
39. Weigelt, J.A., R.W. Haley, and B. Seibert, Factors which influence the 
risk of wound infection in trauma patients. J Trauma, 1987. 27(7): p. 
774-81. 
40. Eagle, M., Wound Assessment: The Patient and the Wound. Wound 
Essentials, 2009. 4: p. 14-24. 
41. Li, J., J. Chen, and R. Kirsner, Pathophysiology of acute wound 
healing. Clinics in Dermatology. 25(1): p. 9-18. 
42. Senoo, M., Epidermal Stem Cells in Homeostasis and Wound Repair 
of the Skin. Adv Wound Care (New Rochelle), 2013. 2(6): p. 273-282. 
43. Kanzler, M.H., D.C. Gorsulowsky, and N.A. Swanson, Basic 
mechanisms in the healing cutaneous wound. J Dermatol Surg Oncol, 
1986. 12(11): p. 1156-64. 
44. Dellinger, R.P., et al., Surviving sepsis campaign: international 
guidelines for management of severe sepsis and septic shock: 2012. 
Crit Care Med, 2013. 41(2): p. 580-637. 
45. Sen, C.K., et al., Human Skin Wounds: A Major and Snowballing 
Threat to Public Health and the Economy. Wound repair and 
regeneration : official publication of the Wound Healing Society [and] 
the European Tissue Repair Society, 2009. 17(6): p. 763-771. 
46. Singer, A.J. and A.B. Dagum, Current management of acute 
cutaneous wounds. N Engl J Med, 2008. 359(10): p. 1037-46. 
47. Berk, W.A., R.D. Welch, and B.F. Bock, Controversial issues in 
clinical management of the simple wound. Ann Emerg Med, 1992. 
21(1): p. 72-80. 
48. Lammers, R.L., D.L. Hudson, and M.E. Seaman, Prediction of 
traumatic wound infection with a neural network-derived decision 
model. Am J Emerg Med, 2003. 21(1): p. 1-7. 
49. Percival, N.J., Classification of Wounds and their Management. 
Surgery - Oxford International Edition. 20(5): p. 114-117. 
156 
 
50. Howell, J.M. and C.D. Chisholm, Outpatient wound preparation and 
care: a national survey. Ann Emerg Med, 1992. 21(8): p. 976-81. 
51. Singer, A.J., et al., Pressure dynamics of various irrigation techniques 
commonly used in the emergency department. Ann Emerg Med, 
1994. 24(1): p. 36-40. 
52. Farion, K.J., et al., Tissue adhesives for traumatic lacerations: a 
systematic review of randomized controlled trials. Acad Emerg Med, 
2003. 10(2): p. 110-8. 
53. Mustoe, T.A., K. O'Shaughnessy, and O. Kloeters, Chronic Wound 
Pathogenesis and Current Treatment Strategies: A Unifying 
Hypothesis. Plastic and Reconstructive Surgery, 2006. 117(7S): p. 
35S-41S. 
54. Robson, M.C. and A. Barbul, Guidelines for the best care of chronic 
wounds. Wound Repair and Regeneration, 2006. 14(6): p. 647-648. 
55. Menke, N.B., et al., Impaired wound healing. Clin Dermatol, 2007. 
25(1): p. 19-25. 
56. PRNewswire, Wound Dressings Market - Global Industry Analysis, 
Size, Share, Growth, Trends and Forecast, 2014 - 2020. 2014: 
London. 
57. Dowling, J., Protocol for the Use of Sterile Larvae in Wound 
Management, C.C.P.G.a.C.Q.a.G. Committee, Editor. 2011: 
Leicestershire. 
58. Sherman, R.A., Maggot Therapy for Foot and Leg Wounds. The 
International Journal of Lower Extremity Wounds, 2002. 1(2): p. 135-
142. 
59. Thomas, S. A structured approach to the selection of dressings. World 
Wide Wounds, 1997. 
60. Thomas Hess, C., Checklist for Factors Affecting Wound Healing. 
Advances in Skin & Wound Care, 2011. 24(4): p. 192. 
61. Guo, S. and L.A. DiPietro, Factors Affecting Wound Healing. Journal 
of Dental Research, 2010. 89(3): p. 219-229. 
62. Shah, J.B., The History of Wound Care. The Journal of the American 
College of Certified Wound Specialists, 2011. 3(3): p. 65-66. 
63. Forrest, R.D., Development of Wound Therapy from the Dark Ages to 
the Present. Journal of the Royal Society of Medicine, 1982. 75(4): p. 
268-273. 
64. Kumar, A., et al., Silver-nanoparticle-embedded antimicrobial paints 
based on vegetable oil. Nat Mater, 2008. 7(3): p. 236-241. 
65. Atiyeh, B.S., et al., Effect of silver on burn wound infection control and 
healing: review of the literature. Burns, 2007. 33(2): p. 139-48. 
66. Fox, C.L. and S.M. Modak, Mechanism of Silver Sulfadiazine Action 
on Burn Wound Infections. Antimicrobial Agents and Chemotherapy, 
1974. 5(6): p. 582-588. 
67. Liedberg, H. and T. Lundeberg, Assessment of silver-coated urinary 




68. Lam, P.K., et al., In vitro cytotoxicity testing of a nanocrystalline silver 
dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci, 2004. 
61(3): p. 125-7. 
69. Innes, M.E., et al., The use of silver coated dressings on donor site 
wounds: a prospective, controlled matched pair study. Burns, 2001. 
27(6): p. 621-7. 
70. Hester, S.-V.M.N.V.C.G.U.D.T.V., Topical silver for preventing wound 
infection. Cochrane Database of Systematic Reviews; WOUNDS, 
2010. 3. 
71. Li, X., et al., Silver-coated endotracheal tube versus non-coated 
endotracheal tube for preventing ventilator-associated pneumonia 
among adults: A systematic review of randomized controlled trials. 
Journal of Evidence-Based Medicine, 2012. 5(1): p. 25-30. 
72. Lam Thomas BL, O.M.I., Fisher Euan, Gillies Katie, MacLennan Sara, 
Types of indwelling urethral catheters for short-term catheterisation in 
hospitalised adults. Cochrane Database of Systematic Reviews, 
2014. 9. 
73. A., L., Silver in Health Care: Antimicrobial Effects and Safety in Use. 
Biofunctional Textiles and the Skin, ed. E.P. Hipler U.-C. Vol. 33. 
2006: Karger. 
74. Rosenblatt, A., T.C.M. Stamford, and R. Niederman, Silver Diamine 
Fluoride: A Caries “Silver-Fluoride Bullet”. Journal of Dental 
Research, 2009. 88(2): p. 116-125. 
75. Vlachou, E., et al., The safety of nanocrystalline silver dressings on 
burns: A study of systemic silver absorption. Burns. 33(8): p. 979-985. 
76. Daubney, L., ACTICOAT Flex 7 - Evaluation of Extensibility, Smith-
Nephew, Editor. 2008. 
77. Jones, S.A., et al., Controlling wound bioburden with a novel silver-
containing Hydrofiber® dressing. Wound Repair and Regeneration, 
2004. 12(3): p. 288-294. 
78. Walker, M., et al., Scanning electron microscopic examination of 
bacterial immobilisation in a carboxymethyl cellulose (AQUACEL®) 
and alginate dressings. Biomaterials, 2003. 24(5): p. 883-890. 
79. Karlsmark, T., et al., Clinical performance of a new silver dressing, 
Contreet Foam, for chronic exuding venous leg ulcers. J Wound Care, 
2003. 12(9): p. 351-4. 
80. Jørgensen, B., et al., The silver-releasing foam dressing, Contreet 
Foam, promotes faster healing of critically colonised venous leg 
ulcers: a randomised, controlled trial. International Wound Journal, 
2005. 2(1): p. 64-73. 
81. Furr, J.R., et al., Antibacterial activity of Actisorb Plus, Actisorb and 
silver nitrate. J Hosp Infect, 1994. 27(3): p. 201-8. 
82. Muangman, P., et al., Benefit of hydrocolloid SSD dressing in the 
outpatient management of partial thickness burns. J Med Assoc Thai, 
2009. 92(10): p. 1300-5. 
83. Downe, A., Use of Urgotul SSD to reduce bacteria and promote 




84. Ballard, K. and F. McGregor, Avance: silver hydropolymer dressing 
for critically colonized wounds. Br J Nurs, 2002. 11(3): p. 206, 208-
11. 
85. Argenta, L.C. and M.J. Morykwas, Vacuum-assisted closure: a new 
method for wound control and treatment: clinical experience. Ann 
Plast Surg, 1997. 38(6): p. 563-76; discussion 577. 
86. Argenta, L.C., et al., Vacuum-assisted closure: state of clinic art. Plast 
Reconstr Surg, 2006. 117(7 Suppl): p. 127s-142s. 
87. Baxter, H.B., Kate, Vacuum-Assisted Closure Nursing Times, 2001. 
97(35): p. 51-52. 
88. Huang, C., et al., Effect of negative pressure wound therapy on wound 
healing. Current Problems in Surgery, 2014. 51(7): p. 301-331. 
89. Penny, H.L., et al., Negative pressure wound therapy with Bio-Dome 
dressing technology in the treatment of complex wounds: a case 
series. J Wound Care, 2014. 23(4): p. S4, s6-9. 
90. Long, M.A. and A. Blevins, Options in Negative Pressure Wound 
Therapy: Five Case Studies. Journal of Wound Ostomy & Continence 
Nursing, 2009. 36(2): p. 202-211. 
91. O'Connor, N., et al., GRAFTING OF BURNS WITH CULTURED 
EPITHELIUM PREPARED FROM AUTOLOGOUS EPIDERMAL 
CELLS. The Lancet, 1981. 317(8211): p. 75-78. 
92. Shakespeare, P. and V. Shakespeare, Survey: use of skin substitute 
materials in UK burn treatment centres. Burns, 2002. 28(4): p. 295-7. 
93. Shores, J.T., A. Gabriel, and S. Gupta, Skin substitutes and 
alternatives: a review. Adv Skin Wound Care, 2007. 20(9 Pt 1): p. 493-
508; quiz 509-10. 
94. Kumar, P., Classification of skin substitutes. Burns, 2008. 34(1): p. 
148-9. 
95. Anish, S., Skin substitutes in dermatology. 
96. Murphy Patrick S., E.G.R.D., Advances in Wound Healing: A Review 
of Current Wound Healing Products. Plastic Surgery International, 
2012. 2012. 
97. Catherine T. Milne, A.C., Mandie Lassy, A Comparison of 
Collagenase to Hydrogel Dressings in Maintenance Debridement and 
Wound Closure. Wounds, 2012. 24(11): p. 317-322. 
98. J. Barry Wright, L.S., Accuzyme® Papain-Urea Debriding Ointment: 
A Historical Review. WOUNDS, 2003. 15(5): p. 133-142. 
99. Frang, D. and F. Gallyas, The use of Reseptyl-Urea dressing powder 
in urological surgery. Ther Hung, 1969. 17(2): p. 91-2. 
100. Agren, M.S., M.A. Engel, and P.M. Mertz, Collagenase during burn 
wound healing: influence of a hydrogel dressing and pulsed electrical 
stimulation. Plast Reconstr Surg, 1994. 94(3): p. 518-24. 
101. Gottlieb, M.E. Histogenesis versus Wound Repair:  the Anatomy of 
Integra’s Properties. in The Boswick Burn and Wound Meeting. 2003. 
Maui February 2003. 
102. Cianfarani, F., et al., Granulocyte/macrophage colony-stimulating 
factor treatment of human chronic ulcers promotes angiogenesis 
159 
 
associated with de novo vascular endothelial growth factor 
transcription in the ulcer bed. Br J Dermatol, 2006. 154(1): p. 34-41. 
103. Lineen, E. and N. Namias, Biologic dressing in burns. J Craniofac 
Surg, 2008. 19(4): p. 923-8. 
104. Jeng, J.C., et al., Seven years' experience with Integra as a 
reconstructive tool. J Burn Care Res, 2007. 28(1): p. 120-6. 
105. Bennett, S.A. and H.C. Birnboim, Receptor-mediated and protein 
kinase-dependent growth enhancement of primary human fibroblasts 
by platelet activating factor. Mol Carcinog, 1997. 20(4): p. 366-75. 
106. Steed, D.L. and t.D.U. Study Group, Clinical evaluation of 
recombinant human platelet – derived growth factor for the treatment 
of lower extremity diabetic ulcers. Journal of Vascular Surgery, 1995. 
21(1): p. 71-81. 
107. Margolis, D.J., et al., Effectiveness of recombinant human platelet-
derived growth factor for the treatment of diabetic neuropathic foot 
ulcers. Wound Repair and Regeneration, 2005. 13(6): p. 531-536. 
108. Hunter, S., et al., Hyperbaric oxygen therapy for chronic wounds. Adv 
Skin Wound Care, 2010. 23(3): p. 116-9. 
109. Boykin, J.V. and C. Baylis, Hyperbaric Oxygen Therapy Mediates 
Increased Nitric Oxide Production Associated With Wound Healing: A 
Preliminary Study. Advances in skin & wound care, 2007. 20(7): p. 
382-388. 
110. R.N. Seetharam, Nanomedicine—emerging area of 
nanobiotechnology 
research. Current Science, 2006. 91(3): p. 260. 
111. Werner, S. and R. Grose, Regulation of wound healing by growth 
factors and cytokines. Physiol Rev, 2003. 83(3): p. 835-70. 
112. G. Lenz and P.Mansson, Growth factors as pharmaceuticals. 
Pharmaceutical technology, 1991. 15(1): p. 34-38. 
113. Senet, P., et al., Topical treatment of hypertensive leg ulcers with 
platelet-derived growth factor-BB: a randomized controlled trial. Arch 
Dermatol, 2011. 147(8): p. 926-30. 
114. MaHam, A., et al., Protein-Based Nanomedicine Platforms for Drug 
Delivery. Small, 2009. 5(15): p. 1706-1721. 
115. Carney, D.H., et al., Enhancement of incisional wound healing and 
neovascularization in normal rats by thrombin and synthetic thrombin 
receptor-activating peptides. Journal of Clinical Investigation, 1992. 
89(5): p. 1469-1477. 
116. Schaffer, M.R., et al., Nitric oxide, an autocrine regulator of wound 
fibroblast synthetic function. J Immunol, 1997. 158(5): p. 2375-81. 
117. Singer, A.J. and R.A. Clark, Cutaneous wound healing. N Engl J Med, 
1999. 341(10): p. 738-46. 
118. Baum, C.L. and C.J. Arpey, Normal cutaneous wound healing: clinical 
correlation with cellular and molecular events. Dermatol Surg, 2005. 
31(6): p. 674-86; discussion 686. 
119. Değim, Z., Use of microparticulate systems to accelerate skin wound 
healing. Journal of Drug Targeting, 2008. 16(6): p. 437-448. 
160 
 
120. Molineux, G., Pegylation: engineering improved pharmaceuticals for 
enhanced therapy. Cancer Treatment Reviews. 28: p. 13-16. 
121. Holland, T.A., et al., Transforming growth factor-β1 release from 
oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that 
model the cartilage wound healing environment. Journal of Controlled 
Release, 2004. 94(1): p. 101-114. 
122. Han, K., et al., Preparation and evaluation of poly(L-lactic acid) 
microspheres containing rhEGF for chronic gastric ulcer healing. J 
Control Release, 2001. 75(3): p. 259-69. 
123. Kawai, K., et al., Accelerated wound healing through the incorporation 
of basic fibroblast growth factor-impregnated gelatin microspheres 
into artificial dermis using a pressure-induced decubitus ulcer model 
in genetically diabetic mice. Br J Plast Surg, 2005. 58(8): p. 1115-23. 
124. Wei, G., et al., Nano-fibrous scaffold for controlled delivery of 
recombinant human PDGF-BB. Journal of controlled release : official 
journal of the Controlled Release Society, 2006. 112(1): p. 103-110. 
125. Qadan, M. and W.G. Cheadle, Common microbial pathogens in 
surgical practice. Surg Clin North Am, 2009. 89(2): p. 295-310, vii. 
126. Moghimi, S.M., A.C. Hunter, and J.C. Murray, Long-circulating and 
target-specific nanoparticles: theory to practice. Pharmacol Rev, 
2001. 53(2): p. 283-318. 
127. Hachicha, W., L. Kodjikian, and H. Fessi, Preparation of vancomycin 
microparticles: importance of preparation parameters. Int J Pharm, 
2006. 324(2): p. 176-84. 
128. Chakraborty, S.P., et al., Nanoconjugated vancomycin: new 
opportunities for the development of anti-VRSA agents. 
Nanotechnology, 2010. 21(10): p. 105103. 
129. Turos, E., et al., Antibiotic-conjugated polyacrylate nanoparticles: new 
opportunities for development of anti-MRSA agents. Bioorg Med 
Chem Lett, 2007. 17(1): p. 53-6. 
130. Melaiye, A. and W.J. Youngs, Silver and its application as an 
antimicrobial agent. Expert Opinion on Therapeutic Patents, 2005. 
15(2): p. 125-130. 
131. Jain, J., et al., Silver Nanoparticles in Therapeutics: Development of 
an Antimicrobial Gel Formulation for Topical Use. Molecular 
Pharmaceutics, 2009. 6(5): p. 1388-1401. 
132. Patra, C.R., et al., Targeted delivery of gemcitabine to pancreatic 
adenocarcinoma using cetuximab as a targeting agent. Cancer Res, 
2008. 68(6): p. 1970-8. 
133. Liu, X., et al., Silver nanoparticles mediate differential responses in 
keratinocytes and fibroblasts during skin wound healing. 
ChemMedChem, 2010. 5(3): p. 468-75. 
134. Prabhu, S. and E. Poulose, Silver nanoparticles: mechanism of 
antimicrobial action, synthesis, medical applications, and toxicity 
effects. International Nano Letters, 2012. 2(1): p. 1-10. 
135. Kim, I.-S., et al., Physicochemical characterization of poly(l-lactic 
acid) and poly(d,l-lactide-co-glycolide) nanoparticles with 
161 
 
polyethylenimine as gene delivery carrier. International Journal of 
Pharmaceutics, 2005. 298(1): p. 255-262. 
136. Mayo, A.S., B.K. Ambati, and U.B. Kompella, Gene delivery 
nanoparticles fabricated by supercritical fluid extraction of emulsions. 
Int J Pharm, 2010. 387(1-2): p. 278-85. 
137. Masotti, A. and G. Ortaggi, Chitosan micro- and nanospheres: 
fabrication and applications for drug and DNA delivery. Mini Rev Med 
Chem, 2009. 9(4): p. 463-9. 
138. Chellat, F., et al., Metalloproteinase and cytokine production by THP-
1 macrophages following exposure to chitosan-DNA nanoparticles. 
Biomaterials, 2005. 26(9): p. 961-70. 
139. Yang, F., et al., Genetic engineering of human stem cells for 
enhanced angiogenesis using biodegradable polymeric 
nanoparticles. Proceedings of the National Academy of Sciences, 
2010. 107(8): p. 3317-3322. 
140. Zhang, X. and Y. Lu, Centrifugal Spinning: An Alternative Approach 
to Fabricate Nanofibers at High Speed and Low Cost. Polymer 
Reviews, 2014. 54(4): p. 677-701. 
141. Zuo, F., et al., Nanofibers from Melt Blown Fiber-in-Fiber Polymer 
Blends. ACS Macro Letters, 2013. 2(4): p. 301-305. 
142. Kikutani, T., et al., High-speed melt spinning of bicomponent fibers: 
Mechanism of fiber structure development in poly(ethylene 
terephthalate)/polypropylene system. Journal of Applied Polymer 
Science, 1996. 62(11): p. 1913-1924. 
143. Nayak, R., et al., Recent advances in nanofibre fabrication 
techniques. Textile Research Journal, 2012. 82(2): p. 129-147. 
144. Wang, Y., et al., Template Synthesis of Carbon Nanofibers Containing 
Linear Mesocage Arrays. Nanoscale Research Letters, 2010. 5(6): p. 
913-916. 
145. Zhang, W., et al., Confined Self-Assembly Approach to Produce 
Ultrathin Carbon Nanofibers. Langmuir, 2009. 25(14): p. 8235-8239. 
146. Góra, A., et al., Melt-Electrospun Fibers for Advances in Biomedical 
Engineering, Clean Energy, Filtration, and Separation. Polymer 
Reviews, 2011. 51(3): p. 265-287. 
147. Huang, Z.-M., et al., A review on polymer nanofibers by 
electrospinning and their applications in nanocomposites. 
Composites Science and Technology, 2003. 63(15): p. 2223-2253. 
148. Ramakrishna, S., An Introduction to Electrospinning and Nanofibers. 
2005: World Scientific. 
149. Elmarco. Application areas: medicine. 2015; Available from: 
http://www.elmarco.com/application-areas/medicine/. 
150. Zhang, X., Fundamentals of Fiber Science. 2014: DEStech 
Publications, Incorporated. 
151. Bhardwaj, N. and S.C. Kundu, Electrospinning: A fascinating fiber 
fabrication technique. Biotechnology Advances, 2010. 28(3): p. 325-
347. 
152. Bit Na Lee, J.H.K., Heung Jae Chun and Moon Suk Kim, ed. Three-
Dimensional Nanofiber Scaffolds for Regenerative Medicine,. 
162 
 
Nanofibers - Production, Properties and Functional Applications, ed. 
D.T. Lin. 2011, InTech. 
153. Vatankhah, E., et al., Artificial neural network for modeling the elastic 
modulus of electrospun polycaprolactone/gelatin scaffolds. Acta 
Biomaterialia, 2014. 10(2): p. 709-721. 
154. Mirzaei, E., et al., Artificial neural networks modeling of 
electrospinning of polyethylene oxide from aqueous acid acetic 
solution. Journal of Applied Polymer Science, 2012. 125(3): p. 1910-
1921. 
155. Brooks, H. and N. Tucker, Electrospinning predictions using artificial 
neural networks. Polymer, 2015. 58(0): p. 22-29. 
156. Desgouilles, S., et al., The Design of Nanoparticles Obtained by 
Solvent Evaporation:  A Comprehensive Study. Langmuir, 2003. 
19(22): p. 9504-9510. 
157. Rosca, I.D., F. Watari, and M. Uo, Microparticle formation and its 
mechanism in single and double emulsion solvent evaporation. J 
Control Release, 2004. 99(2): p. 271-80. 
158. Yu, Y., et al., Antitumor activity of docetaxel-loaded polymeric 
nanoparticles fabricated by Shirasu porous glass membrane-
emulsification technique. Int J Nanomedicine, 2013. 8: p. 2641-52. 
159. Gallarate, M., et al., Peptide-Loaded Solid Lipid Nanoparticles 
Prepared through Coacervation Technique. International Journal of 
Chemical Engineering, 2011. 2011: p. 6. 
160. Li, H.Y. and F. Zhang, Preparation of nanoparticles by spray-drying 
and their use for efficient pulmonary drug delivery. Methods Mol Biol, 
2012. 906: p. 295-301. 
161. Zamani, M., M.P. Prabhakaran, and S. Ramakrishna, Advances in 
drug delivery via electrospun and electrosprayed nanomaterials. Int J 
Nanomedicine, 2013. 8: p. 2997-3017. 
162. Sridhar, R. and S. Ramakrishna, Electrosprayed nanoparticles for 
drug delivery and pharmaceutical applications. Biomatter, 2013. 3(3): 
p. e24281. 
163. Jaworek, A., Micro- and nanoparticle production by electrospraying. 
Powder Technology, 2007. 176(1): p. 18-35. 
164. Jaworek, A. and A.T. Sobczyk, Electrospraying route to 
nanotechnology: An overview. Journal of Electrostatics, 2008. 66(3–
4): p. 197-219. 
165. Hong, Y., et al., Electrohydrodynamic atomization of quasi-
monodisperse drug-loaded spherical/wrinkled microparticles. Journal 
of Aerosol Science, 2008. 39(6): p. 525-536. 
166. Ding, L., T. Lee, and C.-H. Wang, Fabrication of monodispersed 
Taxol-loaded particles using electrohydrodynamic atomization. 
Journal of Controlled Release, 2005. 102(2): p. 395-413. 
167. Xie, J., J.C. Marijnissen, and C.H. Wang, Microparticles developed by 
electrohydrodynamic atomization for the local delivery of anticancer 




168. Bussano, R., et al., Preparation and Characterization of Insulin-
Loaded Lipid-Based Microspheres Generated by Electrospray. 
Journal of Dispersion Science and Technology, 2011. 32(10): p. 
1524-1530. 
169. Juntapram, K., et al., Electrosprayed polyelectrolyte complexes 
between mucoadhesive N,N,N,-trimethylchitosan-homocysteine 
thiolactone and alginate/carrageenan for camptothecin delivery. 
Carbohydrate Polymers, 2012. 90(4): p. 1469-1479. 
170. Enayati, M., et al., One-step electrohydrodynamic production of drug-
loaded micro- and nanoparticles. Vol. 7. 2010. 667-675. 
171. Songsurang, K., et al., Electrospray fabrication of doxorubicin-
chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin. 
Archives of Pharmacal Research, 2011. 34(4): p. 583-592. 
172. Midhun, B.T., et al., Preparation of Budesonide-Loaded 
Polycaprolactone Nanobeads by Electrospraying for Controlled Drug 
Release. J Biomater Sci Polym Ed, 2010. 
173. Roine, J., et al., Dual-capillary electroencapsulation of mesoporous 
silicon drug carrier particles for controlled oral drug delivery. Journal 
of Electrostatics, 2012. 70(5): p. 428-437. 
174. Hazeri, N., H. Tavanai, and A.R. Moradi, Production and properties of 
electrosprayed sericin nanopowder. Science and Technology of 
Advanced Materials, 2012. 13(3): p. 035010. 
175. Unnithan, A.R., et al., Wound-dressing materials with antibacterial 
activity from electrospun polyurethane–dextran nanofiber mats 
containing ciprofloxacin HCl. Carbohydrate Polymers, 2012. 90(4): p. 
1786-1793. 
176. Zahedi, P., et al., A review on wound dressings with an emphasis on 
electrospun nanofibrous polymeric bandages. Polymers for Advanced 
Technologies, 2010. 21(2): p. 77-95. 
177. Paipitak, K., et al., Characterization of PVA-Chitosan Nanofibers 
Prepared by Electrospinning. Procedia Engineering, 2011. 8(0): p. 
101-105. 
178. Naseri, N., et al., Porous electrospun nanocomposite mats based on 
chitosan–cellulose nanocrystals for wound dressing: effect of surface 
characteristics of nanocrystals. Cellulose, 2015. 22(1): p. 521-534. 
179. Naseri, N., et al., Electrospun chitosan-based nanocomposite mats 
reinforced with chitin nanocrystals for wound dressing. Carbohydrate 
Polymers, 2014. 109(0): p. 7-15. 
180. Cai, Z.-x., et al., Fabrication of Chitosan/Silk Fibroin Composite 
Nanofibers for Wound-dressing Applications. International Journal of 
Molecular Sciences, 2010. 11(9): p. 3529. 
181. Torres-Giner, S., Novel Antimicrobials Obtained by Electrospinning 
Methods, in Antimicrobial Polymers. 2011, John Wiley & Sons, Inc. p. 
261-285. 
182. Kenawy, E.-R., et al., Release of tetracycline hydrochloride from 
electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a 
blend. Journal of Controlled Release, 2002. 81(1–2): p. 57-64. 
164 
 
183. Zeng, J., et al., Biodegradable electrospun fibers for drug delivery. 
Journal of Controlled Release, 2003. 92(3): p. 227-231. 
184. Kim, K., et al., Incorporation and controlled release of a hydrophilic 
antibiotic using poly(lactide-co-glycolide)-based electrospun 
nanofibrous scaffolds. Journal of Controlled Release, 2004. 98(1): p. 
47-56. 
185. Torres-Giner, S., et al., Controlled Delivery of Gentamicin Antibiotic 
from Bioactive Electrospun Polylactide-Based Ultrathin Fibers. 
Advanced Engineering Materials, 2012. 14(4): p. B112-B122. 
186. Bolgen, N., et al., In vivo performance of antibiotic embedded 
electrospun PCL membranes for prevention of abdominal adhesions. 
J Biomed Mater Res B Appl Biomater, 2007. 81(2): p. 530-43. 
187. Vega-Lugo, A.-C. and L.-T. Lim, Controlled release of allyl 
isothiocyanate using soy protein and poly(lactic acid) electrospun 
fibers. Food Research International, 2009. 42(8): p. 933-940. 
188. Kriegel, C., et al., Nanofibers as carrier systems for antimicrobial 
microemulsions. Part I: fabrication and characterization. Langmuir, 
2009. 25(2): p. 1154-61. 
189. Son, W.K., et al., Preparation of Antimicrobial Ultrafine Cellulose 
Acetate Fibers with Silver Nanoparticles. Macromolecular Rapid 
Communications, 2004. 25(18): p. 1632-1637. 
190. Kim, E., S. Kim, and C. Lee, Electrospinning of polylactide fibers 
containing silver nanoparticles. Macromolecular Research, 2010. 
18(3): p. 215-221. 
191. Thomas, R., et al., Electrospun Polycaprolactone Membrane 
Incorporated with Biosynthesized Silver Nanoparticles as Effective 
Wound Dressing Material. Applied Biochemistry and Biotechnology, 
2015: p. 1-12. 
192. Dong, G., et al., Preparation and characterization of Ag nanoparticle-
embedded polymer electrospun nanofibers. Journal of Nanoparticle 
Research, 2010. 12(4): p. 1319-1329. 
193. Liang, D., B.S. Hsiao, and B. Chu, Functional Electrospun 
Nanofibrous Scaffolds for Biomedical Applications. Advanced drug 
delivery reviews, 2007. 59(14): p. 1392-1412. 
194. Bai, J., et al., Electrospinning method for the preparation of silver 
chloride nanoparticles in PVP nanofiber. Applied Surface Science, 
2008. 254(15): p. 4520-4523. 
195. Tofoleanu, F., et al., Electrospun gelatin nanofibers functionalized 
with silver nanoparticles. Journal of optoelectronics and advanced 
materials, 2008. 10(12): p. 3512-3516. 
196. Makadia, H.K. and S.J. Siegel, Poly Lactic-co-Glycolic Acid (PLGA) 
as Biodegradable Controlled Drug Delivery Carrier. Polymers, 2011. 
3(3): p. 1377-1397. 
197. Kim, S. and I.H. Choi, Phagocytosis and endocytosis of silver 
nanoparticles induce interleukin-8 production in human 
macrophages. Yonsei Med J, 2012. 53(3): p. 654-7. 
165 
 
198. Yusop, A.H.M., et al., Controlling the degradation kinetics of porous 
iron by poly(lactic-co-glycolic acid) infiltration for use as temporary 
medical implants. Sci. Rep., 2015. 5. 
199. Wenk, H.R. and A. Bulakh, Minerals: Their Constitution and Origin. 
2004: Cambridge University Press. 
200. He, T., et al., Superconductivity in the non-oxide perovskite MgCNi3. 
Nature, 2001. 411(6833): p. 54-56. 
201. Bristowe, N.C., et al., Ferromagnetism induced by entangled charge 
and orbital orderings in ferroelectric titanate perovskites. Nat 
Commun, 2015. 6. 
202. Spinicci, R., et al., Catalytic activity of LaMnO3 and LaCoO3 
perovskites towards VOCs combustion. Journal of Molecular 
Catalysis A: Chemical, 2003. 197(1–2): p. 147-155. 
203. Green, M.A., A. Ho-Baillie, and H.J. Snaith, The emergence of 
perovskite solar cells. Nat Photon, 2014. 8(7): p. 506-514. 
204. Peña, M.A. and J.L.G. Fierro, Chemical Structures and Performance 
of Perovskite Oxides. Chemical Reviews, 2001. 101(7): p. 1981-2018. 
205. Momma, K. and F. Izumi, VESTA 3 for three-dimensional visualization 
of crystal, volumetric and morphology data. Journal of Applied 
Crystallography, 2011. 44(6): p. 1272-1276. 
206. Bailie, C.D., et al., Semi-transparent perovskite solar cells for 
tandems with silicon and CIGS. Energy & Environmental Science, 
2015. 8(3): p. 956-963. 
207. Sarikaya, A., V. Petrovsky, and F. Dogan, Silver Based Perovskite 
Nanocomposites as Combined Cathode and Current Collector Layers 
for Solid Oxide Fuel Cells. Journal of The Electrochemical Society, 
2012. 159(11): p. F665-F669. 
208. Zahir, M.H., et al., Perovskites with cotton-like morphology consisting 
of nanoparticles and nanorods: Their synthesis by the combustion 
method and their NOx adsorption behavior. Applied Catalysis A: 
General, 2009. 361(1–2): p. 86-92. 
209. Fu, D. and M. Itoh, Ferroelectricity in Silver Perovskite Oxides. 
Ferroelectrics - Material Aspects. 2011. 
210. Grinberg, I. and A.M. Rappe, Silver solid solution piezoelectrics. 
Applied Physics Letters, 2004. 85(10): p. 1760-1762. 
211. Mohseni, S., et al., Evaluation of antibacterial properties of Barium 
Zirconate Titanate (BZT) nanoparticle. Braz J Microbiol, 2014. 45(4): 
p. 1393-9. 
212. Hui, W., et al., Antibacterial Properties of V-doped Titanium-bearing 
Blast Furnace Slag Prepared at Different Calcination Temperatures. 
¹ý³Ì¹¤³ÌÑ§±¨, 2010. 
213. Zhang, L., et al., Antibacterial activities of mechanochemically 
synthesized perovskite strontium titanate ferrite metal oxide. Colloids 
and Surfaces A: Physicochemical and Engineering Aspects, 2014. 
456(0): p. 169-175. 
214. Tan, S.Z., et al., Synthesis and antibacterial activity of new layered 
perovskite compounds, AgxNa2−xLa2Ti3O10. Chinese Chemical 
Letters, 2007. 18(1): p. 85-88. 
166 
 
215. Tan, S.-z., et al., Structure and antibacterial activity of new layered 
perovskite compounds. Transactions of Nonferrous Metals Society of 
China, 2007. 17(2): p. 257-261. 
216. Sarabahi, S., Recent advances in topical wound care. Indian Journal 
of Plastic Surgery : Official Publication of the Association of Plastic 
Surgeons of India, 2012. 45(2): p. 379-387. 
217. Tseng, Y.Y., et al., Biodegradable poly( D,L -lactide-co-glycolide) 
nanofibers for the sustainable delivery of lidocaine into the epidural 
space after laminectomy. Nanomedicine, 2014. 9(1): p. 77-87. 
218. Wei, J., et al., Multiple drug-loaded electrospun PLGA/gelatin 
composite nanofibers encapsulated with mesoporous ZnO 
nanospheres for potential postsurgical cancer treatment. RSC 
Advances, 2014. 4(53): p. 28011-28019. 
219. Almajhdi, F.N., et al., In-vitro anticancer and antimicrobial activities of 
PLGA/silver nanofiber composites prepared by electrospinning. 
Journal of Materials Science-Materials in Medicine, 2014. 25(4): p. 
1045-1053. 
220. Chaubey, N., et al., Silver nanoparticle loaded PLGA composite 
nanoparticles for improving therapeutic efficacy of recombinant 
IFN[gamma] by targeting the cell surface. Biomaterials Science, 2014. 
2(8): p. 1080-1089. 
221. Gungor-Ozkerim, P.S., et al., Incorporation of growth factor loaded 
microspheres into polymeric electrospun nanofibers for tissue 
engineering applications. Journal of Biomedical Materials Research 
Part A, 2014. 102(6): p. 1897-1908. 
222. Jiang, J., et al., Mussel-inspired protein-mediated surface 
functionalization of electrospun nanofibers for pH-responsive drug 
delivery. Acta Biomaterialia, 2014. 10(3): p. 1324-1332. 
223. Wang, H.L., et al., Synthesis, Antimicrobial Activity, and Release of 
Tetracycline Hydrochloride Loaded Poly(vinylalcohol)/Soybean 
Protein Isolate/Zirconium Dioxide Nanofibrous Membranes. Journal 
of Applied Polymer Science, 2014. 131(20): p. 8. 
224. WorldHealthOrganization, Prevention of hospital-acquired infections. 
2002. 
225. Mansbridge, J., Skin tissue engineering. J Biomater Sci Polym Ed, 
2008. 19(8): p. 955-68. 
226. Lee, S.B., et al., Study of gelatin-containing artificial skin V: fabrication 
of gelatin scaffolds using a salt-leaching method. Biomaterials, 2005. 
26(14): p. 1961-1968. 
227. Liu, P., et al., Tissue-engineered skin containing mesenchymal stem 
cells improves burn wounds. Artif Organs, 2008. 32(12): p. 925-31. 
228. Cui, W., et al., Evaluation of electrospun fibrous scaffolds of poly(dl-
lactide) and poly(ethylene glycol) for skin tissue engineering. 
Materials Science and Engineering: C, 2009. 29(6): p. 1869-1876. 
229. Altankov, G., et al., Modulating the biocompatibility of polymer 
surfaces with poly(ethylene glycol): Effect of fibronectin. Journal of 
Biomedical Materials Research, 2000. 52(1): p. 219-230. 
167 
 
230. Dahlin, R.L., F.K. Kasper, and A.G. Mikos, Polymeric nanofibers in 
tissue engineering. Tissue Eng Part B Rev, 2011. 17(5): p. 349-64. 
231. Srinivasan, S., et al., Multiscale Fibrous Scaffolds in Regenerative 
Medicine, in Biomedical Applications of Polymeric Nanofibers, R. 
Jayakumar and S. Nair, Editors. 2012, Springer Berlin Heidelberg. p. 
1-20. 
232. Smith, L.A., X. Liu, and P.X. Ma, Tissue engineering with nano-fibrous 
scaffolds. Soft Matter, 2008. 4(11): p. 2144-2149. 
233. Lu, L., et al., In vitro and in vivo degradation of porous poly(DL-lactic-
co-glycolic acid) foams. Biomaterials, 2000. 21(18): p. 1837-45. 
234. Houchin, M.L. and E.M. Topp, Chemical degradation of peptides and 
proteins in PLGA: A review of reactions and mechanisms. Journal of 
Pharmaceutical Sciences, 2008. 97(7): p. 2395-2404. 
235. Ger, T.R., et al., Study of polyvinyl alcohol nanofibrous membrane by 
electrospinning as a magnetic nanoparticle delivery approach. 
Journal of Applied Physics, 2014. 115(17): p. 3. 
236. Shen, L.K., et al., Fabrication and magnetic testing of a poly-L-lactide 
biocomposite incorporating magnetite nanoparticles. Journal of 
Polymer Engineering, 2014. 34(3): p. 231-235. 
237. Khalil Abdelrazek Khalil, H.F., T. Elsarnagawy, Fahad N. Almajhdi, 
Preparation and Characterization of Electrospun PLGA/silver 
Composite Nanofibers for Biomedical Applications. Int. J. 
Electrochem. Sci., 2013. 8(3): p. 3483-3493. 
238. Xu, X., et al., Fabrication of biodegradable electrospun poly(L-lactide-
co-glycolide) fibers with antimicrobial nanosilver particles. J Nanosci 
Nanotechnol, 2008. 8(10): p. 5066-70. 
239. Sondi, I. and B. Salopek-Sondi, Silver nanoparticles as antimicrobial 
agent: a case study on E. coli as a model for Gram-negative bacteria. 
J Colloid Interface Sci, 2004. 275(1): p. 177-82. 
240. Schneider, C.A., W.S. Rasband, and K.W. Eliceiri, NIH Image to 
ImageJ: 25 years of image analysis. Nat Methods, 2012. 9(7): p. 671-
5. 
241. Yarin, A.L., S. Koombhongse, and D.H. Reneker, Taylor cone and 
jetting from liquid droplets in electrospinning of nanofibers. Journal of 
Applied Physics, 2001. 90(9): p. 4836-4846. 
242. Angammana, C.J. and S.H. Jayaram. Analysis of the Effects of 
Solution Conductivity on Electro-Spinning Process and Fiber 
Morphology. in Industry Applications Society Annual Meeting, 2008. 
IAS '08. IEEE. 2008. 
243. Taheri, S., et al., Synthesis and antibacterial properties of a hybrid of 
silver-potato starch nanocapsules by miniemulsion/polyaddition 
polymerization. Journal of Materials Chemistry B, 2014. 2(13): p. 
1838-1845. 
244. C. D’Avila Carvalho Erbetta, R.J.A., J. Magalhães Resende, R. 
Fernando de Souza Freitas and R. Geraldo de Sousa,, Synthesis and 
Characterization of Poly(D,L-Lactide-co-Glycolide) Copolymer. 




245. Bhui, D.K., et al., Synthesis and UV–vis spectroscopic study of silver 
nanoparticles in aqueous SDS solution. Journal of Molecular Liquids, 
2009. 145(1): p. 33-37. 
246. Kunkely, H. and A. Vogler, Photooxidation of N,N′-bis(3,5-di-tert.-
butylsalicylidene)-1,2-diamino hexane-manganese(III) chloride 
(Jacobsen catalyst) in chloroform. Inorganic Chemistry 
Communications, 2001. 4(12): p. 692-694. 
247. Hunt, H.D. and W.T. Simpson, Spectra of Simple Amides in the 
Vacuum Ultraviolet1. Journal of the American Chemical Society, 
1953. 75(18): p. 4540-4543. 
248. Shin, H.J., et al., Electrospun PLGA nanofiber scaffolds for articular 
cartilage reconstruction: mechanical stability, degradation and cellular 
responses under mechanical stimulation in vitro. Journal of 
Biomaterials Science, Polymer Edition, 2006. 17(1-2): p. 103-119. 
249. Yao, J., C. Bastiaansen, and T. Peijs, High Strength and High 
Modulus Electrospun Nanofibers. Fibers, 2014. 2(2): p. 158-186. 
250. Nadworny, P.L., et al., Anti-inflammatory activity of nanocrystalline 
silver in a porcine contact dermatitis model. Nanomedicine: 
Nanotechnology, Biology and Medicine, 2008. 4(3): p. 241-251. 
251. Tse, C., et al., Enhanced optical breakdown in KB cells labeled with 
folate-targeted silver-dendrimer composite nanodevices. 
Nanomedicine: Nanotechnology, Biology and Medicine, 2011. 7(1): p. 
97-106. 
252. Inbathamizh, L., T.M. Ponnu, and E.J. Mary, In vitro evaluation of 
antioxidant and anticancer potential of Morinda pubescens 
synthesized silver nanoparticles. Journal of Pharmacy Research, 
2013. 6(1): p. 32-38. 
253. Kubiak, K.J., et al., Wettability versus roughness of engineering 
surfaces. Wear, 2011. 271(3–4): p. 523-528. 
254. Ning Wu, Y.S., Yanan Jiao, Li Chen, Effect of Inorganic/Organic 
Hybrid on the Wettability of Polymer Nanofibrous Membranes. Journal 
of Engineered Fibers and Fabrics, 2013. 8(4): p. 1-5. 
255. Silver, F.H., J.W. Freeman, and D. DeVore, Viscoelastic properties of 
human skin and processed dermis. Skin Res Technol, 2001. 7(1): p. 
18-23. 
256. Jacquemoud, C., K. Bruyere-Garnier, and M. Coret, Methodology to 
determine failure characteristics of planar soft tissues using a 
dynamic tensile test. Journal of Biomechanics, 2007. 40(2): p. 468-
475. 
257. Ní Annaidh, A., et al., Characterization of the anisotropic mechanical 
properties of excised human skin. Journal of the Mechanical Behavior 
of Biomedical Materials, 2012. 5(1): p. 139-148. 
258. McDonald, P.F., et al., Physical and Mechanical Properties of Blends 
Based on Poly (dl-lactide), Poly (l-lactide-glycolide) and Poly (ϵ-
caprolactone). Polymer-Plastics Technology and Engineering, 2010. 
49(7): p. 678-687. 
169 
 
259. Kim, J.S., et al., Antimicrobial effects of silver nanoparticles. 
Nanomedicine: Nanotechnology, Biology and Medicine, 2007. 3(1): p. 
95-101. 
260. Danilczuk, M., et al., Conduction electron spin resonance of small 
silver particles. Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy, 2006. 63(1): p. 189-191. 
261. Rinaldi, S., et al., Integrated PLGA–Ag nanocomposite systems to 
control the degradation rate and antibacterial properties. Journal of 
Applied Polymer Science, 2013. 130(2): p. 1185-1193. 
262. Mohiti-Asli, M., B. Pourdeyhimi, and E.G. Loboa, Novel, silver-ion-
releasing nanofibrous scaffolds exhibit excellent antibacterial efficacy 
without the use of silver nanoparticles. Acta Biomaterialia, 2014. 
10(5): p. 2096-2104. 
263. Gliga, A., et al., Size-dependent cytotoxicity of silver nanoparticles in 
human lung cells: the role of cellular uptake, agglomeration and Ag 
release. Particle and Fibre Toxicology, 2014. 11(1): p. 11. 
264. Peter Vowden, K.V., Keryln Carville, Antimicrobials Made Easy. 
Wounds International, 2011. 2(1). 
265. David Parsons; Philip G. Bowler; Viv Myles; Samantha Jones, Silver 
Antimicrobial Dressings in Wound Management: A Comparison of 
Antibacterial, Physical, and Chemical Characteristics. Wounds, 2005. 
17(8): p. 222-232. 
266. Rai, M.K., et al., Silver nanoparticles: the powerful nanoweapon 
against multidrug-resistant bacteria. J Appl Microbiol, 2012. 112(5): p. 
841-52. 
267. Mitzi, D.B., Synthesis, Structure, and Properties of Organic-Inorganic 
Perovskites and Related Materials, in Progress in Inorganic 
Chemistry. 2007, John Wiley & Sons, Inc. p. 1-121. 
268. Burn, P.L. and P. Meredith, The rise of the perovskites: the future of 
low cost solar photovoltaics[quest]. NPG Asia Mater, 2014. 6: p. e79. 
269. Snaith, H.J., Perovskites: The Emergence of a New Era for Low-Cost, 
High-Efficiency Solar Cells. The Journal of Physical Chemistry 
Letters, 2013. 4(21): p. 3623-3630. 
270. Kanhere, P. and Z. Chen, A Review on Visible Light Active Perovskite-
Based Photocatalysts. Molecules, 2014. 19(12): p. 19995. 
271. Chen, X. and S.S. Mao, Titanium Dioxide Nanomaterials:  Synthesis, 
Properties, Modifications, and Applications. Chemical Reviews, 2007. 
107(7): p. 2891-2959. 
272. Jesline, A., et al., Antimicrobial activity of zinc and titanium dioxide 
nanoparticles against biofilm-producing methicillin-resistant 
Staphylococcus aureus. Applied Nanoscience, 2015. 5(2): p. 157-
162. 
273. Hassan, M.S., et al., Fabrication, characterization and antibacterial 
effect of novel electrospun TiO2 nanorods on a panel of pathogenic 
bacteria. J Biomed Nanotechnol, 2012. 8(3): p. 394-404. 
274. Percival, S.L., P.G. Bowler, and D. Russell, Bacterial resistance to 
silver in wound care. J Hosp Infect, 2005. 60(1): p. 1-7. 
170 
 
275. Jung, W.K., et al., Antibacterial Activity and Mechanism of Action of 
the Silver Ion in Staphylococcus aureus and Escherichia coli. Applied 
and Environmental Microbiology, 2008. 74(7): p. 2171-2178. 
276. Tiwari, D.K., T. Jin, and J. Behari, Dose-dependent in-vivo toxicity 
assessment of silver nanoparticle in Wistar rats. Toxicol Mech 
Methods, 2011. 21(1): p. 13-24. 
277. De Jong, W.H., et al., Systemic and immunotoxicity of silver 
nanoparticles in an intravenous 28 days repeated dose toxicity study 
in rats. Biomaterials, 2013. 34(33): p. 8333-43. 
278. Li, Z. and C. Wang, Introduction of Electrospinning, in One-
Dimensional nanostructures. 2013, Springer Berlin Heidelberg. p. 1-
13. 
279. Zamani, M., et al., Protein encapsulated core-shell structured 
particles prepared by coaxial electrospraying: investigation on 
material and processing variables. Int J Pharm, 2014. 473(1-2): p. 
134-43. 
280. Leung, V., et al., Bioactive nanofibres for wound healing applications. 
J Fiber Bioeng Informat, 2011. 4: p. 1-14. 
281. Pan, Z. and J. Ding, Poly(lactide-co-glycolide) porous scaffolds for 
tissue engineering and regenerative medicine. Vol. 2. 2012. 366-377. 
282. Gentile, P., et al., An Overview of Poly(lactic-co-glycolic) Acid 
(PLGA)-Based Biomaterials for Bone Tissue Engineering. 
International Journal of Molecular Sciences, 2014. 15(3): p. 3640-
3659. 
283. Toda, K., J. Watanabe, and M. Sato, Synthesis and ionic conductivity 
of new layered perovskite compound, Ag2La2Ti3O10. Solid State 
Ionics, 1996. 90(1–4): p. 15-19. 
284. Toda, K., J. Watanabe, and M. Sato, Crystal structure determination 
of ion-exchangeable layered perovskite compounds, K2La2Ti3O10 
and Li2La2Ti3O10. Materials Research Bulletin, 1996. 31(11): p. 
1427-1435. 
285. Gopalakrishnan, J. and V. Bhat, A2Ln2Ti3O10 (A = potassium or 
rubidium; Ln = lanthanum or rare earth): a new series of layered 
perovskites exhibiting ion exchange. Inorganic Chemistry, 1987. 
26(26): p. 4299-4301. 
286. Kapuscinski, J., DAPI: a DNA-specific fluorescent probe. Biotech 
Histochem, 1995. 70(5): p. 220-33. 
287. Frickmann, H., E. Schröpfer, and G. Dobler, Actin assessment in 
addition to specific immuno-fluorescence staining to demonstrate 
rickettsial growth in cell culture. European Journal of Microbiology & 
Immunology, 2013. 3(3): p. 198-203. 
288. Burridge, K., et al., Focal adhesions: transmembrane junctions 
between the extracellular matrix and the cytoskeleton. Annu Rev Cell 
Biol, 1988. 4: p. 487-525. 
289. Hodgkinson, T., X.-F. Yuan, and A. Bayat, Electrospun silk fibroin 
fiber diameter influences in vitro dermal fibroblast behavior and 
promotes healing of ex vivo wound models. Journal of Tissue 
Engineering, 2014. 5: p. 2041731414551661. 
171 
 
290. Agache, P.G., et al., Mechanical properties and Young's modulus of 
human skin in vivo. Archives of Dermatological Research, 1980. 
269(3): p. 221-232. 
291. Góra, A., et al., Silver nanoparticle incorporated poly(l-lactide-co-
glycolide) nanofibers: Evaluation of their biocompatibility and 
antibacterial properties. Journal of Applied Polymer Science, 2015: p. 
n/a-n/a. 
292. Jeong, L., et al., Cellular response of silk fibroin nanofibers containing 
silver nanoparticles In vitro. Macromolecular Research, 2014. 22(7): 
p. 796-803. 
293. Jones, V., J.E. Grey, and K.G. Harding, Wound dressings. BMJ : 
British Medical Journal, 2006. 332(7544): p. 777-780. 
294. Lukáš, D., et al., Physical principles of electrospinning 
(Electrospinning as a nano-scale technology of the twenty-first 
century). Textile Progress, 2009. 41(2): p. 59-140. 
295. Xu, S.-C., et al., A battery-operated portable handheld electrospinning 
apparatus. Nanoscale, 2015. 7(29): p. 12351-12355. 
296. Reneker, D.H. and A.L. Yarin, Electrospinning jets and polymer 
nanofibers. Polymer, 2008. 49(10): p. 2387-2425. 
297. Garg, K. and G.L. Bowlin, Electrospinning jets and nanofibrous 
structures. Biomicrofluidics, 2011. 5(1): p. 013403. 
298. Lee, J. and K.A. Sallam, Three-dimensional trajectory of electrospun 
polymer solution jet using digital holographic microscopy. Polymer 
Engineering & Science, 2014. 54(8): p. 1765-1773. 
299. Jaeger, R., et al., Electrospinning of ultra-thin polymer fibers. 
Macromolecular Symposia, 1998. 127(1): p. 141-150. 
300. Collins, G., et al., Charge generation, charge transport, and residual 
charge in the electrospinning of polymers: A review of issues and 
complications. Journal of Applied Physics, 2012. 111(4): p. 044701. 
301. Catalani, L.H., G. Collins, and M. Jaffe, Evidence for Molecular 
Orientation and Residual Charge in the Electrospinning of 
Poly(butylene terephthalate) Nanofibers. Macromolecules, 2007. 
40(5): p. 1693-1697. 
302. He, J., et al., Combined application of multinozzle air-jet 
electrospinning and airflow twisting for the efficient preparation of 
continuous twisted nanofiber yarn. Fibers and Polymers, 2015. 16(6): 
p. 1319-1326. 
303. McClure, M.J., et al., The use of air-flow impedance to control fiber 
deposition patterns during electrospinning. Biomaterials, 2012. 33(3): 
p. 771-9. 
304. Fridrikh, S.V., et al., Controlling the fiber diameter during 
electrospinning. Phys Rev Lett, 2003. 90(14): p. 144502. 
 
